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ABSTRACT 
Global mRNA translation impairment has been described during the course of 
apoptosis in both mammalian and yeast. Nevertheless, the molecular pathways 
modulating translation during different scenarios of yeast apoptosis are still largely 
unexplored. Here we show by polysome profile analysis an impairment in cap-
dependent translation initiation, correlated with alterations in translation 
machinery, such as the decrease in eIF4A levels and the phosphorylation of eIF2 
by Gcn2 protein kinase upon acetic acid treatment. Gcn2p proved to play a 
preponderant role for the progression of the acetic acid-induced apoptosis, not only 
through the repression of cap-dependent translation initiation, but also by the 
induction of a cell cycle arrest in G0/G1 phase. Despite the observed impairment of 
cap-dependent translation initiation, some mRNAs, such as AIF1 and eIF4G, were 
translated during acetic acid treatment. eIF4G harbors an IRES in the 5’ 
untranslated region (5’UTR) of the mRNA allowing its translation by a cap-
independent IRES-mediated translation, being also crucial for an efficient IRES-
mediated translation of other mRNAs. The inhibition of the cap-dependent 
translation initiation associated with the observation of AIF1 and eIF4G efficient 
translation during acetic acid treatment made us question the possibility of an 
alternative IRES-mediated translation occur during acetic acid treatment.  
Furthermore, the translation machinery alterations proved to be dependent of 
the yeast caspase like protease, metacaspase, which induced also the specific 
fragmentation of the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH). Although metacaspase role in the induction of the apoptosis is well 
established, its specific substrates were still unknown. The fact that GAPDH is 
specifically cleaved by metacaspase, suggests a role of this enzyme in the 
apoptotic process. In mammalian cells, GAPDH interacts with some virus and 
cellular mRNAs repressing their internal ribosome entry site (IRES)-mediated 
translation. GAPDH cleavage by caspase-1 during apoptosis suggests a regulation 
of its function by derepression of the IRES-mediated translation.  
Upon the inhibition of translation initiation during acetic acid treatment, 
eEF1A, a translation elongation factor responsible for the delivery of aminoacyl-
tRNAs to the ribosomes, appears to play a function unrelated to translation 
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elongation. A proteomic analysis combined with a proteinase K assay showed that 
upon acetic acid treatment, eEF1A is fragmented and the eEF1A N-terminal 
fragments are present in mitochondria where they appear to play a pro-apoptotic 
role. Apart from its role in translation this protein is also an actin-binding protein 
being responsible for the actin cytoskeleton organization. This re-localization to 
mitochondria reduces its binding to actin leading to actin cytoskeleton alterations 
which proved to be conserved from yeast to mammalian cells. 
Our previously reported proteomic analysis in the same apoptotic conditions 
revealed an increased expression of heat shock protein 90 (HSP90) isoforms. We 
herein demonstrate by microarray analysis of polysomal mRNAs combined with the 
HSP90 isoforms 5’ untranslated region (5’UTR) expression in monocistronic 
reporter plasmids harboring an hairpin, that HSP90 isoforms are translated by a 
cap-independent mechanism mediated by (IRES) elements. Moreover, genetic 
abrogation of HSP90 isoforms indicate divergent roles for HSP90 isoforms, Hsc82 
acts as a pro-survival and Hsp82 as a pro-death molecule, upon the acetic acid 
treatment. In fact, the deletion of HSC82 leads to a severe necrotic cell death, in 
spite of an apoptotic cell death, upon acetic acid treatment. These undisclosed 
functions of yeast HSP90 isoforms were confirmed through pharmacological 
inhibition of HSP90 activity, using 17-allylaminogeldanamycin (17AGG), and by 
the overexpression of each HSP90 isoform during acetic acid. These results 
suggest that the efficiency of HSP90 isoforms mRNA translation is an important 
component of the cellular response to acetic acid. In summary, the results 
presented in the scope of this thesis contributed to the understanding of the 
translation mechanisms regulating yeast cell death processes. 
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RESUMO 
A inibição global da tradução foi descrita no decurso da apoptose tanto em 
leveduras como em mamíferos No entanto, as vias moleculares que modulam a 
tradução em diferentes cenários de morte celular programada (MCP) em levedura 
são ainda desconhecidas. Neste trabalho demonstramos, através de perfis 
polissomais, uma inibição da iniciação da tradução dependente da estrutura cap, 
correlacionada com alterações na maquinaria de tradução, tais como a redução 
dos níveis de eIF4A e a fosforilação do eIF2 mediada pela cinase Gcn2p, durante 
o tratamento com ácido acético. Gcn2p provou desempenhar um papel relevante 
na progressão da morte induzida por ácido acético não só pela repressão da 
iniciação da tradução dependente de cap mas também através da indução de um 
bloqueio do ciclo celular na fase G0/G1. Apesar da diminuição da iniciação da 
tradução dependente de cap, alguns mRNAs, tais como o AIF1 e o eIF4G, são 
traduzidos durante o tratamento com ácido acético. eIF4G possui um internal 
ribosome entry site (IRES) na região 5' não traduzida (5'UTR) do mRNA o que 
permite a sua tradução independente de cap, sendo também fundamental para a 
tradução eficiente de outros mRNAs regulados por IRES. A inibição da iniciação da 
tradução dependente de cap associada à observação da tradução de AIF1 e eIF4G 
levanta a possibilidade da ocorrência de uma tradução alternativa mediada por 
IRES durante o tratamento com ácido acético. Para além disso, as alterações na 
maquinaria de tradução observadas durante o tratamento com ácido acético 
parecem ser dependentes da ação da caspase de leveduras, a metacaspase, que 
provou ser ainda responsável pela clivagem específica da enzima glicolítica 
gliceraldeído-3-fosfato desidrogenase (GAPDH). Embora a importância da 
metacaspase na execução da apoptose esteja bem estabelecida, os substratos 
desta protease são ainda desconhecidos. O fato da GAPDH ser especificamente 
clivada pela metacaspase, sugere um papel desta enzima no processo apoptótico. 
Em mamíferos, a GAPDH interage com alguns mRNAs celulares e de vírus inibindo 
a sua tradução mediada por IRES. A clivagem da GAPDH pela caspase-1 durante a 
apoptose sugere uma regulação da sua função na tradução e a desrepressão da 
tradução mediada por IRES. Após a inibição da iniciação da tradução durante o 
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tratamento com ácido acético, o fator de elongação da tradução eEF1A, 
responsável pela entrega dos aminoacil-tRNAs nos ribossomas, parece 
desempenhar uma função independente do processo de tradução. Uma análise 
proteómica em conjunto com um ensaio de proteinase K mostraram que, após o 
tratamento das células com ácido acético, o eEF1A é fragmentado e os fragmentos 
N-terminais de eEF1A são detetados na matriz mitocondrial onde parecem 
desempenhar um papel pró-apoptótico. Para além da sua participação no processo 
de tradução esta proteína está também associada à actina sendo responsável pela 
organização do citoesqueleto de actina. A relocalização para a mitocôndria reduz a 
sua ligação à actina induzindo alterações no citoesqueleto de actina que provaram 
ser conservados tanto em levedura como em mamíferos. 
Anteriormente, uma análise proteómica, nas mesmas condições apoptóticas, 
revelou um aumento dos níveis das isoformas da proteína de choque térmico 90 
(HSP90). A análise de microarrays dos mRNAs presentes em frações polissomais 
complementada com a expressão dos 5’UTR das isoformas da HSP90 em 
plasmídeos monocistrónicos contendo um gancho no 5’UTR, demonstrou a 
presença de IRES no 5’UTR das HSP90 mediando a sua tradução independente de 
cap. A deleção genética das isoformas das Hsp90 sugere que estas desempenham 
funções divergentes durante o tratamento com ácido acético, Hsc82p atua como 
uma molécula de sobrevivência e Hsp82p como uma molécula pró-apoptótica. 
Além disso, a deleção da HSC82 conduz a uma drástica morte celular necrótica 
durante o tratamento com ácido acético, sugerindo que estas isoformas são 
cruciais para o balanço e equilíbrio entre a apoptose e a necrose. Estas novas 
funções das isoformas da HSP90 foram confirmadas através da inibição 
farmacológica da atividade das HSP90, utilizando 17-allylaminogeldanamycin 
(17AGG), e da sobreexpressão de cada isoforma em células tratadas com ácido 
acético. Estes resultados sugerem que a eficiência de tradução do mRNA das 
isoformas da HSP90 é um componente importante da resposta celular ao ácido 
acético. Em resumo, os resultados apresentados no âmbito desta tese contribuíram 
para o aumento do conhecimento dos mecanismos de tradução que regulação 
processo apoptótico em levedura. 
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OBJECTIVES AND OUTLINE OF THE THESIS 
In mammalian cells, posttranslational modifications and cleavage of 
translation factors by caspases during programmed cell death (PCD) lead to the 
impairment of cap-dependent translation. Nevertheless, a selective internal 
ribosome entry site (IRES) mediated translation is activated regulating the 
expression of PCD regulators, both anti- and pro-apoptotic proteins. 
In yeast, a conservation of the alternative translation mechanisms regulating 
PCD is far from being completely disclosed. Despite the report that the 
fragmentation of translation factors occurs in different scenarios of yeast PCD, the 
role of yeast metacaspase in alterations and the evaluation of alternative translation 
mechanisms controlling yeast PCD have never been addressed. 
The work reported in this thesis aimed to get new insights on the yeast 
translation regulatory mechanisms activated during PCD and on the proteins 
translated by these mechanisms as well as their contribution for the PCD process.  
With the intention to drive the reader through the main achievements, this 
thesis was organized in five chapters: 
In chapter 1, a general introduction mainly centered on the knowledge of the 
PCD processes and the translation regulatory mechanisms of PCD will be given.  
In chapter 2, a characterization of the translation process and translation 
regulators modulating acetic acid-induced PCD, will be done. 
In chapter 3, insights on the conservation of molecular pathways targeted by 
proteases during yeast apoptosis will be exposed. Furthermore, results are 
presented suggesting a new pro-apoptotic function of translation elongation factor 
1A (eEF1A) upon acetic acid-induced apoptosis. 
In chapter 4, results will be presented indicating that heat shock protein 90 
(HSP90) chaperones isoforms are translated by an IRES-mediated cap-
independent mechanism during acetic acid treatment, playing antagonistic roles in 
yeast PCD. 
Finally, chapter 5 comprises an integrative discussion focused on the main 
contributions of the present work to the understanding of the yeast PCD processes, 
combined with future perspectives. 
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           CHAPTER 1 
General introduction 
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1.1 PROGRAMMED CELL DEATH (PCD)  
The crucial role of cell death in the cellular homeostasis has been widely described 
[6-8], however, it was only recognized after the discovery that cell death in 
multicellular organisms is subjected to genetic control, and the demonstration that 
abnormalities in cell death regulation lead to the onset of several diseases, 
including neurodegenerative diseases and several forms of cancer [6, 9-12]. The 
first description of the programmed cell death (PCD) process and its role in cellular 
homeostasis was in the 1960s when an insect physiologist, Carrol M. Williams, 
and his group referred for the first time to PCD, meaning that cells followed a 
sequence of controlled (and thereby implicitly genetic) steps towards their own 
destruction [13]. In 1972, John Kerr and coworkers generalized the idea that cell 
death followed a specific pattern that included shrinkage of the cell, apparently 
little damage to the organelles, coalescence and margination of chromatin and 
fragmentation of the cell and the nucleus [14]. These observations suggested that 
the ritualistic nature of cell death implied an organized and conserved mechanism: 
cell death was an aspect of life like any other [14]. Further reports followed, 
describing two distinct types of PCD, apoptosis and necrosis, based on 
morphological and biochemical criteria [12, 13, 15-19]. Apoptosis is the best 
studied and described type of PCD. The term apoptosis emerged in the early 1970 
[14], although the phenomenon of apoptosis had been described already in the 
late 1700s. The word, apoptosis, is derived from Greek roots meaning, "dropping 
off" e.g. falling of leaves. The genetics and molecular mechanisms of apoptosis 
were first characterized in the late 1980s and early 1990s in studies using the 
nematode worm Caenorhabditis elegans. Apoptosis during C. elegans development 
is extremely precise and predictable specific genes are activated to kill exactly 131 
cells, leaving 959 in the adult worm [20-22]. In other words, apoptosis is an 
evolutionarily conserved, genetically regulated, cellular suicide mechanism that 
plays a crucial role in development and in the defence of homeostasis.  
For many years necrosis was considered as an alternative to apoptotic programmed 
cell death [18, 23]. However, in the last decade, necrosis has becoming accepted 
as a form of active and controlled PCD [18, 23-28] that under pathophysiological 
conditions, amplifies and catalyzes the pathological process therefore activating an 
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inflammatory response [18, 23]. The morphology of necrotic cells is very distinct 
from that of cells undergoing apoptosis. Structural changes occur both at the 
cytoplasm and the nucleus [18, 19, 23-31], chromatin flocculates and plasma 
membrane integrity is compromised releasing the cytoplasmic contents into the 
extracellular space leading to inflammation [18]. Unlike in apoptosis, the 
chromatin is not packed into discrete membrane-bound particles, but it forms 
many unevenly textured and irregularly shaped clumps, a feature that is being used 
for differentiating between the two modes of cell death. The mitochondria undergo 
inner membrane swelling and disintegration. Polyribosomes are dissociated and 
dispersed throughout the cytoplasm, giving the cytoplasmic matrix a dense and 
granular appearance and swelling and fragmentation of the cisterns of rough 
endoplasmic reticulum and Golgi apparatus are frequently observed. Necrotic cell 
death can be mediated by passive as well as active mechanisms. However, the 
molecules involved in the active mechanisms are just starting to be identified [18, 
23-28]. The involvement of the death domain receptors like tumour necrosis factor 
(TNF) receptor 1 (TNFR1), Fas/CD95 and TRAIL-R or toll like receptors (TLR) 3 
and 4 in the activation of necrosis by a mechanism dependent on the kinase RIP1 
has been described [25, 32-34].  
During the apoptotic PCD, characteristic morphological alterations are also 
observed, such as cytoplasmic shrinkage, nuclear condensation and cytoplasmic 
blebbing. These initial changes are followed by fragmentation of the nuclear 
contents and subsequent encapsulation of these fragments into apoptotic bodies 
[12, 14, 15, 19, 30], which are quickly phagocytised and digested by 
neighbouring cells or macrophages [12, 14, 35, 36]. As no cytosolic contents are 
released into the intercellular medium during apoptosis, inflammation is not 
triggered [39]. 
Biochemically, apoptotic cells are characterized by the production of reactive 
oxygen species (ROS), reduction in the mitochondrial transmembrane potential, 
intracellular acidification, externalization of phosphatidylserine for the 
cytoplasmatic outer membrane, selective proteolysis of a subset of cellular proteins, 
and degradation of DNA into internucleosomal fragments [9, 12, 15, 37]. These 
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characteristic manifestations of apoptosis reflect the activation of an intrinsic cell 
death apparatus well conserved in eukaryotes [3, 12, 20-22, 26, 36, 38-41].  
During apoptosis, a proteolytic system involving a family of proteases called 
caspases is activated [42-45]. Caspases are aspartate-specific cysteine proteases 
responsible for the cleavage of key enzymatic and structural substrates, resulting in 
the systematic and orderly disassembly of the dying cell [42-48]. These proteases 
were first implicated in apoptosis by genetic analysis in the nematode C. elegans, 
in which the deletion of a single gene, CED-3, resulted in the abrogation of PCD in 
the 131 cells normally undergoing apoptosis during the worm's development [21].  
The mammalian caspase family of proteases consist of at least 14 mammalian 
members that can be divided, according to their structure and function, into 
initiator (pro-caspases 2, 8, 9 and 10) and effector (pro-caspases 3, 6 and 7) 
caspases (Figure 1). These proteases are constitutively expressed in almost all cell 
types as inactive proenzymes (zymogens) that become processed and activated in 
Figure 1 – Mammalian caspase family and C. elegans caspase CED-3. The structural and 
functional organization of caspases. From [1]. 
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response to a variety of pro-apoptotic stimuli [44]. Caspase activation involves 
proteolytic processing of the proenzyme at specific aspartate residues between the 
domains, resulting in removal of the prodomain as well as the linker region and 
formation of a heterodimer containing one large and one small subunit. The active 
caspase is a tetramer composed of two such heterodimers [44]. Initiator caspases 
are responsible for the activation of the effector pro-caspases which after activation 
carry on an apoptotic cascade culminating in the cellular disassembling. This 
cascade begins with autocatalytic activation of initiator caspase (caspase-2, -8, -9 
and -10) that, in turn, transmit the signal by cleaving and thereby activating the 
 
Figure 2 – Death receptor-signalling pathway and mitochondrial pathway of apoptosis. From Cell 
Signalling  (http://www.cellsignal.com/reference/pathway/Death_Receptor.html). 
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downstream effector/executioners caspases such as caspase-3 [44].  
Apoptosis is a highly regulated process, being controlled by tightly interconnected 
signalling pathways (Figure 2). Some of the pathways and events of the apoptotic 
program are conserved among species being considered fundamental events in the 
apoptotic process (Figure 2) [12, 13, 15, 38, 39, 49-51]. These include the 
action and regulation of the Bcl-2 family of proteins, cytochrome c release from 
mitochondria into the cytosol accompanied by mitochondrial dysfunction, and 
activation of caspases (Figure 2). There are two major signalling pathways of 
apoptosis, the death receptor pathway and the mitochondrial pathway [9, 51-54]. 
In the death-receptor signaling pathway, signal is provided by the interaction 
between the ligand and the death receptor. Death receptors, such as Fas/CD95 or 
TNFR1 belong to the tumor necrosis factor receptor (TNFR) superfamily, and the 
ligands belong to the tumor necrosis factor (TNF)/nerve growth factor family (Figure 
2). Members of the death receptor family contain one to five cysteine-rich repeats 
in their extracellular domain and a death domain (DD) in their cytoplasmic tail. The 
DD is essential for initiating the apoptotic signal. Following ligation of death 
receptor by ligand, the death receptor oligomerizes and recruits adapter molecules 
and initiator caspases to a complex, the death-inducing signalling complex (DISC), 
which results in the activation of initiator caspases. Initiator caspases then cleave 
effector/executioner caspases (caspase-3, -6, and -7), which cleave a number of 
target substrates resulting in morphologic and biochemical characteristics of 
apoptosis (Figure 2). Apoptosis is a tightly regulated process. The most extensively 
studied and perhaps the most relevant regulators are Bcl-2 family proteins. This 
family includes anti-apoptotic proteins such as Bcl-2 and Bcl-XL, and pro-apoptotic 
proteins such as Bax and others [9, 55, 56]. 
These molecules either homodimerize or heterodimerize with molecules of 
opposing function (e.g. Bax may heterodimerize with Bcl-2 or Bcl-xL). The 
influence of this interaction in the apoptotic process appears to be dependent on 
the relative concentration of these molecules in heterodimers and the ratio between 
pro-apoptotic and antiapoptotic molecules. Though the regulatory role of Bcl-2 
family proteins in mitochondrial pathway of apoptosis is well-established [9, 55, 
56], their role in the regulation of death receptor signaling is controversial and may 
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be specific for each cell type. Despite the fact that these two pathways are distinct, 
death receptor signaling can activate the mitochondrial pathway via tBid [56]. Bid 
is a BH3-only protein exclusively cytosolic in living cells. Upon activation of cell 
surface death receptors, Bid is cleaved by active caspase-8 and the truncated Bid 
(tBid) translocates from cytosol to mitochondria inducing cytochrome c release 
through the binding to a mitochondria specific lipid, cardiolipin [56]. The ability to 
cleave and activate Bid may not be limited to caspase-8. Other caspases, such as 
caspase-3, as well as other proteases, have been shown to cleave and activate Bid.  
Mitochondria play a crucial role for the progression of the PCD processes [24, 39, 
52, 55, 57]. A number of stimuli, including chemotherapeutic agents, UV 
radiation, stress molecules (ROS and reactive nitrogen species RNS), and growth 
factor withdrawal appear to mediate PCD via the mitochondrial pathway which can 
be independent from death-receptor pathway [57, 58].  
Mitochondria are organelles comprised by the matrix surrounded by the inner 
membrane (IM), the intermembrane space and an outer membrane (OM). In the 
IM are enclosed several molecules, including ATP synthase, electron transport 
chain, and adenine nucleotide translocator (ANT). Under physiological conditions 
these molecules allow the respiratory chain to create an electrochemical gradient 
(membrane potential). The OM contains a voltage-dependent anion channel. The 
intermembrane space contains holocytochrome c, certain procaspases, adenylate 
kinase 2, EndoG, Diablo/Smac, and apoptosis-inducing factor (AIF). IM 
permeabilization leads to changes in mitochondrial membrane potentials while OM 
permeabilization results in the release of these molecules into the cytoplasm. The 
release of cytochrome c is one of the major steps in the mitochondrial pathway of 
apoptosis associated with the permeabilization of mitochondrial OM, promoting the 
formation of the apoptosome which activates caspase 9 leading to the activation of 
the executioner caspases to orchestrate apoptosis. The components of apoptosome 
are cytochrome c, an adapter molecule Apaf-1 (Apoptotic protease-activating 
factor) and procaspase-9. The binding of cytochrome c to Apaf-1 leads to its 
unfolding and exposure of its oligomerization domain which is stabilized in the 
presence of ATP or dATP. Caspase recruiting domain (CARD) in the oligomer binds 
to the CARD domains of procaspase-9 to activate caspase-9. Active caspase-9 
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then cleaves and activates executioner caspases, such as caspase-3, to induce 
apoptosis [57]. CAD (caspase-activated DNase) is responsible for the degradation 
of chromosomal DNA. Activation of CAD is initiated by the cleavage of ICAD 
(inhibitor of caspase-activated DNase) by effector caspases, such as caspase-3. 
EndoG and AIF are released from mitochondria in response to various stimuli being 
translocated to the nucleus, where they have a role in DNA degradation. Unlike 
CAD, activation of EndoG and AIF is independent of caspase activation. It is 
possible that EndoG and AIF may participate in nuclear DNA degradation when 
caspase activation is limited by an apoptosis-like mechanism. 
PCD is a highly regulated mechanisms under a complex and rigorous molecular 
control [26]. Although scientists have focused their research in the genetic 
alterations that regulate PCD, an increasing body of evidence is also emerging 
showing a tight regulation of the translation process and factors during the PCD 
process [5, 59, 60]. 
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1.2 TRANSLATION CONTROL DURING PCD 
Translation process is divided in three phases: initiation, elongation and 
termination [61]. Canonical cap-dependent translation initiation involves the 
binding of the mRNA 5’-m7G cap-structure to the cap-binding protein eIF4E. eIF4G 
binds to eIF4E recruiting other proteins such as the eIF4A helicase, responsible for 
the unfold of the mRNAs 5’ untranslated region (5’UTR) secondary structure, 
forming the cap-binding complex 
(eIF4F). After the assembly of the 
eIF4F complex with the mRNA, 40S 
ribosomal subunit is recruited 
originating the 43S complex comprised 
of the 40S ribosomal subunit, a ternary 
complex containing an initiator tRNA 
molecule (tRNAiMet), the initiation 
factor eIF3, which makes the 
connection between 40S and eIF4G, 
and the initiation factors eIF1 and 
eIF1A, which help the recognition of 
the start codon (Figure 3A). After the 
assembly, the 43S initiation complex 
scans along the 5'UTR searching for 
the initiation AUG codon where the 
60S subunit binds to form an 
elongation-competent 80S ribosome. 
5'- and 3'-ends of the mRNA interact 
during cap-dependent initiation in 
Figure 3 – Cap-dependent and IRES-mediated translation initiation mechanisms. (A) Cap-
dependent translation. (B) IRES-mediated translation (i) using most of the canonical translation 
initiation factors and many ITAFs with the circularization of the mRNA, (ii) using a limited 
number of canonical factors and ITAFs and (iii) canonical factors are dispensable, but some 
ITAFs are required. From [5]. 
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eukaryotes through the poly(A)-binding protein (PABP) interaction with eIF4G, 
leading to the circularization of the mRNA. For decades this cap-dependent 
initiation of translation was assumed as the only mechanism allowing the 
progression of cellular mRNAs translation [62, 63]. 
 
1.2.1 Cap-dependent translation impairment during PCD 
Translation is the final step in the flow of the genetic information, therefore a 
regulation at this level allows for an immediate response to changes in 
physiological conditions, such as cellular stress or activation of PCD, that require 
immediate changes in protein levels. To answer that, diverse adaptation strategies, 
as regulation of global translation combined with selective translation, have evolved 
providing rapid and reversible regulation of protein expression.  
 
Over the last years, several studies have demonstrated that during PCD, 
translation initiation factors, mainly translation initiation factor 4G (eIF4G) family 
members [59, 65, 73, 82-87], but also translation initiation factor 2 (eIF2) 
[64, 65], 3 (eIF3) [65], 4B (eIF4B) [65], 4E (eIF4E) [78-80], DAP5/p97 [88-92] 
Translation initiation 
factor 
Modification References 
eIF2α Cleavage by caspase-3 [64, 65] 
eIF2α Ser51Phosphorylation [66-73] 
eIF3 (p35), eIF3b, 
eIF3f, eIF3g, eIF3k 
Cleavage by caspase-3 or 
inhibition of activity by interaction 
with other protein 
[65, 74-77] 
eIF4B Cleavage by caspase-3 [65] 
eIF4E Cleavage by caspase-3 [78-80] 
4E-BP1 Cleavage by caspase-3 [65, 81] 
eIF4GI and eIF4GII 
Fragmentation by caspase-3 and 
caspase-8 
[59, 65, 73, 
82-87] 
DAP5/p97 
Reduced levels or cleavage by 
caspase 
[88-92] 
   
Table 1 – Translation initiation factors alterations during PCD. 
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and eIF4E binding proteins (4E-BP1) [65, 81], are targets of specific cleavage 
mediated by caspases in a variety of cell types and in response to different stimuli 
(Table 1). Moreover, post-translational modifications such as the phosphorylation 
of eIF2 mediated by haem-regulated inhibitor kinase (HRI), protein kinase RNA 
(PKR), PKR-like endoplasmic reticulum kinase (PERK) or general control non-
derepressibe-2 (GCN2), lead to the reduction of the canonical cap-dependent 
translational initiation [66-73]. However, others mechanisms, such as the GCN4 
translation by four upstream open reading frames (ORFs), firstly described in yeast, 
being induced by the phosphorylation of eIF2 as a response to amino-acid 
starvation [93, 94] and cap-independent internal ribosome entry site (IRES)-
mediated translation, which selectively recruits mRNAs harbouring IRES in their 5’ 
untranslated region (5’UTR), have shown to be activated in order to fulfil the 
cellular requirements.  
 
1.2.2.1 IRES-mediated translation 
IRES-mediated translation is a tightly controlled mechanism of translation of 
specific mRNAs regulated by their unique sequences in the 5’UTR, in conditions of 
global translation impairment such as stress and apoptosis. IRES are sequences 
with a high percentage of GC and several AUGs usually present in long 5’ UTRs 
mRNAs but that can also be found in the mRNA coding sequence. These 
sequences form a complex secondary structure, which directly recruit ribosomes 
independently of the mRNA cap-structure and of the eIF4E [4]. However, no 
similarities between the structures or sequences of these cellular IRES were 
identified so far. Several canonical translation initiation factors may participate in 
the initiation of IRES-mediated translation. Different IRES-containing mRNAs have 
shown to require specific canonical translation initiation factors (Figure 3B) [4, 5, 
95]. Furthermore, for an efficient IRES-mediated translation, auxiliary cellular 
proteins, known as IRES trans-acting factors (ITAFs), are also required [96]. These 
ITAFs can stimulate or inhibit the activity of IRES elements by affecting ribosome 
recruitment or modifying the structure of the IRES mRNA itself.  
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This alternative translation has proven to be an important regulatory 
mechanism for the organism homeostasis being associated both to survival or 
death of the cell. 
 
1.2.2 Apoptotic regulators IRES-mediated translation during PCD 
During the last decade, IRES sequences have been reported in the mRNA of 
proteins with important roles in cell growth, differentiation and regulation of PCD 
[4]. Example of this mechanism is the translation of several mammalian apoptotic 
regulators, both inhibitors and inducers of apoptosis (Figure 3).  
Mammalian anti-apoptotic proteins, such as c-IAP1 [97], HIAP2 [98, 99] 
and the well described X-chromosome-linked inhibitor of apoptosis (XIAP) [99-
108] are translated by an IRES-mediated mechanism blocking the apoptotic 
process through direct binding and inhibition of caspases activity. The contribution 
Figure 4 – IRES-mediated translation initiation regulates the expression of key apoptotic 
players, both pro-apoptotic and anti-apoptotic factors. From [4] 
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of pro-apoptotic proteins such as Apaf-1 [109-111], c-myc [112-117], DAP5 [91, 
118] and p53 [119-121] for PCD is also regulated by IRES, leading to the 
activation of the apoptotic cascade. The balance between the relative levels of 
these apoptotic regulators will determine the cells fate, survival or cell death 
(Figure 3).  
 
A role of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a glycolytic 
enzyme, in the repression of p53 translation by direct binding to the p53 3’UTR 
has been described [134]. In mammalian cells, this enzyme is a known inhibitor of 
virus and mammalian mRNAs IRES-mediated translation [119, 134-138]. Hence, 
GAPDH is responsible for the inhibition/repression of cap-independent IRES-
mediated translation in higher eukaryotes as a protective mechanism against 
opportunistic viral infections and apoptosis. Its specific cleavage by caspase-1 
during apoptosis [139] might lead to the unblock of p53 IRES-mediated translation 
and ultimately to the apoptotic cell death.  
IRES-containing 
PCD regulator 
Function in PCD References 
Bcl-2 Anti-apoptotic protein [122-124] 
c-IAP1 Anti-apoptotic protein [97] 
HIAP2 Anti-apoptotic protein [98, 99] 
HSP70 Anti-apoptotic protein [125-127] 
OCT4B-190 Anti-apoptotic protein [128] 
Sp1 Anti-apoptotic protein [129] 
XIAP Anti-apoptotic protein [99-106, 130-133] 
Apaf-1 Pro-apoptotic protein [109-111] 
CDK1 Pro-apoptotic protein [123] 
c-myc Pro-apoptotic protein [112-117] 
DAP5 Pro-apoptotic protein [91, 118] 
p53 Pro-apoptotic protein [119-121] 
   
Table 2 – IRES-containing mRNAs with a role in the modulation of PCD. 
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Therefore, IRES-mediated translation is an important piece of the intricate 
puzzle that controls PCD and a deregulation of this process may lead cellular 
alterations. 
 
1.3 HSP90 CHAPERONES AND PCD 
HSP90 chaperones are highly conserved constitutively abundant proteins 
with crucial roles in protein folding/refolding as well as in the general response to 
stress and PCD [140-143]. Although HSP70 chaperones proved to be translated 
by IRES-mediated translation [125], and despite the overlapping functions of 
HSP70 and HSP90 [2, 144-149], a regulation of HSP90 chaperones translation 
at this level was never addressed. Prominent members of mammalian HSP90 
family are the cytoplasmic chaperones Hsp90 and Hsp90β [141, 142]. Hsp90β 
is expressed constitutively to a higher level than Hsp90, which is generally stress-
inducible [141]. Unlike to other eukaryotic HSPs [150], the nucleotide sequence of 
HSP90 chaperones include several introns and exons, mainly in the 5’ and 3’UTRs 
Figure 5 – HSP90 client proteins have a crucial role in PCD. Proteins marked in blue are anti-
apoptotic proteins which stability is regulated by HSP90. Proteins marked in red are involved in 
the progression of PCD and are repressed by interaction with HSP90. 
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[151, 152]. The differences in the amino acid sequence and the differential 
patterns of expression of Hsp90 and Hsp90β isoforms raises the possibility of 
their interaction with distinct client proteins, being involved in different cellular 
functions. However, most of the studies do not differentiate the functions of 
HSP90 and HSP90β. Despite this obstacle for the elucidation of HSP90 isoforms 
cellular functions, recent studies suggest that some functions of the HSP90β are 
not overlapped by HSP90 [153, 154]. During oxidative stress induced by 
ascorbate/menadione, in mammalian cells only the HSP90β is cleaved leading to 
the reduction of the levels of its client proteins Bcr-Abl, RIP and Akt [153, 154]. 
 
Figure 6 – Modulation of apoptosis by HSP90 through interaction with client proteins. From [2]. 
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Their function influences the activity and stability of a wide range of client 
proteins such as key regulators in cellular growth, differentiation and cell death 
pathways [155]. Hsp90 chaperones are responsible for the stability of anti-
apoptotic proteins, such as: Survivin, IGF-IR, Cdc37, Zap-70, BcR-Abl, IKK/β, 
rp53, Bcl-2 and AKT [143, 153, 156-166] and in the repression of pro-apoptotic 
proteins such as Apaf-1, Bid and FKBP38 [167-171] (Figure 5). In fact, the 
regulation of the Fas- and Tumor-necrosis factor receptor 1 necrotic process by 
mammalian HSP90 chaperones through the interaction with its client protein RIP1 
has also been described [25, 172, 173]. Modulation of the HSP90 expression 
leads to cellular alterations. The overexpression of HSP90 induces cell survival and 
their depletion by siRNA or inhibition using geldanamycin triggers apoptosis [32, 
160, 165, 172, 174-180]. The fact that Apaf-1 translation is tightly regulated by 
IRES and its contribution for the PCD process in under control of HSP90, is a good 
evidence that PCD is a complex process under the control of different sequential 
mechanisms and molecules and the smallest alteration in this process may lead to 
carcinogenesis.  
Since HSP90 chaperones are powerful inhibitors of apoptosis, a modulation 
of their cellular levels affects the cellular homeostasis. In fact, HSP90 are the only 
chaperones targeted in cancer therapy, namely in anti-Acute Myeloid Leukemia 
(AML) treatment to sensitize tumor cells to chemotherapy-induced death through 
the use of HSP90 specific inhibitor geldanamycin [159, 181-185], [184, 186, 
187]. However, the outcome of these treatments is below expectations, probably 
due to an undifferentiated inhibition of all the HSP90 isoforms therefore affecting 
the function of different client proteins in distinct molecular pathways [188]. 
 
1.4 Yeast PCD 
For decades, the apoptotic process was assumed to occur only in 
multicellular organisms as a protective mechanism of rapid removal of unwanted or 
damaged cells that could otherwise inflame the surrounding cells with their 
cytoplasmic contents. This perception changed in 1997, when Madeo and 
coworkers showed that the yeast Saccharomyces cerevisiae also undergoes PCD 
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with typical apoptotic markers such as externalization of phosphatidylserine to the 
leaflet of the outer plasma membrane, degradation of DNA, condensation of 
chromatin, and production of reactive oxygen species (ROS) [189]. Several reports 
followed showing the occurrence of this process induced by diverse exogenous 
stimuli like H
2
O
2
 [190] and acetic acid [191], the two most extensively studied 
apoptotic stimuli in yeast [3, 189, 191, 192], or by endogenous stimuli such as 
mating pheromones [193, 194] and aging [195, 196]. This was the starting point 
for the study of an old process in a new unicellular eukaryotic model. Scientist 
focused their attention on the molecular pathways and regulators controlling the 
apoptotic process searching for conserved mechanisms from yeast to mammalian 
cells. In fact, throughout this decade, the knowledge on the yeast apoptotic 
regulatory mechanisms had a massive development. Yeast apoptosis proved to be 
mediated by several orthologues of mammalian apoptotic regulators, both anti-
apoptotic proteins such as Bir1p (XIAPp) [197] and Cdc48p (VCP) [189] and pro-
Figure 7 – Proteins and pathways regulating yeast apoptosis. From [3] 
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apoptotic proteins as Aif1p (AIF) [41], Nuc1p (endoG) [198], and Nma111p 
(HtrA2/Omi) [197] (Figure 7). Furthermore, a conservation of the molecular 
pathways involved in the regulation of the apoptotic process was also observed 
(Figure 7). The activation of an yeast caspase like protease, metacaspase [40], the 
mitochondrial membrane depolarization [199], release of cytochrome c from 
mitochondria to cytoplasm [199], mitochondrial fission and fusion [200, 201] and 
actin cytoskeleton alterations [202-204] support the conservation of the main 
apoptotic hallmarks of PCD from yeast to mammalian cells (Figure 7). 
Over a decade ago, a family of proteases presenting structural similarities to 
caspases was identified in protists, fungi and plants [205]. These proteases were 
named metacaspases and classified, according to the presence or absence of a N-
terminal prodomain containing a proline-rich repeat motif, as type I or type II, 
respectively. In spite of the structural similarity with the remotely related caspases, 
a large body of accumulating evidence shows that all metacaspases are highly 
specific for P1-Arg and P1-Lys substrates [206].  
Yeast cells have a single gene, YCA1, encoding a type I metacaspase that 
was first implicated in the execution of oxidative stress induced cell death [40] but 
that is estimated to participate in approximately 40% of the described yeast 
apoptotic scenarios [207]. Nevertheless, non-death functions have also been 
assigned to yeast metacaspase such as cell cycle regulation [208] and protein 
catabolism [209]. Although the mechanisms regulating this multifunctional 
protein, metacaspase, still remain elusive, it is known that metacaspases activity is 
regulated through S-nitrosation and thus dependent on the endogenous levels of 
nitric oxide (NO) [210]. S-nitrosation of one metacaspase Cys residue keeps it 
inactive. However, a second catalytic Cys residue, highly conserved in all known 
metacaspases but absent in all members of caspases, can rescue metacaspase 
activity in the presence of high NO levels [210]. Accordingly, in yeast H
2
O
2
-
induced apoptotic conditions [40, 190], a cell death process dependent on 
metacaspase activity and NO generation, metacaspase activity and cell death are 
abolished in the presence of L-NAME, an inhibitor of NO synthesis [211, 212].  
One of the major mechanistic challenges for understanding the role of 
metacaspases in cell survival and death is still the identification of their natural 
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substrates. Until recently, the only protein known to be cleaved by metacaspases in 
vivo was the evolutionarily conserved TSN (Tudor staphylococcal nuclease) [213] 
found in all eukaryotes except in budding yeast [213]. Thus, although in yeast, 
metacaspase is essential for apoptosis execution upon a wide range of either 
physiological or external stimuli [40, 214], the substrates and therefore the 
specific molecular pathways targeted/regulated by this protease are still unknown.  
 
1.4.1 Acetic acid and H
2
O
2
: the paradigmatic inducers of yeast PCD 
Over the last decade, diverse stimuli have been associated to the induction of 
yeast apoptosis. Among those stimuli, acetic acid and H
2
O
2,
 are the most studied 
and were used in most of the experiments presented in this thesis. 
Although acetic acid is used as an external apoptotic stimulus, this 
compound is an end product of yeast alcoholic fermentation and could be 
considered as a natural physiological apoptotic stimulus. In the course of acetic 
acid apoptotic process, mitochondria appear to play a preponderant role. Acetic 
acid treatment leads to the production of ROS in mitochondria, induction of the 
mitocondrial membrane depolarization [199], release of cytochrome c to cytoplasm 
[199], translocation of Aif1p from mitochondria to the nucleus [41], leading to 
DNA fragmentation, culminating with the mitochondria fission and fusion [200]. 
Moreover, during acetic acid-induced apoptosis, a severe intracellular amino acid 
starvation occurs, leading to the inhibition of the target of rapamycin (TOR) and of 
protein phosphatases Pph21p and Pph22p, downstream mediators of TOR 
signaling [215], derepressing Gcn2p kinase and therefore leading to a cell cycle 
arrest in G0/G1 phase [215]. Proteomic analysis of acetic acid-treated cells also 
revealed a decrease in the levels of several translation factors, namely eIF4A, 
eEF1A, eEF2 and eEF3A [215]. Furthermore, an extensive degradation of 
ribosomal RNAs occurs during acetic acid-induced apoptosis [216]. These data 
together with the literature regarding the translation regulation of apoptosis in 
mammalian cells, strongly suggests a regulation of translation process during acetic 
acid induced-apoptosis. Despite the described degradation of mitochondria and 
ribosomal RNA during acetic acid treatment, a recent report demonstrated that 
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autophagy is not involved in the modulation of acetic acid-induced apoptosis 
[201]. Curiously, it is suggested that the yeast metacaspase, performs a role in the 
acetic acid-induced apoptosis, unrelated to its caspase activity [217]. 
During H
2
O
2
-induced apoptosis, a different apoptotic cascade appears to be 
activated, in which metacaspase plays a key role [40, 214, 218, 219], having 
high levels of activity [40]. Metacaspase participation in acetic acid-induced 
apoptosis is not as essential as in H
2
O
2
-induced apoptosis [217]. Moreover, 
alterations in the translation process also proved to contribute for the H
2
O
2
-induced 
apoptosis, such as the extensive degradation of ribosomal RNAs [216] and the 
decrease of global translation mediated by the phosphorylation of eIF2 through 
Gcn2p kinase (the amino acid control kinase) [220].  
Although the knowledge in the yeast apoptotic cell death has been greatly 
improved during the last years, establishing yeast as a good model for the study of 
PCD, the participation/conservation of some apoptotic mechanisms, such as the 
IRES-mediated translation, from yeast to mammalian was never addressed. 
Nevertheless, similar to what occurs in mammalian cells, the occurrence of a 
PCD with typical necrotic features, such as the increase in cell volume (oncosis), 
swelling of organelles, DNA degradation and plasma membrane disruption with the 
loss of intracellular contents, has also been described in yeast [221]. Moreover, the 
nuclear release of yeast HMGB1 (Nhp6Ap) was considered a molecular marker of 
necrosis in yeast [222]. The balance between the occurrence of apoptotic or 
necrotic cell death upon acetic acid or H
2
O
2
 treatment was previously reported to 
be determined, for the same period of treatment, by concentration, higher 
concentrations will lead to necrosis, while lower concentrations to apoptosis [190, 
191]. This balance is important for the cellular homeostasis, therefore a 
methodical study of the mechanisms controlling this balance is of utmost 
importance. 
In yeast, it has been reported that the inhibition of yeast HSP90, by radicicol, 
leads to the inhibition of tunicamycin-induced necrosis [223]. Yeast HSP90 family 
of chaperones, as well as their mammalian counterparts, are responsible for the 
protein folding/refolding, influencing the activity and stability of a wide range of 
client proteins that function as key regulators in PCD [142, 224]. These data 
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suggest a conservation of the molecular regulators of necrosis from yeast to 
mammalian cells. Nonetheless, no homologue of RIP1 in yeast is known, but other 
serine/threonine kinase, Slt2p, interacts with HSP90 [225, 226] and may have a 
role in the regulation of necrotic cell death. 
 
1.4.2 Translation control in yeast PCD 
In yeast, few reports showed the involvement of translation control in PCD. A 
recent study in S. cerevisiae revealed that oxidative stress, by exposure to H
2
O
2
, 
causes a dose-dependent inhibition of translation through Gcn2 kinase (the amino 
acid control kinase) phosphorylation of eIF2, but that some mRNAs are still 
translated after oxidative stress [220]. Interestingly, our published results, using 
yeast S. cerevisiae as model, also showed that under acetic acid induced PCD, the  
expression of some translation factors such as eIF4A, eEF1A, eEF2 and eEF3A is 
diminished [215], but the levels of several other proteins, such as the HSP90 
chaperones were increased [215]. These data, strongly suggests the existence of 
IRES-containg 
mRNAs 
Function in yeast cell References 
BOI1 Protein implicated in polar invasive growth  [227] 
FLO8 
Transcription factor required for flocculation, 
also related to invasive growth 
[227] 
GIC1 
Protein involved in initiation of budding and 
cellular polarization 
[227] 
GPR1 
Golgi matrix protein involved in the structural 
organization of the cis-Golgi 
[227] 
HAP4 
Transcriptional activator and global regulator of 
respiratory gene expression 
[228] 
L-A 
Double-stranded RNA (dsRNA) virus of the yeast 
S. cerevisiae 
[229] 
MSN1 
Transcriptional activator involved in invasive 
growth 
[227] 
NCE102 
Protein of unknown function involved in invasive 
growth 
[227] 
TIF4632 
Translation initiation factor eIF4G, subunit of the 
mRNA cap-binding protein complex (eIF4F) 
[227] 
URE2 
Transcriptional regulator involved in nitrogen 
catabolism repression  
[230-233] 
YAP1 
Transcription factor required for oxidative stress 
tolerance 
[234] 
YMR181c 
Protein of unknown function involved in invasive 
growth 
[227] 
   
Table 3 – Yeast mRNAs capable of being IRES mediated translated. 
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an alternative IRES-mediated cap-independent mechanism regulating the 
translation of specific mRNAs upon the apoptotic stimulus, similar to what is 
described in mammalian cells [4, 5, 95, 235]. In yeast, IRES were mainly 
reported in transcriptional regulators involved in the response to yeast stress 
stimulus such as transcription factor FLO8 required for invasive growth [227], 
transcription factor YAP1 [234] and transcriptional activators HAP4 [228] and 
MSN1 [227], involved in the response to oxidative stress and transcriptional 
repressor of genes involved in nitrogen catabolism URE2 [230] (Table 3). 
Moreover, during yeast nutrient starvation an eIF4G-dependent IRES-mediated cap-
independent translation of several genes is required for invasive growth as a 
response to stress [227] (Table 3). However, the role of IRES in the regulation of 
yeast PCD phenomena has never been addressed. 
The identification of the yeast apoptotic regulators capable of putative IRES-
mediated translation during PCD would allow an integrated view of the signaling 
pathways that control the yeast life and cell death decisions. 
 
 
This chapter attempts to summarize the relevant findings on the translation 
control of mammalian cells apoptotic processes and the information relative to a 
conservation of this regulation from yeast to mammalian cells. However, several 
questions concerning the control of the translation process and its contribution for 
the yeast apoptotic process remain to be answered. On the next chapters, results 
will be presented in an attempt to get new insights on the yeast translation 
regulation of apoptosis, through the study of translation machinery alterations, 
mRNAs capable of overcoming global translation impairment during apoptosis, as 
well as their role in the PCD processes, hopping to contribute for the continuous 
knowledge of the molecular regulatory mechanism controlling cell death. 
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CHAPTER 2 
Global translation impairment during acetic acid-induced apoptosis in 
Saccharomyces cerevisiae  
 
Silva, A., Sampaio-Marques, B., Holcik, M., Santos, M.A. and Ludovico, P. 
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2.1 ABSTRACT 
The decrease of global mRNA translation efficiency during the progression of 
apoptosis in mammalian cells is a well recognized event [95]. In yeast a correlation 
between these two processes has also been observed, but the molecular basis of 
this regulation was never deeply explored. Our previous report revealed a 
downregulation of translation factors eIF4A, eEF1A, eEF2 and eEF3A levels during 
yeast acetic acid-induced apoptosis [215], suggesting an impairment of translation 
during the apoptotic process. In order to better understand the cascade of events 
leading to translation alterations upon acetic acid treatment, a thorough study of 
the translation process and of the changes induced by abrogation of one of its key 
described regulator, Gcn2p kinase [236-238], during acetic acid-induced 
apoptosis was studied. Polysome profiling kinetic analysis showed a premature 
dose-dependent reduction of cap-dependent translation initiation correlated with 
the phosphorylation of eIF2α by Gcn2p kinase, and a later inhibition of translation 
elongation. Furthermore, Gcn2p kinase proved to be a crucial player in acetic acid-
induced apoptosis, due to the more resistant phenotype displayed by GCN2 deleted 
cells and the severe reduction of eIF2α phosphorylation. Nevertheless, RT-PCR 
analysis of polysomal fractions revealed that some mRNAs, such as the pro-
apoptotic factor AIF1, are translated under these conditions, suggesting the 
activation of an alternative translation process. Altogether, these results 
demonstrate that translation regulation is an important component of the cellular 
response to acetic acid-induced apoptosis. 
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2.2 INTRODUCTION 
Although apoptosis is a phenotypical well characterized programmed cell 
death (PCD) process, the complete uncover of the molecular pathways underneath 
this phenomenon is a continuous challenge. The involvement of the translation 
process in the regulation of apoptosis is a still emerging concept [95, 96, 239-
243]. In mammalian cells, global cap-dependent translation proved to be reduced 
during the progression of apoptosis [95] due to mRNA 5’ decapping and specific 
fragmentation of translation factors, mainly the translation initiation factor 4G 
(eIF4G) family members [59], mediated by caspases. Besides caspases, other pro-
apoptotic proteins were associated to the regulation of translation factors during 
apoptosis, such as the apoptosis-inducing factor AIF, which binds to the eIF3g 
during the apoptotic stimulus blocking translation [76]. Post-translational 
modifications of translation initiation factors, such as, phosphorylation of subunit α 
of translation initiation factor 2 (eIF2α) were also described [59]. However, the 
involvement of translational control in yeast PCD is still scarce. The deletion of 
LSM4 gene, involved in yeast mRNA decay, inhibits mRNA decapping leading to 
an increase in mRNA stability and ultimately triggering a caspase-dependent 
apoptotic process [244-246]. Furthermore, an extensive degradation of ribosomal 
RNAs is observed during H
2
O
2
- and acetic acid-induced apoptosis and a decrease 
of global translation due to the phosphorylation of eIF2 by Gcn2p kinase (the 
amino acid control kinase) also occurs during oxidative stress [220]. In fact, Gcn2p 
appears to play a crucial role in the regulation of distinct cellular processes. Apart 
from its role in the regulation of translation initiation through eIF2α 
phosphorylation, this kinase has been related to the control of cell cycle, through a 
DNA damage checkpoint between G1 and S phase [247, 248], being also involved 
in the TOR-mediated activation of autophagy [249]. Previously, we have shown by 
proteomic analysis that during acetic acid-induced apoptosis, a severe intracellular 
amino acid starvation occurs [215] and the levels of translation initiation factor 4A 
(Tif1/2p) and translation elongation factors 1A (Tef1/2p), 2 (Eft1/2p) and 3A 
(Yef3p) were decreased [215] suggesting an impairment of translation during yeast 
apoptosis regulation. Herein we show the occurrence of translation alterations 
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during the execution of acetic acid-induced apoptosis and disclose the involvement 
of the known translation regulator, Gcn2p kinase, in this process. 
 
2.3 MATERIALS AND METHODS 
Strains, media and treatments 
Saccharomyces cerevisiae strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) and its isogenic derivatives tif1, eft1, gcn2 and aif1 (EUROSCARF, 
Frankfurt, Germany) were used. For acetic acid treatment, S. cerevisiae cells were 
grown until the middle exponential phase in liquid YPD medium containing glucose 
(2%, w/v), yeast extract (0.5%, w/v) and peptone (1%, w/v) at 26ºC (150 r.p.m.). 
Cells were initially harvested, ressuspended in fresh medium (pH 3.0) and 
incubated at 26ºC for 1h. Afterwards, cells were ressuspended (10
8
 cells/mL) in 
fresh medium (pH 3.0) followed by the addition of 180, 195, 210 or 225 mM of 
acetic acid and incubated during 15, 30, 60, 120 and 200 min at 26ºC with 
stirring (150 r.p.m.), with or without the presence of 2.5 mM chloroquine, 1.1 µM 
rapamycin and 2% threalose (in this condition glucose in not added to the YPD 
medium). After the 200 min treatment, approximately 300 cells were spread on 
YPD agar plates and viability was determined by counting colony forming units 
after 2 days of incubation at 26ºC [199]. Cells were also harvested for further 
studies described below.  
 
Protein synthesis analysis 
Protein synthesis was analysed in cells exposed to 195 mM of acetic acid 
during 15 min. Cultures were labelled with 85 M L-[35S] methionine during the 
last 5 min of the acetic acid treatment, and 100 µg/mL cycloheximide (CHX) was 
just added before harvesting the cells. Total protein extracts were resolved by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), as 
described below, and either the gels were stained with Coomassie blue or protein 
extracts were detected by enhanced chemiluminescence. 
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Polysome profile analysis  
Yeast cells were grown to middle exponential phase and treated with acetic 
acid as described above. Five minutes before cells being harvested, CHX was 
added to a
 
final concentration of 100 µg/mL, cells were collected, washed with 
cold phosphate-buffered saline (PBS) and disrupted using lysis buffer [20 mM Tris 
(pH 8.0), 140 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 1 mM PMSF, 100 µg/mL 
CHX] and glass beads (Sigma). 40 units A
280nm
 were loaded onto 11 mL 15 - 50 % 
sucrose gradients containing 20 mM Tris-HCl at pH 8.0, 140 mM KCl, 5 mM 
MgCl2, 0.5 mM DTT, 100 µg/mL CHX and 500 µg/mL heparin. Gradients were 
centrifuged using a SW41 rotor (Beckman-Coulter) at 35000 rpm for 2 hours and 
45 min at 4ºC. Polysomal profiles were visualized by monitoring RNA absorbance 
at 254nm using a Bio-Rad Biologic LP system adapted for this use. Monosomal 
and polysomal fractions of the gradient were collected into tubes containing 8M 
guanidine-HCl, ethanol was added to a final concentration of 50% and fractions 
were stored at – 80 ºC.  
 
Polysomal RNA preparation 
Polysomal mRNA was precipitated with ethanol 85%, extracted using phenol: 
chloroform and precipitated, first with 1.5 M lithium chloride (LiCl) for removing 
any residual heparin, and then with 100% ethanol plus 110 mM sodium acetate, 
pH 5.3. 
 
RT-PCR analysis 
Total RNA was isolated from monosomal and polysomal fractions. For 
quantitative reverse transcription polymerase chain reaction (RT-PCR), reverse 
transcription of RNA to cDNA was carried out using the First-Strand cDNA 
synthesis kit (GE Biosciences). The quantitative PCR was performed on a 
Stratagene Mx3005PTM real-time thermocycler using EVAGreen (Bio-Rad) and 
gene-specific primers as described in Table 4.  
Relative expression levels were determined using the standard curve method. 
Controls lacking reverse transcriptase (RT) demonstrated no significant genomic 
DNA amplification. 
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Assessment of intracellular reactive oxygen species 
Free intracellular reactive oxygen species (ROS) were detected with 
dihydrorhodamine 123 (DHR123) (Molecular Probes). DHR123 was added from a 
1 mg/mL stock solution in ethanol to 5x10
6
 cells/mL suspended in PBS, reaching a 
final concentration of 15 g/mL. Cells were incubated for 90 min at 30°C in the 
dark, washed in PBS and analyzed by flow cytometry. Flow cytometric assays were 
performed on a BD LSR II™ (Becton Dickinson, NJ, USA) using BD FACSDiva 
Software 6.0 (Becton Dickinson, NJ, USA). Twenty thousand cells per sample were 
analyzed using the FlowJo software (Tree Star, Ashland, OR, USA). Data express 
the percentage of DHR123-positive cells compared to the total number of counted 
cells. 
 
Immunoblot analysis 
For detection of protein levels in total cellular extracts, untreated or acetic 
acid-treated cells (195 Mm) were collected and disrupted using glass beads in lysis 
buffer [1% v/v Triton X-100, 120 mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM 
EDTA, 10% v/v Glycerol, 1 mM PMSF and Complete Mini protease inhibitor 
Gene Primer sequence Eff (%) 
AIF1 
F: GATACGGCTGCCAGCTTTGAT 
R: TGAGCCAGTTGCAAGAACCAA 
96.5 
BIR1 
F: CGTCCGATTTTTCACCATCA 
R: CATGCAAACTGCGTGTGAGA 
99.3 
CLN3 
F: GCCCCTTTGGAAGCTTTCATT 
R: TGGCACCCAATTTGATCTCG 
98.4 
TIF4632 
F: TCCGAGGAGACATTAGAGTCCG 
R: ACCGAACCTTCAAGAGTTGCC 
99.1 
ACT1 
F: GATCATTGCTCCTCCAGAA 
R: ACTTGTGGTGAACGATAGAT 
98.2 
TDH2 
F: CCGCTGAAGGTAAGTTGA 
R: CGAAGATGGAAGAGTTAGAGT 
95.1 
PDA1 
F: TGACGAACAAGTTGAATTAGC 
R: TCTTAGGGTTGGAGTTTCTG 
94.8 
TUB2 
F: TACCACATCCATTGCTGAG 
R: CACCTTCTTCCATACCTTCA 
93.2 
Table 4 - List of primers for quantification of mRNA expression by RT-PCR and their efficiency 
(Eff). 
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cocktail (Roche, Mannheim, Germany)]. From total protein extracts, 40 g (100 g 
for the protein synthesis analysis assay) were resolved on a 12% SDS-PAGE gel 
and transferred to a nitrocellulose membrane (Amersham) over 90 min at 100 V. 
Membranes were then probed with polyclonal rabbit Ser51 phosphorylated eIF2 
(Sui2p) antibody (1:2000, Upstate), polyclonal rabbit anti-eIF2 (1:2000, Cell 
Signaling Technology), polyclonal rat anti-eIF4G (Tif4631/Tif4632p) (1:1000, 
kindly provided by Michael Altmann), polyclonal rabbit anti-eEF2 (Eft1/2p) (1:15 
000), polyclonal rabbit anti-eEF1A (Tef1/2p) (1:15 000, both antibodies were 
kindly supplied by Prof. T.G. Kinzy), polyclonal rabbit anti-eIF4A (Tif1/2p) (1:15 
000, kindly supplied by Prof. M. Montero-Lomelí) and polyclonal goat anti-actin 
(1:5000, kindly provided by Prof. Campbell Gourlay). Horseradish peroxidase 
(HRP)-conjugated anti-rabbit, anti-rat and anti-goat IgG secondary antibody were 
used, at a dilution of 1:5000 and detected by enhanced chemiluminescence. 
 
Cell cycle analysis 
Cell-cycle analysis was performed in wild-type and gcn2 untreated and 195 
mM acetic acid-treated cells after 200 min of treatment. Cells were harvested, 
washed and fixed with ethanol (70% v/v) at 4ºC. Following, cells were sonicated, 
treated with RNase for 1 h at 50ºC in sodium citrate buffer (50 mM sodium 
citrate, pH 7.5), and subsequently incubated with proteinase K (0.02 mg per 10
7
 
cells). Cellular DNA was then stained overnight at 4ºC with SYBR Green 10000X 
(Molecular Probes), diluted tenfold in Tris-EDTA (pH 8.0). Samples were then 
diluted 1:4 in sodium citrate buffer, sonicated and analyzed by flow cytometry as 
described in [215]. Determination of cells in each phase of the cell cycle was 
performed offline using MODFIT LT 3.2 software (Verity Software House, Topsham, 
ME). 
 
Vacuolar membrane staining 
FM 4-64 (N-(3-Triethylammoniumpropyl)-4-(6-(4-
(Diethylamino)phenyl)hexatrienyl) Pyridinium Dibromide, Molecular Probes Inc., 
Eugene, OR) staining was performed as described [250]. Prior to staining, wild-
type and gcn2 cells expressing GFP-Atg8 (pRS416-GFP-Atg8 plasmid was kindly 
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provided by F. Reggiori) were cultured overnight in YPD medium, harvested during 
mid-logarithmic phase, pre-incubated for 1h in YPD (pH 3.0) and treated for 200 
min in YPD (pH 3.0) with 195 mM of acetic acid. For FM 4-64 staining, cells 
were harvested and ressuspended in fresh YPD medium. FM 4-64 was added to 
25 µM from a stock solution of 16 mM in DMSO. The cells were then incubated 
with shaking for 10-15 min at 30ºC. After this preliminary labelling step, the cells 
were harvested at 700 g for 3 min at room temperature, ressuspended in fresh 
YPD medium and incubated with shaking for 60 min. Afterwards, the cells were 
harvested, ressuspended in fresh YPD medium, placed on standard slides, and 
visualized by epifluorescence microscopy with an Olympus BX61 microscope 
equipped with a high-resolution DP70 digital camera and with an Olympus 
UPlanSApo 100X/oil objective, with a numerical aperture of 1.40. 
 
Preparation of protein extracts for 2-D gel electrophoresis (2-DE) 
For preparation of total cellular extracts, untreated and acetic acid-treated 
wild-type and gcn2 cells (195 and 270 mM) were collected and disrupted using 
glass beads in lysis buffer [1% v/v Triton X-100, 120 mM NaCl, 50 mM Tris-HCl 
pH 7.4, 2 mM EDTA, 10% v/v Glycerol, 1 mM PMSF and Complete Mini protease 
inhibitor cocktail (Roche, Mannheim, Germany)]. Protein concentrations were 
determined with a commercially available kit (RotiNanoquant, C. Roth, Karlsruhe, 
Germany) and protein aliquots (100 μg, 600 μg) stored at -20°C. To verify the 
reproducibility, three independent samples from total cellular extract were obtained 
for each of the three conditions (control and 195 and 270 mM acetic acid-treated 
cells) and each sample separated within four 2-DE gels. 
 
2-DE 
For 2-DE the protein pellet was ressuspended in urea buffer (8 M urea, 2 M 
thiourea, 1% [w/v] CHAPS, 20 mM DTT, 0.8% [v/v] carrier ampholytes and 
Complete Mini protease inhibitor cocktail). The protein separation was done as 
previously described [164]. Briefly, the protein solution was adjusted with urea 
buffer to a final volume of 350 µL and in-gel rehydration was performed over night. 
Isoelectric focusing (IEF) was carried out in IPG strips (pH 3–10, non linear, 18 
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cm; GE Healthcare, Uppsala, Sweden) with the Multiphor II system (GE 
Healthcare) under paraffin oil for 55 kVh. SDS-PAGE was done overnight in 
polyacrylamide gels (12.5% T, 2.6% C) with the Ettan DALT II system (GE 
Healthcare) at 1-2 W per gel and at 12ºC. The gels were silver stained and 
analyzed with the 2-DE image analysis software Melanie 3.0 (GeneBio, Geneva, 
Switzerland). The apparent isoelectric points (pI) and molecular masses (Mr) of the 
proteins were calculated with Melanie 3.0 (GeneBio) using identified proteins with 
known parameters as a reference. An expression change was considered significant 
if the intensity of the corresponding single spot differed reproducibly more than 
two-fold and was reproducible for all three experiments. 
  
Identification of altered proteins by mass spectrometry  
To identify low abundant proteins, the spots were excised from 2-D gels 
separated with 600 μg of protein, in-gel digested, and identified from the peptide 
fingerprints as described elsewhere [251]. Proteins were identified with the 
ProFound database, version 2005.02.14 (http://prowl.rockefeller.edu/prowl-
cgi/profound.exe) using the following parameters: 20 p.p.m.; 1 missed cut; MH+; 
+C2H2O2@C (Complete), +O@M (Partial). The identification of a protein was 
accepted if the peptides (mass tolerance 20 p.p.m.) covered at least 30% of the 
complete sequence. Sequence coverage below 20% was only accepted if at least 
three main peaks of the mass spectrum matched with the sequence and the 
number of weak-intensity peaks was clearly reduced. If the protein spot was 
detected at a lower molecular mass than expected, which indicates processing or 
fragmentation, the spot-specific peptides in the mass spectrum were also analyzed 
to confirm which parts of the corresponding protein sequence matched with these 
peptides. If the mass spectrum of the spot lacked peptides observed for the 
complete protein it was indicated as a protein fragment. Therefore, both the spot 
position observed by 2-DE and the specific peptides in the corresponding mass 
spectrum were analyzed to indicate a putative protein fragment. 
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Statistical analysis 
Arithmetic means of ROS pruduction and cell survival rates are presented 
with standard deviation with a 95% confidence value. Statistical analysis was 
carried out using independent samples t-test analysis. A p-value <0.05 was 
assumed to denote a significant difference.  
 
2.4 RESULTS 
2.4.1 Global translation impairment triggered by acetic acid 
Our previous work on the proteomic profile of acetic acid apoptosing cells has 
shown that translation is severely affected, indicating a failure of the protein 
synthesis machinery in these conditions [215]. To further elucidate the regulation 
of protein synthesis, the translation alterations occurring during acetic acid 
treatment were assessed. Although acetic acid-induced apoptosis is a paradigmatic 
scenario to study yeast cell death [41, 191, 199, 215, 252], a scale-up condition 
of acetic acid treatment for the induction of apoptosis in approximately 50% of the 
wild-type exponential S. cerevisiae cells was optimized. This scale-up allowed to 
collect high amounts of total cellular extracts and to isolate enough RNA to perform 
polysome profile studies and to evaluate the role of translation in this process. 
Results showed that 195 mM of acetic acid induces about 50% of apoptotic cell 
death upon 200 min treatment and this was the concentration selected for the 
studies herein described (Figure 8A). In a first approach to evaluate the rate of 
translation process during acetic acid treatment, the incorporation of L-
35
[S] 
methionine in the yeast cells was analyzed. After 15 min of acetic acid treatment, 
and even though the same amount of protein was loaded, as shown by Coomassie 
blue staining (Figure 8B), no protein synthesis was detected by chemiluminescence 
in total protein extracts of treated cells. This result suggests that L-
35
[S] methionine 
was unable to enter the cells (Figure 8B) and supports our previously published 
data suggesting the blockage of amino acid uptake in acetic acid treated cells, 
leading to a severe cellular amino acid starvation [215]. Thus, translation 
alterations during acetic acid-induced apoptosis were assessed. For such purpose, 
the polysomal profile of wild-type cells treated with two different acetic acid 
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concentrations (180 and 195 mM) was obtained. This analysis revealed an 
impairment of global translation in acetic acid treated cells, as reflected by the 
decrease of the polysomal fraction (corresponding to the polypeptide chains that 
are being actively assembled) and the increase of the monosomal fraction 
(corresponding to the small, large and both ribosomal subunits, 40s, 60s and 80s, 
respectively) (Figure 8C). This effect was shown to be dependent on the acetic acid 
concentration tested as cells treated with the highest concentration (195 mM) 
displayed a pronounced decrease of the polysomal fraction (Figure 8C). The impact 
of acetic acid on translation efficiency was further addressed by a kinetic analysis 
Figure 8 - Global translation impairment during acetic acid-induced apoptosis. (A) Kinetic 
analysis of the survival rate of wild-type S. cerevisiae cells untreated and treated with 195 mM 
of acetic acid. (B) Protein synthesis analysis of wild-type S. cerevisiae cells in the absence or 
presence of 195 mM of acetic acid during 15 min. Cultures were pulse-labelled with [
35
S] 
methionine during the final 5 min of the acetic acid treatment, and protein levels were analysed 
by SDS-PAGE. (C) Polysome profile of yeast cells treated with the indicated concentrations of 
acetic acid for 15 min. The peaks containing the small ribosomal subunit (40S), the large 
ribosomal subunit (60S), and both subunits (80S) are indicated. 
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of polysome profile in association with the kinetic analysis of cell viability 
throughout the 200 min of treatment with 195 mM acetic acid (Figure 8A, 9). The 
acetic acid concentration selected (195mM) induced a progressive decline of 
survival along the treatment time course, compatible with a first response to the 
imposed stress and a later activation of the apoptotic cell death. At 200 min of 
acetic acid treatment, a heterogeneous population where 40% of cells are still 
coping with stress but 60% have lost the proliferative capacity is observed (Figure 
8A). The analysis of polysome profile showed a decrease in the percentage of 
polysomes in acetic acid treated cells after 15 min that was aggravated at 60 min 
(Figure 9A). The impairment of translation was also confirmed by the observation 
of a decrease in the polysomal fraction and an increase in the monosomal fraction 
of acetic acid treated cells that was maintained and exacerbated throughout the 
200 min of acetic acid treatment (Figure 9B).  
Figure 9 – Translation impairment increases throughout the 200 min of acetic acid treatment. 
(A) Statistic analysis of the percentage of total mRNA present in the polysomal fractions in the 
absence or presence of 195 mM of acetic acid during 0, 15 and 60 min. (B) Kinetic analysis of 
the polysomal profile of wild-type cells treated with or without 195 mM of acetic acid reveals a 
gradual and non transient translation impairment. 
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These results showing that acetic acid affects both the initiation and the 
elongation steps of translation leading to a drastic reduction of the translation 
process efficiency raised three important questions: the cells are not able to recover 
from the acid stress imposed, translation control is an important event during the 
process of acetic acid-induced apoptosis, or both. 
 
2.4.2 Translation impairment induced by acetic acid is mediated by alterations in 
translation machinery 
The observation of global translation impairment upon acetic acid-induced 
apoptosis prompted us to investigate the cascade of events leading to this 
alteration. Thus, we decided to perform a kinetic analysis of the protein levels of 
the translation initiation factors 4A (eIF4A/Tif1/2p) and 4G (eIF4G/Tif4631/2p) 
Figure 10 - Global translation impairment during acetic acid-induced apoptosis is mediated by 
translation factors downregulation and post-translational modifications. (A) Immunoblot kinetic 
analysis of eIF2α (Sui2p) phosphorylation and translation initiation factors eIF2α (Sui2p), eIF4A 
(Tif1/2p) and eIF4G (Tif4631/2p) and translation elongation factors eEF1A (Tef1/2p) and eEF2 
(Eft1/2p) levels in wild-type S. cerevisiae cells upon treatment with or without (untreated) 195 
mM of acetic acid. Actin was used as loading control. (B) Survival assay of wild-type, TIF1 and 
EFT1 deleted strains upon acetic acid treatment. (C) Percentage of wild-type, tif1 and eft1 
cells exhibiting high levels of intracellular ROS detected by FACS measurements of the 
dihydrorhodamine 123 fluorescence. *p0.05 versus control, t-test, n=3. 
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and of the elongation factors 1A (eEF1A/Tef1/2p) and 2 (eEF2/Eft1/2p), previously 
shown in our proteomic analysis to be decreased upon acetic acid challenge [215]. 
The phosphorylation status of the translation initiation factor 2α (eIF2α/Sui2p) was 
also determined due to its well-known role on translation regulation [236, 253-
256]. Immunoblot analysis revealed that just after 15 min of acetic acid treatment, 
the previously shown impairment of translation was correlated to alterations in 
translation initiation (Figure 10A). An increase in the levels of phosphorylated 
eIF2 and a decrease in the levels of eIF4A (Figure 10A), suggested an 
impairment in the assembly of the translation initiation complex, crucial for the 
cap-dependent translation initiation [237], leading to a translation initiation 
impairment at early points of acetic acid treatment. The decrease in the levels of 
the elongation factors eEF1A and eEF2 and of the initiation factor eIF4G (a subunit 
of the mRNA cap-binding protein complex [237] was observed only at 120 min 
(Figure 10A). The concurred decrease of these translation factors at the same time 
point suggests that the drastic impairment of translation elongation only occurs 
after about 120 min (Figure 10A). These findings, together with the knowledge 
that eIF4G plays a role in yeast and mammalian internal ribosome entry site 
(IRES)-mediated translation [59, 82, 90, 227, 257-259] and that eEF1A 
increases the efficiency of the yeast IRES-mediated translation [232], raises the 
hypothesis that a minor selective translation mediated by cap-independent 
mechanisms might occur during acetic acid treatment.  
In order to assess the relevance of the above described translation factors for 
the modulation of the apoptotic process induced by acetic acid a survival assay 
with the respective deleted strains was performed. Deletion of SUI2 (eIF2α) and 
TIF4631/2 (eIF4G) genes lead to unviable strains and a reliable TEF1/2 (eEF1A) 
deleted strain is not available thus, we evaluated the resistance of TIF1 (eIF4A) 
and EFT1 (eEF2) deleted strains to acetic acid treatment (Figure 10B). Despite the 
fact that during acetic acid-induced apoptosis a decrease in the levels of both Tif1p 
and Eft1p is observed, the disruption of the respective genes leads to an increased 
resistance to acetic acid (Figure 10B). The deleted cells also displayed low reactive 
oxygen species (ROS) levels when compared to wild-type treated cells (Figure 
10C). These results suggest that the alterations occurring in the translation process 
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during acetic acid treatment are also contributing to the apoptotic process. Thus, 
the control of the translation process upon acetic acid treatment appears to be 
crucial to determine the fate of the cells treated with acetic acid. 
 
2.4.3 Gcn2p kinase modulates translation initiation impairment induced by 
acetic acid 
Gcn2p is the only kinase described to be responsible for the phosphorylation 
of eIF2 in yeast [253, 256, 260, 261]. Due to the observed increased levels 
Figure 11 - Gcn2 kinase modulation of translation alterations during acetic acid-induced 
apoptosis. (A) Comparison of the survival rate of wild-type and gcn2 S. cerevisiae cells upon 
treatment with the indicated concentrations of acetic acid; *p0.05 versus wild-type, t-test, n= 
3. (B) Immunoblot kinetic analysis of eIF2α (Sui2p) phosphorylation levels, translation initiation 
factors eIF2α (Sui2p), eIF4A (Tif1p) and eIF4G (Tif4631/2p) and translation elongation factors 
eEF1A (Tef1/2p) and eEF2 (Eft1/2p) levels in gcn2 S. cerevisiae cells upon treatment with or 
without (untreated) 195 mM of acetic acid. Actin was used as loading control. (C) Polysomal 
profile of GCN2-disrupted yeast cells treated with the indicated concentrations of acetic acid for 
15 min.  
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of eIF2 phosphorylated (Figure 10A), we decided to study the role of Gcn2p in 
the regulation of translation during acetic acid treatment. Thus, the resistance of 
the respective deleted strain to acetic acid treatment was studied. A more resistant 
phenotype of the GCN2 deleted cells was observed, when compared to the wild-
type cells (Figure 11A), associated with a drastic decrease in the phosphorylation 
levels of eIF2, observed by immunoblot analysis (Figure 11B). Nevertheless, 
phosphorylation of eIF2 was detected in the first time points of acetic acid 
treatment (Figure 11B) suggesting the presence of other undisclosed kinases 
capable of its phosphorylation. Abrogation of GCN2 also elicited an efficient 
translation as reflected by the levels of translation factors eIF4A, eIF4G, eEF1A and 
eEF2 (Figure 11B) and by the polysomal profile analysis (Figure 11C). These 
findings showed that acetic acid treatment leads to an impairment of translation 
initiation mainly regulated by the phosphorylation of eIF2 under the control of 
Gcn2p kinase. Disruption of GCN2 turns cells resistant to acetic acid, a phenotype 
associated with the recovery of translation competence. These data implicate the 
control of translation by Gcn2p in the progression of cell death induced by acetic 
acid.  
Besides Gcn2p involvement in the regulation of protein synthesis, this kinase 
has also been described as a cell cycle regulator of cells exposed to ultraviolet (UV) 
irradiation through a Gcn2-dependent checkpoint which delays cells entry into S 
phase [247]. In fact, when we analyzed the cell cycle profile of wild-type cells after 
acetic acid treatment, an arrest in the G0/G1 phase was observed [215]. However, 
in the GCN2 deleted strain this arrest in G0/G1 was alleviated (Figure 12A), 
suggesting that upon acetic acid treatment, the control of cell cycle related 
alterations, is under the regulation of Gcn2p kinase. Gcn2p is under control and 
repression by the target of rapamycin (TOR) pathway, responsible for the sensing of 
amino acid [237, 262-264], which was found to be inhibited during acetic acid-
induced apoptotic cell death [191, 215, 218]. It is well known that amino acid 
starvation-induced inhibition of TOR leads to induction of autophagy [265-272] 
through Gcn2p-dependent activation of Atg8p and Atg4p autophagic components 
[249]. Since our previous data showed that acetic acid-induced a severe 
intracellular amino acid depletion [215], a role for autophagy in this cell death 
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process was addressed despite the recent report that autophagy is not involved in 
acetic acid-induced apoptosis [201]. Atg8p (homologous to the mammalian LC3 
autophagic marker protein) is a phosphatidylethanolamine-conjugated ubiquitin-
like protein required for the formation of autophagosomes and a key molecular 
component of the autophagic process [273]. The analysis of the mRNA expression 
levels of ATG8 revealed a slight increase in ATG8 mRNA levels in wild-type cells 
after 200 min of incubation, both untreated and acetic acid treated cells, when 
compared to GCN2 disrupted cells (Figure 12B). To further assess the role of 
autophagy, wild-type and gcn2 cells were transformed with a plasmid expressing 
the Atg8p tagged with GFP and the cellular vacuoles were marked with a 
fluorescent dye which binds to the vacuolar membrane (FM 4-64). After acetic 
acid treatment we observed a discrete increase in the levels of GFP-Atg8p and its 
localization in the internal membrane of the vacuole in the wild-type-treated cells. 
In GCN2 deleted cells GFP-Atg8p was not found in the vacuoles (Figure 12C) and 
a diffuse green fluorescence, corresponding to the GFP-Atg8p, was observed all 
over the cell (Figure 12C). These results indicate that, as previously reported 
[249], in GCN2 deleted cells autophagy is abrogated. However, some activation is 
observed in wild-type treated cells. To further address the role of autophagy, a 
pharmacological modulation of the autophagic process during acetic acid-induced 
apoptosis was performed and the survival rate of wild-type and GCN2 deleted cells 
was assessed. For the inhibition of the autophagic process we used chloroquine 
which raises the lysosomal/vacuole pH leading to the inhibition of 
lysosome/vacuole-autophagosome fusion and lysosomal/vacuole protein 
degradation [274-278]. The induction of autophagy was achieved through a TOR-
dependent pathway, using rapamycin [265, 267-270, 272, 279], and by a TOR-
independent pathway using trehalose [280-282]. In wild-type acetic acid-treated 
cells, the inhibition of the lysosome/vacuole-autophagosome fusion by chloroquine 
led to a more pronounced cell death (Figure 12D). This result corroborates the 
previous observed colocalization of GFP-Atg8p with the vacuoles (Figure 12C), and 
suggests that upon acetic acid stimulus, activation of autophagy might be an 
important stress response mechanism. The incubation of the cells with acetic acid 
and rapamycin produced no synergistic effect (Figure 12D), most probably due to 
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Figure 12 - The role of cell cycle and autophagy regulation by Gcn2p during acetic acid-induced 
apoptosis. (A) Analysis of the percentage of cells in each phase of the cell cycle in wild type and 
GCN2 deleted cells untreated or upon 200 min of acetic acid treatment (195 mM). (B) 
Normalized relative expression levels of ATG8 mRNA (ACT1, TDH2, PDA1 and TUB1 as internal 
references) in wild-type and gcn2 cells. (C) Image of wild-type and gcn2 cells harboring a 
plasmid expressing the GFP-Atg8 protein and colocalization with the vacuoles stained with a 
fluorescent dye (FM 4-64). (D) Comparison of the survival rate of wild-type and gcn2 S. 
cerevisiae cells upon treatment with 195 mM acetic acid in the presence of 2.5 mM 
chloroquine, 1.1 M rapamycin or 2% trehalose.*p0.05 versus wild-type, t-test, n= 3. 
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the repression of TOR pathway promoted by acetic acid [215]. Autophagy 
induction by a pathway independent of TOR, and therefore independent of Gcn2p 
kinase, increased survival (Figure 12D) suggesting that during acetic acid-induced 
apoptosis the activation of a TOR pathway-independent autophagy might play a 
protective role. Results showed that the manipulation of the autophagic process, 
even at a basal level, induces different responses in wild-type cells to acetic acid 
treatment (Figure 12D). The fact that the inhibition of autophagy increased cell 
death and induction of autophagy protected from cell death mediated by acetic 
acid was a good evidence of the involvement of autophagy in the cell’s response to 
acetic acid treatment as a pro-survival mechanism. Nevertheless, GCN2 disrupted 
cells, showing low levels of ATG8 mRNA (Figure 12B), displayed an increased 
resistance to acetic acid treatment in the presence of both inhibitor and inducers of 
the autophagic process (Figure 12D). These data showed that Gcn2p role in acetic 
acid-induced apoptosis is related with the control/repression of cell cycle and cap-
dependent translation initiation, and not with the regulation of the autophagic 
process, being an important player in the cellular response to acetic acid. In fact, 
the pro-survival effect of autophagy during acetic acid treatment appears to be 
under the control of other pathways besides TOR pathway.  
 
2.4.4 Proteomic analysis of AIF1 deleted cells revealed alterations in 
translation factors upon acetic acid treatment 
In mammalian cells a regulation of translation initiation by the apoptosis-
Figure 13 – Survival assay for the optimization of the ideal acetic acid concentration for the 
induction of about 50% of cell death in wild-type and AIF1 deleted strain. 
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Figure 14 – Proteomic profile analysis of the acetic acid-induced Aif1p-independent apoptotic 
process. Representative silver-stained 2-D gel of total protein extracts wild-type and aif1 cells 
untreated and treated with 195 or 270 mM of acetic acid. Spots altered upon acetic acid 
treatment are represented by numbers (1 – 132).  
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inducing factor (AIF), homologous to yeast Aif1p, through interaction with subunit 
p44 of translation initiation factor 3 (eIF3g) has been described [76]. Since in 
yeast, Aif1p is a crucial player during acetic acid-induced apoptosis [41, 283-
285], we decided to evaluate the proteomic profile of aif1 cells using two 
different concentrations of acetic acid capable of inducing about 50% of apoptotic 
cell death in wild-type (195 mM) and in the more resistant AIF1 deleted cells (270 
mM) (Figure 13). By comparing the total cellular proteome of untreated and acetic 
acid- treated cells both in wild-type and AIF1 deleted cells, several spots were 
found affected (Figure 14). Among them 10 spots related with the translation 
process showed decreased intensity (Figure 15). Mass spectrometry analysis 
revealed that 1 spot corresponded to eEF1A (Tef1/2p), 3 spots to eIF4A (Tif1/2p) 
and 6 spots to eEF3A (Yef3p) (Figure 15), previously described as down-regulated 
in wild-type cells [215]. No differences in the levels of translation initiation and 
elongation factors were found comparing the proteomic profile of wild-type and 
Figure 15 – Deletion of AIF1 gene does not prevent alterations in translation machinery when 
cells are challenged with acetic acid. Enlarged 2-D gel parts represent altered proteins in total 
cellular extracts from wild-type and aif1 untreated and treated (195 mM and 270 mM acetic 
acid) yeast cells.  
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aif1 acetic acid treated cells. In fact, the treatment of AIF1 deleted cells with 
195mM or 270 mM of acetic acid, the later inducing 50% of cell death in aif1 
cells (Figure 13), revealed a decrease in the levels of translation factors eIF4A, 
eEF1A and eEF3A in both conditions (Figure 15). Results showed that translation 
machinery alterations are maintained in the absence of AIF1, suggesting that these 
alterations are independent of AIF1 and therefore Aif1p does not have a role in the 
regulation of translation during acetic acid treatment. 
 
2.4.5 Evaluation of apoptotic regulators translation during acetic acid-
induced apoptosis. 
 In mammalian cells, after an apoptotic stimulus, cap-dependent translation 
process is reduced [95, 243]. However, it has been reported that several apoptotic 
regulators, both inhibitors and inducers of apoptosis such as XIAP and Apaf-1, 
respectively [109, 132], are capable of being translated by an alternative 
mechanism, a selective cap-independent translation mechanism [95]. In yeast, 
cap-independent translation has also been described [227, 230], however, its 
occurrence in an apoptotic condition was never addressed. Based on the results 
described above and in the knowledge that the inhibition of translation elongation 
by cycloheximide prevents acetic acid-induced apoptosis [199], we hypothesized 
that although cap-dependent translation is impaired, an alternative translation 
might have a role in the apoptotic process. Therefore, we evaluated if in yeast, the 
translation of key apoptotic regulators, namely the pro-apoptotic protein Aif1p [41], 
crucial for the progression of acetic acid-induced apoptosis [41], and the anti-
apoptotic protein Bir1p (homologous of mammalian IAP proteins [197], such as 
XIAP) where translated during acetic acid treatment. Monosomal and polysomal 
fractions of wild-type cells (Figure 16A) were analyzed by RT-PCR. The analysis of 
the percentage of AIF1 mRNA present in each fraction of the polysomal profile 
revealed that despite of a small increase in the percentage of AIF1 in the 
monosomal fraction of treated cells (Figure 16B), there was still a significant 
amount of AIF1 mRNA in polysomal fractions upon 15 min (Figure 16B) and 30 
min (data not shown) of incubation with acetic acid, when compared to polysomal 
fractions of untreated cells. The results indicated that AIF1 mRNA translation is 
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Figure 16 - RT-PCR analysis of apoptotic regulators mRNA levels by upon acetic acid treatment. (A) 
Illustration of the polysomal fractions from which mRNAs were extracted and analysed by RT-PCR (M, 
monosomal fraction; P1, P2, P3 and P4, polysomal fractions). Analysis of the percentage of (B) AIF1, 
(C) BIR1, (D) TIF4632 and (E) CLN3 mRNA absolute expression, by RT-PCR and DNA electrophoresis 
in agarose gel, in each of the polysomal profile fractions of untreated and acetic acid treated cells (195 
mM) during 15 min. 
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occurring despite global translation impairment. As an opposite results almost no 
BIR1 mRNA was observed in the polysomal fractions upon 15 (Figure 16C) and 
30 min (data not shown) of acetic acid treatment. In fact, after acetic acid 
treatment, the percentage of BIR1 mRNA (Figure 16C) was reduced in the 
polysomal fractions and increased in monosomal fraction, both at 15 (Figure 16C) 
and 30 min of incubation (data not shown), indicating that upon acetic acid 
treatment the translation of this apoptotic regulator was reduced. These results 
were confirmed by the analysis, as a negative control, of the percentage of CLN3 
mRNA in each fraction (Figure 16E). Cln3 is a G1 cyclin described as unable of 
being translated by a cap-independent mechanism [234], and as expected the 
percentage of CLN3 mRNA in the polysomal fractions was also decreased in cells 
challenged with acetic acid (Figure 16E). eIF4G (TIF4632) was previously shown 
to be translated by an IRES-mediated cap-independent mechanism being also 
crucial for the efficient IRES-mediated translation of other mRNAs during nutrient 
starvation [227]. Therefore, the percentage of TIF4632 (eIF4G) mRNA was also 
assessed in an attempt to uncover if during acetic acid treatment, a condition 
known to induce amino acid starvation [215], and translation impairment, eIF4G 
was also translated. Results showed that, similar to AIF1 mRNA, TIF4632 mRNA 
levels slightly increased in the monosomal fraction but were strongly present in the 
polysomal fractions (Figure 16D) proving its ability to be translated during acetic 
acid treatment and suggesting the activation of an IRES-mediated translation. 
These results suggest that in yeast, like in mammalian cells, a cap-independent 
translation mechanism may be mediating the translation of several mRNAs 
involved in the modulation of the apoptotic process. 
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2.5 DISCUSSION 
Over the past few years, the involvement of the translation process in the 
regulation of apoptosis has emerged as a crucial mechanism both in mammalian 
and yeast cells [4, 59, 60, 95, 215, 218, 220, 243, 286, 287]. Since translation 
is the final stage in the course of genetic information flow, regulation at this level 
leads to a direct response to changes in physiological conditions. During S. 
cerevisiae acetic acid-induced apoptosis, a general amino acid starvation occurs 
and a translation reduction might allow cells to conserve resources and to initiate a 
reconfiguration of gene expression. In fact, our results clearly demonstrate a 
gradual impairment of the translation process during acetic acid treatment. In an 
early stage, a decrease in the levels of translation initiation factor eIF4A and an 
increase in the phosphorylation levels of eIF2α mediated by Gcn2p occur, leading 
to the inhibition of cap-dependent translation initiation. However, only at later time 
points a decrease in the levels of translation initiation factor eIF4G and elongation 
factors eEF1A and eEF2 is observed. In fact, in yeast, the eIF4G, a translation 
factor known to harbor an IRES in the 5’UTR [227], and eEF1A have been 
described as crucial factors for an efficient IRES-mediated translation [227, 232]. 
These data strongly suggest that although cap-dependent translation is impaired 
during acetic acid treatment, an alternative translation mechanism may be 
activated, such as the IRES-mediated process. A similar regulation of translation 
process has been described during oxidative stress induced by H
2
O
2
 [220], but an 
alternative translation mechanism has never been suggested. The alternative cap-
independent translation might be important in controlling the translation of proteins 
with a central role in the stress response to stress of cells struggling to survive and 
the apoptotic process of cells committed to death. Curiously, Gcn2 kinase appears 
to be a key mediator of the acetic acid-induced apoptosis, since deletion of GCN2 
gene reverts not only the previously described decrease in eIF4A, eEF1A and eEF2 
levels, but also the eIF2 phosphorylation, leading to unblocked translation and to 
the abrogation of acetic acid-induced cell death. Besides Gcn2p role in the control 
of translation initiation, this kinase is also involved in the regulation of other 
processes, such as cell cycle [247] and autophagy [249]. Investigation of the 
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contribution of these processes for Gcn2 key participation in the acetic acid-
induced apoptosis revealed that cell cycle arrest in G0/G1 phase upon acetic acid 
treatment [215] is mediated by Gcn2p.  
Although we could not detect a marked autophagic response after 200 min of 
acetic acid treatment in the wild-type strain, a slight increase in the levels of ATG8 
mRNA detected by RT-PCR and Atg8p visualized by epifluorescence microscopy 
analysis of Atg8p-GFP localization with the cell vacuoles suggest that autophagy 
might be activated during acetic acid treatment. Furthermore, the pharmacological 
modulation of the autophagic process revealed that in acetic acid challenged cells 
autophagy acts as a pro-survival mechanism in response to the acid stress despite 
the diminished levels of ATG8 after 200 min of acetic acid treatment. These data 
made us hypothesize that autophagy might be activated during yeast cells early 
response to stress decreasing during the course of acetic acid treatment due to the 
activation of the apoptotic cascade. However, the activation of autophagy during 
acetic acid treatment appears to be mediated by other autophagy regulators 
besides Gcn2p. Thus, these studies allowed the elucidation of Gcn2p function 
during acetic acid-induced apoptosis, showing the critical contribution of this 
kinase to the inhibition of cap-dependent translation initiation and cell cycle arrest, 
increasing the knowledge on the acetic acid apoptotic cascade. 
In mammalian cells, the control of translation initiation by the apoptosis 
inducing factor 1 (AIF1), homologous of yeast Aif1p, has been described [76]. 
Aif1p is a crucial player of yeast acetic acid-induced apoptosis [41]. Thus, a role 
for this pro-apoptotic protein in translation machinery alterations during acetic acid 
treatment was address through proteomic analysis of AIF1 deleted cells treated 
with acetic acid. The proteomic analysis of wild-type and AIF1 deleted cells 
showed the same alterations in the levels of translation factors upon acetic acid 
treatment. A decrease in the levels of translation factors eIF4A, eEF1A and eEF3 in 
AIF1 deleted cells was observed both in acetic acid-induced stress (195 mM) and 
cell death conditions (270 mM) proving that, in yeast, Aif1p is not involved in the 
control of translation initiation during apoptosis. In fact, it appears that it is the 
translation process that regulates Aif1p function in apoptosis. Polysomal fractions 
RT-PCR analysis shows that AIF1 as well as eIF4G (TIF4632) mRNAs are 
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efficiently translated upon acetic acid treatment despite the observed impairment of 
cap-dependent translation suggesting the activation of an alternative cap-
independent mechanism mediating AIF1 and eIF4G mRNA translation, during 
acetic acid treatment.  
Altogether, our data demonstrate the importance of translation control during 
acetic acid treatment at a concentration that induces a stress response in 40% of 
the cells and commits to death the remaining 60% of the cells upon 200 minutes 
of treatment. The translation alterations observed in this heterogeneous population 
strongly suggest that translation control is important both for the cell survival 
response and the cell death process. Furthermore, this study highlighted some of 
the translation regulatory mechanisms controlling acetic acid induced apoptosis. 
The early impairment of cap-dependent translation initiation, mediated by Gcn2p, 
and the later decrease in the levels of eIF4G, eEF1A and eEF2 strongly suggest the 
activation of an alternative IRES-mediated cap-independent translation during 
acetic acid treatment. This cap-independent translation appears to mediate the 
translation of AIF1 and eIF4G (TIF4632) mRNAs during acetic acid treatment. 
AIF1 is a pro-apoptotic factor and its translation during acetic acid treatment is 
clearly related to the cell death process. However, IRES-mediated translation of 
eIF4G has been related to nutrient starvation-induced stress conditions [227], 
therefore its translation during acetic acid treatment might be related with the 
cellular response to stress.  
These results showed an intricate network of regulatory pathways in the 
course of the apoptotic process induced by acetic acid, thus opening new 
perspectives for future investigations. In this apoptotic scenario, translation process 
appears to be an important link for the different pathways. 
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CHAPTER 3 
 
Metacaspase-mediated alterations in translation machinery during 
apoptosis 
Silva, A., Almeida, B., Sampaio-Marques, B., Reis, M.I.R., Silva, T.L., Logarinho, E., 
Rodrigues, F., Ohlmeier, S., Gourlay, C.W., do Vale, A. and Ludovico, P.
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3.1 ABSTRACT 
In mammalian cells, translation factors are substrates of caspases during the 
apoptotic process. In yeast, metacaspase (Yca1p), a caspase-like protease, is 
required for the execution of apoptosis upon a wide range of stimuli. However, the 
specific degradome of this protease has not been unraveled so far. In a search for 
conserved translation factors targeted as substrates by metacaspase, a degradome 
and deletion analysis were performed using two paradigmatic scenarios of yeast 
apoptosis, H
2
O
2
 and acetic acid. Degradome analysis revealed several spots 
corresponding to proteins fragments. However, only a small group of individualized 
spots were identified corresponding to the glycolytic enzyme, the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) [219]. Nitric oxide (NO) signaling was shown 
to be required for metacaspase specific GAPDH cleavage [219]. 
In a search for possible mitochondrial substrates, mitochondrial proteomic 
analysis showed the cleavage and translocation of translation elongation factors 1A 
(eEF1A) and 2 (eEF2) to mitochondria. Furthermore, a proteinase K assay revealed 
that eEF1A N-terminal fragments are imported to mitochondrial matrix, performing 
a putative pro-apoptotic role, upon acetic acid-induced apoptosis [215]. Interaction 
between eEF1A and Dnm1p [288], a dynamin-related GTPase required for 
mitochondrial fission [289], has been previously reported [288]. Nevertheless, 
Dnm1 appears to play no role in the eEF1A mitochondrial localization. eEF1A is a 
yeast well described bona fide actin binding and bundling protein, and its 
translocation to mitochondria was correlated with a decrease of its binding to actin 
leading to alterations in the actin cytoskeleton [290]. Therefore, the role of 
mammalian eEF1A1 isoform and DRP1, a Dnm1p homolog, in the actin 
cytoskeleton organization and cell survival was also addressed in HeLa cells during 
staurosporine-induced apoptosis. These results unravel eEF1A as an important 
player in cell death process both in yeast and mammalian cells, in a way unrelated 
to its function in translation. Nevertheless, eEF1A cleavage upon acetic acid 
treatment proved not to be mediated by metacaspase. Despite that, the analysis of 
other translation factors levels during acetic acid-induced apoptosis in the absence 
of metacaspase, suggests a role for this protease in the activation of Gcn2 kinase-
mediated phosphorylation of subunit α of translation initiation factor 2 (eIF2α) and 
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in the downregulation of the translation initiation factor 4A (eIF4A), observed 
during the apoptotic process. However, to assess if this regulation is mediated by 
direct interaction of Gcn2p and eIF4A with metacaspase or by interaction with its 
upstream regulators further studies are required. In conclusion, in this work, we 
demonstrate eEF1A and eEF2 cleavage and translocation to mitochondria, where 
they appear to play a role unrelated to translation. Moreover, we highlight GAPDH 
as a substrate of metacaspase, speculating its possible role in the regulation of 
translation, and reveal translation initiation factors eIF2α and eIF4A as 
downstream targets of the metacaspase cascade, in apoptotic conditions, 
consolidating the existence of conserved molecular pathways targeted during 
apoptosis from yeast to mammals.  
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3.2 INTRODUCTION 
The apoptotic cascade is orchestrated by different “executioner” caspases 
which target specific substrates within the cell producing the biochemical and 
morphological alterations associated to apoptosis. Fragmentation of translation 
factors by caspases, namely translation initiation factor 2 subunit α (eIF2α), 3 
(eIF3), 4B (eIF4B) and 4G (eIF4G) [59, 72, 83], as a mechanism of translational 
control during the apoptotic process is widely described in mammalian cells [59, 
72, 83] [4, 66, 67, 95, 286, 287]. One of the strategies reported is the 
acquisition of distinct functions, unrelated with the translation process, of 
translation factors upon the induction of apoptosis. The translation elongation 
factor 1A (eEF1A) is committed to translation through the delivery of aminoacyl-
tRNAs (AA-tRNAs) to ribosomes, but has also been implicated in several other 
processes, such as, nuclear export of proteins [291], cancer, aging and apoptosis 
[287, 288, 292-294]. Moreover, eEF1A plays an imperative role, conserved from 
yeast to mammalian cells, in the control of the actin cytoskeleton organization, by 
a direct C-terminal interaction with F-actin. A deregulation of eEF1A levels within 
the cell leads to severe actin cytoskeleton alterations [289, 295-300]. In 
Trypanosoma brucei, this translation factor was even associated to the import of 
tRNAs to the mitochondria [301, 302]. Nevertheless, the role of eEF1A in tRNA 
import to mitochondria in yeast and mammalian cells [303-305] was never 
addressed. In yeast, interaction between eEF1A, codified by TEF1 and TEF2 
isoforms [306-308], and Dnm1p, a dynamin-related GTPase with a role in 
mitochondrial fission, has been established [288]. Despite the function of eEF1A 
isoforms in the translation process, these isoforms appear to acquire divergent 
functions in other processes, both in yeast and in mammalian cells [287, 309-
313]. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a well-known 
glycolytic enzyme playing multiple functions and interacting with multiple partners 
independent of its role in energy metabolism [314-316]. In fact, a role of GAPDH 
in the repression of specific mammalian cells mRNAs translation, such as 
angiotensin II type 1 receptor (AT1R) [317] and p53 [134, 318], which was 
proven to harbor an internal ribosome entry site (IRES) sequence in the mRNA 
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[119-121], through binding to the 3’ untranslated region (3’UTR) of the mRNAs 
[134, 317] has been suggested. The repression of virus translation by GAPDH, 
through interaction with IRES present in the virus mRNAs [135-138], has also 
been reported. The specific cleavage of GAPDH by caspase-1 during apoptosis 
[139], a process known to require IRES-mediated translation [4, 95, 243], 
suggests a tight regulation of GAPDH function in the repression of mRNAs 
translation during apoptosis. 
Although in yeast, a member of a family of caspase-like proteases [40], 
metacaspase (Yca1p), has been reported as an apoptotic executor upon a wide 
range of either physiological or external stimuli [40, 214], the substrates targeted 
by this protease are still unknown. Yeast single metacaspase is a type I 
metacaspase with a prodomain, similar to that of inflammatory and pro-apoptotic 
initiator caspases [319], that is processed during its activation [40]. Conflicting 
data exists regarding the ability of yeast metacaspase to cleave typical mammalian 
caspase substrates [40]. However, yeast metacaspase was shown to cleave P1-Arg 
and P1-Lys substrates similarly to plant metacaspases [48, 320]. Metacaspases 
activity was also found to be regulated through S-nitrosation and thus dependent 
on the endogenous levels of nitric oxide (NO) [210]. Accordingly, during yeast 
H
2
O
2
-induced apoptotic conditions [189], a cell death process dependent on 
metacaspase activity [40] and NO generation [211, 212], metacaspase activity 
and cell death are abolished in the presence of L-NAME, an inhibitor of NO 
synthesis [211, 212]. In this context, the identification of yeast metacaspase 
specific substrates mediating translation alterations and of putative new functions 
performed by translation factors, unrelated to the translation process, during acetic 
acid treatment is crucial. This information is of utmost importance for the 
integrated understanding of translation process contribution to the acetic acid-
induced apoptosis and to clarify if a conservation of the apoptotic targeted 
pathways occurs from yeast to mammalian.  
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3.3 MATERIALS AND METHODS 
Strains, media and treatments  
Saccharomyces cerevisiae strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 
ura3Δ0) and its isogenic derivatives yca1 and dnm1 (EUROSCARF, Frankfurt, 
Germany) were used. Strain M198 (MATa leu2-3,112 his4-713, met2-1, ura3-
52, trp1-Δ1 Δtef1::LEU2) (kindly provided by Prof. Sandbaken), corresponding to 
Δtef1 cells previously described in [35], was also used. For construction of the 
metacaspase-overexpressing strain, YCA1 was amplified by PCR (primers 5’-
ccgggaattcgatgtatccaggtagtggacgt-3’ and 5’-ccg 
gggatccctacataataaattgcagatttacgtc-3’), using genomic DNA, isolated from BY4742 
strain and cloned into the EcoRI and BamHI sites of pGREG546 (EUROSCARF, 
Frankfurt, Germany), in order to express a N-terminal GST fusion under the control 
of a galactose-inducible promoter, generating pGREG546YCA1. Strain Δyca1 was 
transformed with pGREG546YCA1, generating strain YCA1
overexp
. Construction of 
p416 plasmids eEF1A and eEF1A fragments N6C458, N1C146 and N1C177 
were amplified by PCR using the primers described in Table 5, digested and cloned 
into the BamHI and SalI sites of p416 which displays a galactose-inducible 
promoter. Wild-type cells were transformed with the plasmids. For construction of 
Gene Primer sequence 
p416 eEF1A N1C458 
F: GGCCGGATCCATGGGTAAAGAGAAGTCTGAC 
R: GGCCGTCGACTTACTTAGCAGCCTTTTGAGCAGC 
p416 eEF1A N6C458 
F: GGCCGGATCCTCTGACATTAACGTTGTCGTT 
R: GGCCGTCGACTTACTTAGCAGCCTTTTGAGCAGC 
p416 eEF1A N1C146 
F: GGCCGGATCCATGGGTAAAGAGAAGTCTGAC 
R: GGCCGTCGACTCTAACACCCAAGGTGAAAGC 
p416 eEF1A N1C177 
F: GGCCGGATCCATGGGTAAAGAGAAGTCTGAC 
R: GGCCGTCGACCTTGATAAAGTTGGAGGTTTC 
pYX222 eEF1A N1C458 
F: GCGGGATCCATGGGTAAAGAGAAGTCTCAC 
R: GCGGGATCCTTTCTTAGCAGCCTTTTGAGCAGCC 
pYX222 eEF1A N6C177 
F: GCGGGATCCTCTCACATTAACGTTGTCGTT 
R: GCGGGATCCCTTGATAAAGTTGGAGGTTTC 
  
Table 5- List of primers for construction of p281 monocistronic plasmids. 
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pYX222 plasmids harboring the eEF1A gene or eEF1A N6C177 between a 
mitochondrial localization sequence (MLS) and a DsRed reporter gene eEF1A gene 
and N6C177 fragment were amplified by PCR using the primers described in Table 
1, digested with BamHI, and cloned into pYX222 vector between the N-terminal 
MLS and the C-terminal DsRed (kindly provided by Dr. Stephan Jacobs). tef1 
cells were transformed with the plasmids.  
Wild-type cells expressing the p416 plasmids with the eEF1A fragments were 
grown until exponential growth phase (OD640nm=0.5) on synthetic complete (SC) 
medium containing glucose (2%, w/v), yeast nitrogen base (0.17%, w/v, Difco), 
300 mg/L of L-leucine, 50 mg/L of L-histidine and 50 mg/L of L-lysine. Cells were 
washed, ressuspended in SC medium containing galactose (2%, w/v) and 
incubated at 26ºC with stirring (150 r.p.m.) to induce the eEF1A total protein and 
fragments expression. After 16 hours, 10
8
 cells/mL were harvested and 
ressuspended in fresh SC medium with galactose (2%, w/v) (pH 3.0), treated with 
210 or 225 mM of acetic acid and incubated for 200 min at 26ºC with stirring 
(150 r.p.m.).  
For H
2
O
2 
treatment, yeast cells were grown until the early stationary growth 
phase in liquid YPD medium containing glucose (2%, w/v), yeast extract (0.5%, 
w/v) and peptone (1%, w/v), harvested and ressuspended (10
7
 cells/mL) in fresh 
YPD medium followed by the addition of 0.5, 1, 1.5 and 2 mM H
2
O
2
 and 
incubation for 200 min at 26°C with stirring (150 r.p.m.) in the dark, as previously 
described [211]. For acetic acid treatment, S. cerevisiae cells were grown until the 
middle exponential phase in liquid YPD medium, harvested, ressuspended in fresh 
medium (pH 3.0) and incubated at 26ºC for 1h. Then cells were ressuspended 
(10
8
 cells/mL) in fresh medium (pH 3.0) followed by the addition of 180, 195, 
210 or 225 mM of acetic acid and incubation during 0, 15, 30, 60, 120 and 200 
min at 26ºC with stirring (150 r.p.m.). After H
2
O
2
 or acetic acid treatment, 
approximately 300 cells were spread on YPD agar plates and viability was 
determined by counting colony forming units after 2 days of incubation at 26ºC 
[199]. Cells were also harvested for protein extraction and immunoblot analysis as 
described below.  
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HeLa cells were cultured in DMEM medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (FBS), 1% glutamax, and 1% 
antibiotics mixture (Invitrogen) and grown at 37°C in a 5% CO
2
 humidified 
chamber. eEF1A1 (NM_001402.5), eEF1A2 (NM_001958.2), and DNM1 
(NM_005690.3) RNAi depletions were achieved using a pool of small interfering 
siRNAs (siRNAs) generated from nonconserved sequences (nucleotides 1383-
2519, 327-1334, and 348-1757 from the start codon, respectively) with the 
BLOCK-iT Dicer RNAi kit accordingly to the manufacturer's instructions 
(Invitrogen). Cells (10
5
 cells/well) were plated in DMEM medium with 5% FBS and 
without antibiotics, on six-well plates (Nunc, Naperville, IL) containing poly-L-
lysine–coated glass coverslips. Two hours later, cells were transfected with siRNA-
oligofectamine complexes prepared in Opti-MEM I medium (Invitrogen) according 
to the manufacturer's instructions and analyzed 24 or 48 h after transfection. Mock 
transfections were used as control. Afterwards, cells were treated with 
staurosporine for 18h (0.1 μM, Sigma, St. Louis, MO), and cell viability using the 
CellTiter-Blue® Cell Viability Assay (Promega, Madison, USA), 
immunofluorescence of eEF1A and actin, and apoptosis detection by TUNEL assay 
were assessed, as described below. 
 
Metacaspase overexpression and activation 
Strain YCA1
overexp
 was grown until exponential growth phase (OD640nm=0.5) 
on synthetic complete (SC) medium containing glucose (2%, w/v), yeast nitrogen 
base (0.17%, w/v, Difco), 300 mg/L of L-leucine, 50 mg/L of L-histidine and 50 
mg/L of L-lysine. Cells were washed, ressuspended in SC medium containing 
galactose (2%, w/v) and incubated at 26ºC with stirring (150 r.p.m.) to induce 
metacaspase overexpression. After 16 hours, 10
7
 cells/mL were harvested and 
ressuspended in fresh SC medium with galactose (2%, w/v), and metacaspase was 
activated by the addition of 2 mM of H
2
O
2
 [40] and incubation for 200 min at 
26ºC with stirring (150 r.p.m.).  
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Preparation of protein extracts 
For total protein extracts, untreated, H
2
O
2
- and acetic acid-treated cells were 
collected and disrupted using glass beads in lysis buffer [1% v/v Triton X-100, 120 
mM NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA, 10% v/v Glycerol, 1 mM PMSF 
and Complete Mini protease inhibitor cocktail (Roche, Mannheim, Germany)] as 
described in [211, 215]. For mitochondrial protein extracts, yeast cells were 
harvested and cell wall was digested with zymolyase buffer [2 M Sorbitol-D, 
Phosphate buffer 1 M (pH 7.5), Zymolyase 20.000 U, 125 mM β-
mercaptoethanol, 0.5 M EDTA] at 30ºC for 1 hour. Protoplasts were disrupted 
with lysis buffer [Sorbitol-D 0.5 M, Tris 20 mM, EDTA 1 mM, and 2.85 mM 
phenylmethanesulphonyl fluoride (PMSF)] using a Potter homogenizator. 
Mitochondria extracts were separated, washed by high speed centrifugation at 
12000 r.p.m. for 15 min at 4ºC (Beckman Coulter, JA-25.50 Rotor) and 
ressuspended in sorbitol buffer [0.5 Sorbitol-D, 5 mM EDTA, 50 mM Tris]. HeLa 
cells were collected by centrifugation and disrupted using RIPA buffer [50 mM 
Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% Na-deoxycholate, 0.1% SDS]. 
Protein concentration was determined by Bradford method [321] and protein 
aliquots of yeast total extracts (1 mg, 40 µg), yeast mitochondrial extracts (600 
µg, 100 µg and 40 µg) and HeLa cells total extracts (40 µg) were stored at -20ºC. 
 
Digestome analysis 
Digestome analysis was performed according to the methodology previously 
described in [322], with adaptations. Four hundred micrograms of total protein 
extracts obtained from untreated wild-type yeast cells or HeLa cells were resolved 
by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 12% 
(first dimension). After migration, the lanes were excised and treated as described 
in [322], soaked in digestion buffer [50 mM Tris-HCl, 150 mM NaCl and 10 mM 
DTT] with 5 mg of either active metacaspase-enriched extracts (obtained from 
H
2
O
2
-treated YCA1overexp cells) or inactive metacaspase-enriched extracts 
(obtained from H
2
O
2
-treated yca1 or untreated YCA1overexp cells), incubated 
overnight at 37ºC, washed with ultrapure water and incubated in loading buffer 
[50 mM Tris-HCl (pH 6.8), 2% SDS, 0.1% bromophenol blue, 10% glycerol, 
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2.5% β-mercaptoethanol] for 10 min at 95ºC. After cooling, lanes were subjected 
to a second dimension SDS-PAGE. Proteins in the gels were immunoblotted as 
described below or stained using Colloidal Blue Staining Kit (Invitrogen) for mass 
spectrometry identification.  
 
2-DE 
Three independent samples from mitochondrial extract were used to verify the 
reproducibility for each of the two conditions (control and 195 mM acetic acid-
treated cells) and each sample separated within four 2-D gels. For 2-DE the 
protein pellet was ressuspended in urea buffer (8 M urea, 2 M thiourea, 1% [w/v] 
CHAPS, 20 mM DTT, 0.8% [v/v] carrier ampholytes and Complete Mini protease 
inhibitor cocktail). The protein separation was done as previously described [164]. 
Briefly, the protein solution was adjusted with urea buffer to a final volume of 350 
µL and in-gel rehydration was performed over night. Isoelectric focusing (IEF) was 
carried out in IPG strips (pH 3–10, non linear, 18 cm; GE Healthcare, Uppsala, 
Sweden) with the Multiphor II system (GE Healthcare) under paraffin oil for 55 
kVh. SDS-PAGE was done overnight in polyacrylamide gels (12.5% T, 2.6% C) 
with the Ettan DALT II system (GE Healthcare) at 1-2 W per gel and at 12ºC. The 
gels were silver stained and analyzed with the 2-DE image analysis software 
Melanie 3.0 (GeneBio, Geneva, Switzerland). The apparent isoelectric points (pI) 
and molecular masses (Mr) of the proteins were calculated with Melanie 3.0 
(GeneBio) using identified proteins with known parameters as a reference. An 
expression change was considered significant if the intensity of the corresponding 
single spot differed reproducibly more than two-fold and was reproducible for all 
three experiments. 
  
Identification of altered proteins by mass spectrometry  
To identify low abundant proteins, the spots were excised from 2-D gels 
separated with 600 μg of protein, in-gel digested, and identified from the peptide 
fingerprints as described elsewhere [251]. Proteins were identified with the 
ProFound database, version 2005.02.14 (http://prowl.rockefeller.edu/prowl-
cgi/profound.exe) using the following parameters: 20 ppm; 1 missed cut; MH+; 
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+C2H2O2@C (Complete), +O@M (Partial). The identification of a protein was 
accepted if the peptides (mass tolerance 20 ppm) covered at least 30% of the 
complete sequence. Sequence coverage below 20% was only accepted if at least 
three main peaks of the mass spectrum matched with the sequence and the 
number of weak-intensity peaks was clearly reduced. If the protein spot was 
detected at a lower molecular mass than expected, which indicates processing or 
fragmentation, the spot-specific peptides in the mass spectrum were also analyzed 
to confirm which parts of the corresponding protein sequence matched with these 
peptides. If the mass spectrum of the spot lacked peptides observed for the 
complete protein it was indicated as a protein fragment. Therefore, both the spot 
position observed by 2-DE and the specific peptides in the corresponding mass 
spectrum were analyzed to indicate a putative protein fragment. 
 
Proteinase k assay 
Three aliquots of 100 µg mitochondrial protein extracts of each sample were 
centrifuged at 13000 r.p.m. for 10 min at 4ºC. Supernatants were discarded and 
two aliquots pellets (1 and 2) of each sample were ressuspended in 500 µL of HS 
buffer [0.6 M Sorbitol-D, 20 mM HEPES-KOH, pH 7.4] and the other (3) was 
ressuspended in H buffer [20 mM HEPES-KOH, pH 7.4]. 5 µL of dH
2
O was added 
to pellet 1 and 5 µL of 10 mg/mL proteinase K to pellets 2 and 3. Mitochondrial 
extracts were incubated for 25 min on ice and 5 µL of 0.2 M PMSF was added to 
each sample followed by 5 min incubation on ice. Samples were centrifuged at 
13000 r.p.m. for 10 min at 4ºC, pellets were ressuspended in HS buffer, 
precipitated overnight in acetone, and centrifuged at 13000 r.p.m. for 30 min at 
4ºC. Supernatants were discarded, pellets were dried, ressuspended in 30 µL of 
Laemmli buffer (BioRad) and immunoblotted as described in below. 
 
Immunoprecipitation 
Anti-actin antibody was added to 1 mg of total protein extracts from 
untreated and acetic acid treated yeast cells in a total volume of 500 µL and 
incubated for 4h at 4ºC on a shaker. Afterwards, 20 µL of washed protein A/G 
agarose beads (Pierce) were added to each sample and incubated overnight at 4ºC 
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on a shaker. Agarose beads were collected by centrifugation (3000 rpm, 1min, 
4ºC), washed twice with 1 mL ice-cold lysis buffer [1% v/v Triton X-100, 120 mM 
NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA, 10% v/v Glycerol, 1 mM PMSF and 
Complete Mini protease inhibitor cocktail (Roche, Mannheim, Germany)] and with 
1mL ice-cold wash buffer [0.1% v/v Triton X-100, 120 mM NaCl, 50 mM Tris-HCl 
pH 7.4, 2 mM EDTA and 10% v/v Glycerol]. Afterwards, agarose beads were 
eluted in 30 µL of Laemmli buffer (BioRad), boiled for 5 min to dissociate the 
immunocomplexes from the beads and collected by centrifugation (10000 r.p.m., 
1min). The supernatant fraction was immunoblotted as described in below. 
 
Immunoblotting 
Yeast total and mitochondrial protein extracts, mitochondrial extracts from 
proteinase K assay, supernatants from actin immunoprecipitation and HeLa cells 
total extracts were resolved on a 12% SDS-PAGE gel and transferred to a 
nitrocellulose membrane (Amersham) over 90 min at 100 V. Total protein extracts 
of the digestome analysis were probed with a monoclonal mouse anti-GAPDH 
(MAB474, Chemicon) as described [211] and a polyclonal rabbit anti-S-nitroso-
cysteine (CSNO) (N5411, Sigma-Aldrich) at a dilution of 1:500. Total protein 
extracts of H
2
O
2
- and acetic acid-treated cells were probed with polyclonal rabbit 
Ser51 phosphorylated eIF2 (Sui2) antibody (1:2000, Upstate), polyclonal rabbit 
anti-eIF2 (1:2000, Cell Signaling Technology), polyclonal rat anti-eIF4G 
(Tif4631/Tif4632p) (1:1000, kindly provided by Michael Altmann), polyclonal 
rabbit anti-eEF2 (Eft1/2p) (1:15000), polyclonal rabbit anti-eEF1A (Tef1/2p) 
(1:15000, both antibodies were kindly supplied by Prof. T.G. Kinzy), polyclonal 
rabbit anti-eIF4A (Tif1/2p) (1:15000, kindly supplied by Prof. M. Montero-Lomelí), 
polyclonal goat anti-actin (1:5000, kindly provided by Campbell Gourlay), 
monoclonal rabbit anti-aconitase antibody (1:1500, kindly provided by Lill, R.) and 
monoclonal mouse anti-porin antibody (1:5000, MAB474, Chemicon). Membranes 
of HeLa cells protein extracts were probed with polyclonal mouse anti-eEF1A 
(1:750, Santa Cruz Biotechnology, Inc) and polyclonal goat anti-actin (1:300, 
Santa Cruz Biotechnology, Inc). Horseradish peroxidase (HRP)-conjugated anti-
rabbit, anti-rat, anti-goat and anti-mouse IgG secondary antibodies (Cell Signaling 
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Technology) were used, at a dilution of 1:5000 and detected using an enhanced 
chemiluminesce’s kit (Pierce). 
 
Assessment of intracellular reactive oxygen species (ROS) 
Free intracellular ROS were detected with dihydrorhodamine 123 (DHR123) 
(Molecular Probes, Eugene, OR, USA). DHR123 was added from a 1 mg/mL stock 
solution in ethanol, to 5x10
6
 cells/mL suspended in PBS, reaching a final 
concentration of 15 µg/mL. Cells were incubated for 90 min at 30°C in the dark, 
washed in PBS and analyzed by flow cytometry. Flow cytometric assays were 
performed on a BD LSR II™ (Becton Dickinson, NJ, USA) using BD FACSDiva 
Software 6.0 (Becton Dickinson, NJ, USA). Twenty thousand cells per sample were 
analyzed using the FlowJo software (Tree Star, Ashland, OR, USA). Data express 
the percentage of DHR123-positive cells compared to the total number of counted 
cells. 
 
TUNEL assay 
DNA strand breaks were assessed by Terminal Deoxynucleotidyl Transferase-
mediated dUTP Nick End Labeling (TUNEL) assay with the In situ Cell Death 
Detection Kit, POD (Roche Applied Science, Indianapolis, IN). Yeast cells were 
initially fixed with 3.7% formaldehyde followed by digestion of the cell walls with 
lyticase. After preparation of cytospins, the slides were rinsed with PBS, incubated 
in permeabilization solution (0.1%, v/v, Triton X-100 and 0.1%,w/v, sodium 
citrate) for 3 min on ice, rinsed twice with PBS, and incubated with 10 L of 
TUNEL reaction mixture (terminal deoxynucleotidyl transferase and FITC-dUTP) for 
60 min at 37ºC . Finally, the slides were rinsed three times with PBS and 
incubated with 40 µl of PI/RNase solution (PI 50 µg/mL and RNase 12.5 µg/mL) 
in Tris buffer (10 mM, pH 7.0) for 20 min at 37ºC in the dark. Coverslip was 
mounted with a drop of anti-fading agent Vectashield (Molecular Probes, Eugene, 
OR). HeLa cells DNA strand breaks were assessed according to the manufacturer's 
instructions. Cells were visualized with an Olympus PlanApo 60X/oil objective, with 
a numerical aperture of 1.42. For quantification of TUNEL-positive cells, at least 
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400 cells from three independent assays were counted. Data express the 
percentage of TUNEL-positive cells compared to the total number of counted cells. 
 
Immunofluorescence 
HeLa cells were fixed for 20 min in freshly prepared 2% paraformaldehyde 
(Sigma) in phosphate-buffered saline (PBS), permeabilized with 0.5% Triton X-100 
in PBS for 5 min, washed in PBS and blocked with 10% FBS. Primary antibodies 
were used as follows: mouse anti-eEF1A (1:250, Cruz Biotechnology, Inc) and 
goat anti-actin (1:300, Cruz Biotechnology, Inc). Alexa Fluor 488, and 568 
conjugated secondary antibodies were used at 1:1500 (Molecular Probes, Eugene, 
OR) and DNA was stained using 4,6-di-amino-2-phenyl-indole dihydrochloride 
(DAPI) (Sigma). Most images were acquired as Z-stacks with 0.2–0.3-μm spacing 
using a 60x 1.42 NA objective on an Olympus FluoView FV1000 confocal 
microscope.  
 
Statistical analysis  
Arithmetic means of free intracellular ROS, TUNEL staining and cell survival 
rates are presented with standard deviation with a 95% confidence value. 
Statistical analysis was carried out using independent samples t-test analysis. A p-
value <0.05 was assumed to denote a significant difference.  
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3.4 RESULTS 
To disclose if translation factors are specific substrates of yeast metacaspase 
in yeast apoptotic scenarios associated with an impairment of translation process, 
namely H
2
O
2
- [220] and acetic acid-induced apoptosis (chapter 2), a digestome 
analysis [322] and a mutagenesesis analysis of YCA1 deleted cells were 
performed. 
 
3.4.1 Metacaspase-mediated alterations during H
2
O
2
-induced 
apoptosis 
 
3.4.1.1 Digestome analysis revealed GAPDH as a cleavage target of 
metacaspase  
With the aim of disclosing translation factors as substrates of yeast 
metacaspase during H
2
O
2
-induced apoptosis a digestome analysis was performed. 
Although digestome analysis, an in vitro assay, does not mimic cellular 
physiological conditions, it represents a starting point in the search for putative 
specific substrates of proteases. In a first dimension SDS-PAGE, total protein 
extracts from untreated wild-type yeast cells were resolved. Upon protein 
separation, gel lanes were excised and incubated with active metacaspase-enriched 
extracts obtained from YCA1
overexp
 cells undergoing apoptosis induced by H
2
O
2
 
treatment (a condition known to induce metacaspase activation [40]). After 
incubation, gel lanes were mounted on a second SDS-PAGE gel and proteins 
resolved a second time by molecular weight. Digestome analysis of total protein 
extracts revealed numerous spots below the diagonal, corresponding to putative 
protein fragments of metacaspase substrates cleaved during the incubation of the 
gel lane with active metacaspase-enriched extracts (Figure 17A) [219]. However, 
by mass spectrometry, we were only able to identify three of these spots Figure 
17A, spot 1, 2 and 3), corresponding to peptide fragments of the isoforms 2 or 3 
(Tdh2p/Tdh3p), but not of the isoform 1 (Tdh1p), of the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Figure 17B). Immunoblot of 
the digestome analysis using active metacaspase-enriched extracts with an anti-
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GAPDH antibody showed three GAPDH fragments immediately below the diagonal 
(Figure 17A, spot 4, 5 and 6) [219]. Some of these labelled fragments are most 
likely the complementary GAPDH protein fragments of the peptides identified by 
mass spectrometry (Figure 17A, 10B, spots 3, 2 and 1, respectively). The question 
whether GAPDH cleavage observed was due to metacaspase or to other activated 
proteases was addressed. For such purpose, gel lanes were also incubated either 
with extracts from untreated YCA1
overexp
 cells or H
2
O
2
-treated yca1 cells, two 
paradigmatic conditions of absence of metacaspase activity. Digestome analysis 
showed that the absence of metacaspase activity (Figure 18B, 18C) resulted in the 
appearance of a GAPDH fragment (spot 6) below the full-length GAPDH protein 
that is also present in the digestome obtained with H
2
O
2
-treated YCA1
overexp
 cells, 
indicating that this is a biological phenomenon independent of metacaspase 
Figure 17 - GAPDH is cleaved by metacaspase-enriched protein extracts. (A) Total protein 
extracts from untreated wild-type cells subjected to SDS-PAGE, incubated with active 
metacaspase-enriched extracts (from H
2
O
2
-treated YCA1
overexp
 cells) and then subjected to a 
second SDS-PAGE. The gel was stained with Coomassie blue. Spots below diagonal (1, 2 and 3), 
corresponding to cleaved proteins, were excised and analysed by MALDI-TOF mass spectrometry. 
(B) Sequence of GAPDH isoforms Tdh1p (NP_012483.1), Tdh2p (NP_012542) and Tdh3p 
(NP_011708) retrieved from NCBI. Mass spectrometry analyses of the three spots identified 
peptides matches to Tdh2p and Tdh3p but not Tdh1p. Sequences of the detected peptides are 
indicated with different colours. Pink coloured peptide was identified both in spot 2 and 3. 
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activity. However, two other spots (spots 4 and 5) were detected in the digestome 
analysis under active metacaspase conditions (Figure 18A) and were not generated 
when active metacaspase was absent. These data suggest that GAPDH is cleaved 
Figure 18 – Digestome analysis of protein extracts from wild-type untreated cells incubated with 
protein extracts from (A) H
2
O
2
-treated YCA1
overexp
 cells; (B) untreated YCA1
overexp
 cells and (C) 
H
2
O
2
-treated ∆yca1 cells. Immunoblot analyses with a monoclonal anti-GAPDH antibody 
revealed spots 4, 5 and 6. Data are representative of at least three independent experiments. (D) 
Immunoblot analysis of diagonal gel represented in (A) with anti-S-nitroso-cysteine (CSNO) 
antibody. 
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by metacaspase and that specific cleavage products only occur when metacaspase 
is active.  
Our previous data have demonstrated that upon H
2
O
2
-induced apoptosis, 
yeast cells are able to synthesize nitric oxide (NO) leading to the S-nitrosation of 
GAPDH [211]. Therefore, we questioned if the metacaspase specific GAPDH 
cleavage and NO signalling are correlated. Immunoblot with an anti-CSNO 
antibody in the same experimental conditions revealed that the three GAPDH 
fragments were nitrosated (Figure 18D). Therefore, these results suggest the 
occurrence of an NO signalling for metacaspase-mediated GAPDH cleavage and 
demonstrate that the role of metacaspase in yeast H
2
O
2
-induced apoptosis involves 
the cleavage of the glycolytic enzyme GAPDH.  
Since in mammalian cells the cleavage of GAPDH by caspase-1 has been 
described [139] and GAPDH sequence is highly conserved among species, we 
decided to evaluate a functional conservation of GAPDH cleavage sequences from 
yeast to mammalian cells. Digestome analysis of HeLa cells total protein extracts 
incubated with active metacaspase-enriched extracts was performed. As expected, 
metacaspase was able to cleave mammalian GAPDH (Figure 19A). Immunoblot 
analysis of the diagonal gels revealed two GAPDH spots immediately below the 
Figure 19 - Mammalian GAPDH is a cleavage target of metacaspase-enriched protein extracts. 
Coomassie-stained diagonal gels of total protein extracts from untreated HeLa cells incubated 
with protein extracts from (A) H
2
O
2
-treated YCA1
overexp
 cells; (B) untreated YCA1
overexp
 cells and 
(C) H
2
O
2
-treated ∆yca1 cells, and respective immunoblot analysis with a monoclonal anti-
GAPDH antibody. Data are representative of at least three independent experiments. 
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diagonal (Figure 19A) although these fragments were distinct from the ones 
produced by incubation with yeast protein extracts, showing that these proteases 
have distinct cleavage target sites. Furthermore, diagonal gels of HeLa cells total 
protein extracts after incubation with extracts from untreated YCA1
overexp
 cells or 
H
2
O
2
-treated yca1 cells showed that the absence of metacaspase activity (Figure 
19B, 19C) resulted in the lack of GAPDH fragments below the full-length GAPDH 
protein, indicating that mammalian GAPDH specific cleavage products only occur 
when metacaspase is active. Our results indicate that yeast metacaspase 
recognizes target sequences distinct from the ones recognized by caspases of 
higher eukaryotes corroborating previous results that attributed to metacaspase an 
arginine/lysine-specific endopeptidase activity in contrast to the cysteine-aspartic 
proteases of caspases [320]. Altogether, these results show that although 
metacaspases have a proteolytic activity distinct from caspases, their targeted 
molecular pathways upon an apoptotic stimulus display similarities and during 
apoptotic cell death both of them degrade metabolic enzymes. Despite these 
results, we were unable to address a role for metacaspase in the cleavage of 
translation factors, as described in mammalian cells, since we could not identify 
the other numerous spots observed below the diagonal in the digestome analysis. 
Nevertheless, in mammalian cells a regulation of internal ribosome entry site 
(IRES) mediated cap-independent translation of virus and mammalian mRNAs 
[135-138] and of mRNA stability by GAPDH [323] has been addressed. The 
conserved degradation of GAPDH in the course of the apoptotic cascade might be a 
regulatory mechanism for the activation of an IRES-mediated translation upon the 
apoptotic stimulus from yeast to mammalian cells. 
 
3.4.1.2 In vivo metacaspase cleavage of GAPDH during H
2
O
2
-induced 
apoptosis  
Several proteins shown to be specifically cleaved by in vitro methodologies, 
such as the digestome analysis, proved later not to be substrates of the caspases 
under in vivo apoptotic conditions. Thus, metacaspase specific GAPDH 
fragmentation was evaluated by immunoblot analysis of GAPDH levels, in total 
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Figure 20 - GAPDH specific cleavage by metacaspase during H
2
O
2
-induced apoptosis. (A) 
Immunoblot analysis of GAPDH and actin protein levels in 40 µg of total protein extracts of H
2
O
2
-
treated and untreated wild-type and Δyca1 cells. (B) Comparison of the survival rate of wild-type 
and Δyca1 cells upon H
2
O
2 
treatment. (C) Percentage of wild-type and yca1 cells exhibiting high 
levels of intracellular ROS detected by FACS measurements of the dihydrorhodamine 123 
fluorescence. (D) Percentage of wild-type and yca1 cells displaying TUNEL positive phenotype. 
(E) Epifluorescence and bright field micrographs of untreated and H
2
O
2
-treated wild-type and 
Δyca1 cells displaying TUNEL reaction to visualize double-strand DNA breaks. Cells were co-
stained with propidium iodide in order to facilitate nuclei visualization. Bar, 5 µm. 
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protein extracts from wild-type and Δyca1 cells challenged with H
2
O
2 
(Figure 20A). 
As expected, H
2
O
2
 (concentrations ranging from 0.5 mM to 2 mM) induced 
apoptotic cell death of wild-type cells (Figure 20B) as revealed by the high levels of 
reactive oxygen species (ROS) (Figure 20C) and the increasing percentage of cells 
displaying TUNEL positive phenotype (Figure 20D, 20E). In contrast, yca1 cells 
were more resistant to H
2
O
2
 and thus had increased survival (Figure 20B), TUNEL 
negative phenotype (Figure 20D, 20E) and lower percentage of cells with high ROS 
levels (Figure 20C). Moreover, apoptotic cell death of wild-type cells was 
accompanied by a clear reduction of the GAPDH levels that was not observed in 
Δyca1 cells (Figure 20A), suggesting the requirement of metacaspase for the 
occurrence of fragmentation of this protein in vivo. Simultaneously, it was possible 
to detect a GAPDH fragment with lower molecular weight (15kDa) (Figure 20A) 
compatible with one of the fragments observed by digestome analysis (Figure 20A). 
The absence of other fragments in the immunoblot analysis, as observed by in vitro 
digestome assay, suggests that the peptides liberated from the precursor protein, 
can be further processed, resulting in fragments that are released or degraded.  
These results suggest that GAPDH is a specific target of metacaspase during 
H
2
O
2
-induced apoptosis. As demonstrated in mammalian cells [119, 134, 139], 
the fragmentation of GAPDH during apoptosis might be part of a mechanism of 
derepression/activation of an alternative cap-independent translation of specific 
mRNAs with a role in the yeast apoptotic process.  
Altogether these data reinforce a link between translation control, metabolism 
and cell death. However, the role of metacaspase in translation machinery 
alterations during cell death remains elusive. 
 
3.4.2 Metacaspase-mediated alterations during acetic acid-induced 
apoptosis 
Since digestome analysis was unable to reveal metacaspase substrates 
related to the translation machinery, a different approach was followed. As 
opposed to the incubation of protein extracts with metacaspase, we analysed the 
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effect of the deletion of YCA1 in the levels of translation factors affected during the 
acetic acid-induced apoptosis. 
 
3.4.2.1 eEF1A as a modulator of cell death 
eEF1A N-terminal metacaspase-independent fragmentation and re-localization to 
mitochondrial matrix upon acetic acid-induced apoptosis 
In mammalian cells, the target of mitochondria by caspases has been 
described as part of the apoptotic cascade [322]. To identify potential 
metacaspase substrates in mitochondria during acetic acid-induced apoptosis, an 
apoptotic scenario in which mitochondria plays a prominent role [39, 41, 199-
201, 324-328], a proteomic analysis, combined with mass spectrometry, of 
purified mitochondrial extracts from untreated and acetic acid treated cells was 
performed, showing that two spots corresponding to fragments of the translation 
elongation factor eEF1A (Tef1p/Tef2p) were present in mitochondria, upon acetic 
acid treatment (Figure 21A) [290]. These two eEF1A fragments were composed by 
the N-terminal sequences of the protein from amino acids 6-177 (Figure 21B, 
amino acid sequence highlighted at orange) and amino acids 6-146 (Figure 21B, 
amino acid sequence highlighted at orange and green), with a molecular weight of 
about 19 kDa [290]. To further validate the proteomic analysis eEF1A levels and 
cellular localization were assessed. Upon acetic acid treatment a decrease in the 
levels of eEF1A in cytoplasm was observed together with a re-localization of the 
total protein and eEF1A fragments (with molecular weight of about 19 kDa and 31 
kDa) to mitochondria (Figure 21C). Moreover, to elucidate if the eEF1A fragments 
detected in the mitochondria upon the apoptotic stimulus were only interacting 
with mitochondria outer membrane or were able of enter the mitochondrial matrix, 
a proteinase K assay was performed. Mitochondrial extracts of untreated and acetic 
acid-treated cells were incubated with proteinase K in the presence or absence of 
sorbitol (osmotic protector of the mitochondrial membrane integrity). The digestion 
of the proteins interacting with the outer membrane was assessed through the 
incubation with proteinase K and sorbitol. Proteins of the outer membrane and 
intermembrane space were digested through the incubation with proteinase K in 
the absence of sorbitol. This assay revealed that upon the induction of apoptosis by 
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acetic acid, an eEF1A fragment of 30 kDa and total eEF1A protein interact with 
the outer surface of the mitochondria being immediately removed after digestion 
with proteinase K in the presence of sorbitol (Figure 21D). However, the eEF1A N-
 
Figure 21 - Re-localization of eEF1A N-terminal fragments to mitochondria during acetic acid-
induced apoptosis. (A) Comparison of protein levels in purified mitochondrial extracts of 
untreated and acetic acid-treated wild-type S. cerevisiae cells. Selected two-dimensional gel 
regions are shown enlarged. Putative protein fragments are marked with an asterisk. Arrows 
indicate the respective spots. (B) Peptide fingerprints of the two eEF1A fragments corresponding 
amino acids 5-146 and 6-177 to N-terminal sequences as identified in 2D gel electrophoresis of 
mitochondrial extracts from acetic acid treated cells. (C) Immunoblot analysis of eEF1A levels in 
cytoplasmic and mitochondrial extracts of untreated and acetic acid treated wild-type cells. (D) 
Immunoblot analysis of eEF1A levels after proteinase K assay of mitochondrial extracts from 
untreated and acetic acid treated cells.  
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terminal fragment of 19kDa was detected in the mitochondrial matrix even after 
the incubation of mitochondrial protein extracts with proteinase K without sorbitol 
(Figure 21D). The fact that eEF1A was fragmented during acetic acid-induced 
apoptosis, but was not degraded, being re-localized to the mitochondria raised the 
hypothesis that beyond its role in translation and the other described functions, 
eEF1A plays a role in acetic acid-induced apoptosis. Despite this fact, immunoblot 
analysis of eEF1A levels in cytoplasmic and mitochondrial extracts of YCA1 deleted 
cells showed that eEF1A cleavage upon the acetic acid stimulus was not mediated 
by metacaspase (Figure 22). Although an interaction between these two proteins 
has been described [209], eEF1A fragmentation and re-localization to 
mitochondria still occurs in YCA1 disrupted cells (Figure 22).  
Yeast eEF1A, as well as that of other organisms, is a bona fide actin binding 
and bundling protein [289, 295-299] with a crucial role in the regulation of actin 
cytoskeleton organization. Therefore, we addressed whether acetic acid treatment 
affects the eEF1A binding to actin and the possible implications to the actin 
cytoskeleton organization. Immunoprecipitation of actin from total protein extracts 
of acetic acid treated cells followed by immunoblot of eEF1A levels revealed that 
during acetic acid treatment the affinity of eEF1A to actin was diminished, and this 
Figure 22 – eEF1A fragmentation during acetic acid treatment is independent of yeast 
metacaspase. Immunoblot analysis of eEF1A expression in cytoplasmic and mitochondrial 
extracts of untreated and acetic acid treated (195 mM) yca1 cells. 
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decrease was dependent on the acetic acid concentration (Figure 23A). The 
interaction of mitochondria with cytoskeleton elements regulating mitochondrial 
dynamics, namely mitochondria fusion and fission, has been described both in 
yeast and mammalian cells [329-331]. In fact, actin and Tef1p, but not Tef2p, 
interaction with the Dynamin-related GTPase, Dnm1p, involved in mitochondrial 
fission, has been previously shown [332]. Although Tef1p interacts with several 
mitochondrial proteins, the interaction with Dnm1p might be of importance for the 
execution of the apoptotic process, as Dnm1p has previously been linked to the 
promotion of mitochondria fragmentation/degradation and cell death upon acetic 
acid-induced apoptosis in yeast [200, 333]. Our results showed that during acetic 
acid treatment, eEF1A binding to actin decreased (Figure 23A) and eEF1A N-
terminal fragments re-localized to mitochondrial matrix (Figure 21). Thus, we 
decided to evaluate the relevance of Dnm1p on the translocation of eEF1A 
fragments to mitochondria. With this purpose, we observed the levels of the eEF1A 
in cytoplasmic and mitochondrial extracts of untreated and acetic acid treated 
dnm1 cells. Immunoblot results exhibited the eEF1A fragments in mitochondria 
Figure 23 - Fragmentation and translocation of eEF1A to mitochondria reduces its affinity to 
actin and is independent of mitochondria dynamics. (A) Immunoprecipitation of actin from total 
protein extracts of untreated and acetic acid treated cells, followed by immunoblot analysis of 
eEF1A levels and binding to actin. (B) Immunoblot analysis of eEF1A levels in cytoplasmic and 
mitochondrial extracts of untreated and acetic acid treated yca1 cells. 
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extracts of DNM1 deleted cells upon acetic acid-induced apoptosis (Figure 23B) 
excluding the possibility of the Dnm1p-mediated translocation of eEF1A to 
mitochondria. Nevertheless, Dnm1p is not the only regulator of the mitochondria 
fission/fusion process during acetic acid-induced apoptosis [200] and other 
proteins could be interacting with eEF1A, regulating this process.  
A second mitochondrial proteomic analysis was performed under the same 
apoptotic conditions. This analysis revealed a new spot in mitochondria extracts 
upon acetic acid treatment, corresponding to the translation elongation factor 2 
(eEF2/Eft1/2p) (Figure 24). Nevertheless, a thorough analysis of the function of 
this protein in mitochondria during acetic acid treatment and of a putative 
correlation with the eEF1A fragments in this process should be performed. 
These results suggest that upon acetic acid treatment the apoptotic cascade is 
activated, and after 120 min of incubation (Figure 10A) eEF1A is cleaved by a 
caspase-independent pathway and N-terminal fragments are re-localized to the 
mitochondrial matrix. The presence of eEF1A N-terminal fragments in mitochondria 
matrix during the apoptotic process allows us to hypothesize the involvement of 
eEF1A fragments in the mitochondrial apoptotic cascade. The fact that both eEF1A 
and eEF2 are found in mitochondria at later time points of the acetic acid 
treatment strongly suggest that this translocation and the function performed by 
these fragments in the mitochondria are related with the progression of the 
apoptotic process. Since in silico analysis suggests that the N-terminal fragments of 
eEF1A, re-localized to the mitochondrial matrix, are GTP-binding domains involved 
Figure 24 – Translocation of eEF2 fragment to mitochondria during acetic acid-induced 
apoptosis. Comparison of protein levels in purified mitochondrial extracts of untreated and acetic 
acid-treated (195 mM) wild-type S. cerevisiae cells. Selected regions of the two-dimensional gel 
are shown. Arrows indicate the respective spots.  
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in the delivery of the aminoacyl-tRNAs to ribosomes and eEF2 is involved in 
ribosomal translocation during protein synthesis [334], their re-localization to 
mitochondria might be a signalling for this translation factors participation in the 
translation of mitochondrial mRNAs with a role in apoptosis. 
Moreover, given that eEF1A is an inhibitor of Gcn2p [294, 335], and this kinase 
plays a crucial role in the regulation of translation initiation during the acetic acid-
induced apoptosis (Figure 10A, 11B), the cleavage of eEF1A might be a cellular 
mechanism to impair this inhibition. 
 
The eEF1A N-terminal fragments act as pro-apoptotic molecules upon acetic acid 
treatment 
Although the previous results ruled out eEF1A as a substrate of metacaspase 
during the acetic acid-induced apoptosis, we cannot reject the hypothesis that 
eEF1A N-terminal fragments are players in the apoptotic cascade. To understand 
the role of eEF1A N-terminal fragments in mitochondria during acetic acid-induced 
apoptosis, p416 plasmids harbouring eEF1A full gene and eEF1A truncated in 
N6C458, N1C146 or N1C177 were transformed in wild-type cells. Higher 
concentrations of acetic acid were used in order to achieve about 50% (210 mM) 
and 35% (225 mM) of cell death in the wild-type cells harbouring the empty 
plasmid vector (Figure 25). The expression of the eEF1A total protein (N1C458) 
did not affect the resistance of wild-type cells to acetic acid. However, expression 
of eEF1A protein truncated in the first 5 amino acids (N6C458) revealed a slight 
increase in the resistance to acetic acid, suggesting a role of the eEF1A 5 N-
terminal amino acids in the signalling of the protein to mitochondria and therefore 
in its function during the apoptotic process. Survival assay also showed that the 
expression of the eEF1A N1C146 or N1C177 fragments enhanced the 
susceptibility of the cells to acetic acid-induced apoptosis (Figure 25). 
Furthermore, the N1C177 fragment appears to have a more pronounced effect in 
this phenotype (Figure 25). Nevertheless, the expression of the eEF1A fragments 
without the apoptotic stimulus was not able to induced cell death. eEF1A is 
involved in different functions such as translation elongation and actin cytoskeleton 
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organization and its fragmentation affects these processes which might contributing 
to the induction of the apoptotic process. On the other and, eEF1A N-terminal 
fragments pro-apoptotic role may only be activated upon their translocation to 
mitochondria, which only occurs during the apoptotic process. Moreover, eEF1A N-
terminal fragments are probably downstream players on the apoptotic cascade, 
therefore an interaction with the upstream regulators, upon the triggering of 
apoptosis, is necessary for their pro-apoptotic function. To disclose the mechanism 
beneath this phenotype, eEF1A isoform TEF1 deleted cells, harbouring a pYX222 
plasmid expressing eEF1A full gene (N1C458) or eEF1A N-terminal fragment 
N6C177 (the eEF1A fragment that induced a more pronounced apoptotic 
phenotype) in frame with a mitochondrial localization sequence (MLS) in the N-
terminal and a DsRed reporter in the C-terminal were transformed in TEF1 deleted 
cells (Figure 26A, 26B). The TEF1 deleted cells expressing the pYX222 empty 
vector proved to be more resistant to acetic acid treatment (Figure 26) that wild-
Figure 25 – eEF1A N-terminal fragments N1C146 and N1C177 play pro-death function in cells 
challenged with acetic acid. (A) Scheme of the eEF1A fragments inserted in the p416 plasmid. 
(B) Comparison of the survival rate of wild-type S. cerevisiae cells expressing eEF1A total 
protein, N6C458 fragment and N-terminal N1C146 or N1C177 fragments upon treatment with 
210 and 225 mM acetic acid. 
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type cells (Figure 25), suggesting the involvement of eEF1A in the apoptotic 
process. The eEF1A total protein and N6C177 fragment translocation to 
mitochondria was confirmed by confocal microscopy visualization of the DsRed 
expression in mitochondria under physiological conditions (Figure 26B). 
Nonetheless, no alteration in the cell survival and mitochondria morphology was 
observed upon the expression of eEF1A N6C177 fragment in mitochondria under 
these conditions (Figure 26B), proving that expression and translocation of eEF1A 
N6C177 fragment to mitochondria by itself is not capable of inducing apoptosis, 
 
Figure 26 – The pro-apoptotic function of eEF1A N-terminal fragment in the mitochondria is 
only active upon the acetic acid apoptotic stimulus. (A) Comparison of the survival rate of tef1 
S. cerevisiae cells expressing eEF1A total protein and N-terminal N6C177 fragment with a 
mitochondria localization sequence (MLS) in the N-terminal and a DsRed reporter in the C-
terminal, upon treatment with 195, 210 and 225 mM acetic acid. (B) Confocal micrographs of 
strains used in (A) treated with 210 mM acetic acid in order to confirm the mitochondrial 
localization of the eEF1A protein and the N-terminal fragment. 
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therefore ruling out our first hypothesis. However, acetic acid triggers an apoptotic 
cascade that might promote the pro-death role of eEF1A protein (Figure 26A). 
Protection conferred by the deletion of TEF1, when compared to wild-type cells 
(Figure 25), was abrogated upon the expression of eEF1A total protein during 
acetic acid treatment (Figure 26B), excluding also the second hypothesis. An even 
higher susceptibility to cell death was observed in cells expressing the eEF1A 
N6C177 fragment in mitochondria matrix (Figure 26A), supporting our third 
hypothesis and revealing eEF1A N-terminal N6C177 fragment as a downstream 
player in the apoptotic cascade. Despite that, confocal microscopy, could not 
confirm the eEF1A fragments localization in the mitochondria upon acetic acid 
treatment (Figure 26B). The reason for the observed DsRed degradation could rely 
on the cleavage of eEF1A N-terminal sequences, as occurs in the eEF1A total 
protein upon the apoptotic stimulus or the well described fission and degradation 
of mitochondria during acetic acid-treatment [39, 200, 201, 336]. Thus, the 
elucidation of the specific function exerted by these fragments and at which step of 
the mitochondrial acetic acid-induced apoptotic cascade they play a part, namely 
during the production of reactive oxygen species (ROS), reduction of mitochondrial 
potential, depolarization of mitochondria outer membrane, translocation of Aif1p 
from mitochondria to the nucleus, release of cytochrome c to cytosol, or 
mitochondrial fragmentation/degradation [41, 199, 200, 326, 328], is of utmost 
importance for the disclose of acetic acid-induced apoptotic cascade of events.  
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siRNA-mediated eEF1A1 knockdown in HeLa cells leads to actin cytoskeleton 
alterations with increased susceptibility to apoptosis 
Since previous results from our lab showed that the deletion of TEF1, but not 
TEF2, reverted the apoptotic phenotype induced by acetic acid in yeast and a 
decrease of the actin cytoskeleton alterations observed [290], we decided to 
evaluate if this phenomenon was evolutionarily conserved. Mammalian eEF1A 
isoforms, eEF1A1 and eEF1A2, are expressed mutually exclusive [337]. eEF1A2, 
is normally expressed only in muscles and neurons, being also related with tumor 
development in tissues that normally express only eEF1A1 [292, 309, 310, 312, 
313, 338-340]. Both isoforms of eEF1A have been characterized to function in the 
protein elongation step of translation. However, eEF1A1, but not eEF1A2, has 
Figure 27 – Staurosporine (STS)-induced apoptotic cell death in HeLa cells. (A) Cell titer-blue 
cell viability assay of untreated and STS treated cells. (B) TUNEL assay of untreated and STS 
treated cells. 
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Figure 28 – eEF1A RNAi depletion in HeLa cells increases susceptibility to staurosporine-
induced apoptosis with actin cytoskeleton alterations. (A) Confirmation of the depletion 
efficiencies of eEF1A isoforms by immunoblot analysis. (B) Survival assay of untreated and STS 
treated cells upon eEF1A1, eEF1A2 and DRP1 RNAi depletions for 48h. (C) 
Immunofluorescence of eEF1A and actin protein expression levels. 
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additional non-canonical roles in actin binding/bundling [341]. Therefore, relevance 
of eEF1A isoforms in the actin cytoskeleton organization during the induction of 
apoptotic cell death was determined in HeLa cells, an immortalized human cell line 
of epithelial cells from cervical carcinoma. Mitochondrial fission-mediated apoptotic 
cell death was induced in HeLa cells using staurosporine (STS) [342]. In order to 
confirm the induction of apoptosis by STS in about 50% of HeLa cells in our 
experimental conditions, viability and TUNEL assays were performed after eighteen 
hours of incubation with 0.1 µM of STS (Figure 27A, 27B). RNAi depletion of 
eEF1A1 and eEF1A2 isoforms and DRP1 (the mammalian homolog of yeast 
DNM1) was performed. Forty eight hours after transfection with the siRNAs, 
efficient repressions were ascertained as confirmed by immunoblot analysis of 
eEF1A levels (Figure 28A). Although silencing of eEF1A1 proved to be very 
efficient, the silencing of eEF1A2 produced almost no effect in eEF1A total levels 
(Figure 28A), suggesting that either eEF1A2 silencing was not efficient or eEF1A2 
isoform levels in these cells are low as expected [309, 313]. The silencing of 
DRP1 affected the levels of eEF1A (Figure 28A) suggesting a regulation of eEF1A 
by DRP1. Furthermore, we evaluated the viability of RNAi cells exhibiting 
low/absent levels of eEF1A isoforms when treated with STS. In HeLa cells, the 
depletion of eEF1A1, but not of eEF1A2, increased the susceptibility to apoptotic 
cell death (Figure 28B), which could be explained by the fact that mRNA silencing 
is an immediate process leaving no time for cells to adapt to new conditions or 
because in mammalian cells these proteins perform a protective role upon the 
apoptotic stimulus. Furthermore, immunostaining of eEF1A and actin revealed 
actin cytoskeleton alterations in the absence of eEF1A1, the described actin 
binding/bundling protein in mammalian cells, (Figure 28C) and its complete 
destruction after STS treatment (data not shown). Therefore, similar to yeast, in 
mammalian cells eEF1A1, but not eEF1A2, is a crucial player in the regulation of 
actin cytoskeleton organization, playing also an important role in the apoptotic 
process. However, the suggested pro-apoptotic role of eEF1A in yeast is dissimilar 
from the protective role observed in mammalian cells. These antagonist roles are 
most likely due to the distinct apoptotic cell death pathways activated. 
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Nonetheless, these results demonstrate the relevance of eEF1A in the modulation 
of apoptosis both in yeast and mammalian cells. 
 
3.4.2.2 The phosphorylation of eIF2 and the levels of IF4A are not affected 
in yca1 cells challenged with acetic acid 
Despite the observed metacaspase-independent cleavage and mitochondrial 
re-localization of eEF1A during acetic acid induced-apoptosis, the role of yeast 
metacaspase in other translation factors alterations upon acetic acid treatment was 
evaluated. For this purpose, an immunoblot kinetic analysis of eIF2α 
phosphorylation levels and translation initiation factors eIF2α (Sui2p), eIF4A 
(Tif1p) and eIF4G (Tif4631/2p) and translation elongation factor eEF2 (Eft1/2p) 
levels in YCA1 deleted cells upon acetic acid treatment was performed (Figure 
29A). This experiment revealed a decrease in the phosphorylation levels of eIF2α 
to a basal level upon acetic acid treatment (Figure 29), when compared to the 
wild-type cells (Figure 10A). Since in mammalian cells PERK kinase activation for 
the phosphorylation of eIF2α is caspase-dependent [59, 72], and in yeast, the 
Figure 29 - Yeast metacaspase (Yca1p) involvement in translation regulation during acetic acid-
induced apoptosis. Immunoblot kinetic analysis of eIF2α phosphorylation levels, translation 
initiation factors eIF2α (Sui2p), eIF4A (Tif1p) and eIF4G (Tif4631/2p) and translation elongation 
factor eEF2 (Eft1/2p) levels in yca1 S. cerevisiae cells untreated or treated with 195 mM of 
acetic acid. Actin was used as loading control.  
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deletion of YCA1 reduced the Gcn2p-mediated phosphorylation of eIF2α, a 
regulation of translation initiation through the control of Gcn2p kinase activity by 
metacaspase might be occurring. Moreover, the levels of eIF4A appeared almost 
unaltered when yca1 cells were challenged with acetic acid suggesting once more 
a regulation of translation machinery by metacaspase during the apoptotic process 
(Figure 29). Despite this observation, no eIF4A fragmentation was detected by 
immunoblot analysis. Therefore, we could not infer if eIF4A is a metacaspase 
substrate or if it is indirectly regulated by this protease. The levels of eEF4G and 
eEF2 were also less affected (Figure 29) that in wild-type cells. However, this 
effect was not as notorious as the one observed in the eIF4A. Altogether, these 
data showed that translation machinery is also a target of yeast metacaspase, 
directly or indirectly, in scenarios of apoptotic cell death highlighting a new 
putative link, which deserves further investigation, between translational control 
and cell death.  
Altogether these results show the relevance of metacaspase in the regulation 
of the translation during the apoptotic process. The down-regulation of translation 
initiation factors levels upon the apoptotic stimulus combined with the specific 
cleavage of GAPDH, which might lead to the derepression of an IRES-mediated 
translation, by metacaspase, strongly suggests metacaspase as an apoptotic 
upstream regulator of the translation process during acetic acid-induced apoptosis. 
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3.5 DISCUSSION 
In mammalian cells, the targeting of translation machinery by caspases 
during apoptosis [59, 72, 83] is well established. In yeast, metacaspase seems to 
be one of the executors of the apoptotic events [214] despite its enigmatic role. 
The routes to unravel metacaspase functions undoubtedly have to pass through the 
identification of its specific substrates and how substrates cleavage is involved in 
the apoptotic phenotype. Therefore, using different methodologies, digestome and 
mutagenesis analysis, we studied the targeting of translation machinery by 
metacaspase during different scenarios of yeast apoptosis. A relation between 
metacaspase and apoptosis has been previously established during acetic acid-
induced apoptosis since a metacaspase-dependent decapping of mRNA leading to 
mRNA degradation has been reported [218, 244, 246]. Digestome analysis 
revealed the first yeast metacaspase substrate, the glycolytic enzyme GAPDH, a 
common apoptotic substrate from yeast to mammalian [219]. GAPDH is S-
nitrosated during H
2
O
2
-induced apoptosis [211]. Since metacaspase activity is 
dependent on the NO intracellular levels [212] and we show that GAPDH 
fragments appear nitrosated, similarly to what occurs in higher eukaryotic cells, a 
NO signalling appears to be regulating metacaspase substrates targeting [45]. 
Nonetheless, we were unable to identify the other spots observed below the 
diagonal, corresponding to other putative metacaspase substrates, and to disclose 
a role of metacaspase in the cleavage of translation machinery by this 
methodology. However, in mammalian cells a relation between translation 
impairment and the activation of a GAPDH mediated apoptotic pathway has been 
established [343]. Furthermore, the specific binding of this glycolytic enzyme to 
IRES of virus RNAs leading to the inhibition of virus RNA cap-independent 
translation in mammalian cells and blocking the viral infection has been widely 
reported [135-138], as well as the binding to mammalian cells mRNAs, such as 
the pro-apoptotic molecule p53 and AT1R [136, 317, 323, 344], impairing their 
IRES-mediated translation. The translation of several apoptotic regulators, both 
pro-apoptotic [101] and anti-apoptotic [109], is regulated by IRES. The cleavage 
of GAPDH by caspase-1 [139] upon an apoptotic stimulus might prevent its 
interference in the cap-independent translation crucial for the development of the 
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apoptotic process [4, 95, 243]. Therefore, the activation of metacaspase during 
acetic acid treatment leading to the cleavage of GAPDH might be an upstream 
regulatory mechanism to trigger an alternative cap-independent translation process 
mediated by IRES which in physiological conditions is repressed by the binding of 
GAPDH to the mRNAs. The elucidation of mRNAs target of GAPDH binding in 
yeast and the relevance of these interactions for the efficient translation of these 
mRNAs and consequently their function is of utmost importance for the 
understanding of the regulatory mechanisms mediating apoptosis. 
The targeting of mitochondrial proteins by caspases during apoptosis in 
mammalian cells [322] prompted us to investigate a conservation of this regulation 
during yeast apoptosis. Analysis of mitochondrial proteomic profile revealed eEF2 
protein and two N-terminal fragments of eEF1A in the purified mitochondrial 
fractions [290] of acetic acid-treated cells despite the decreased of eEF1A and 
eEF2 levels in total cellular extracts [215]. These data strongly suggested a role of 
these translation elongation factors in the apoptotic process and further studies 
were performed. Despite the fact that both eEF1A total protein and N-terminal 
fragments were found in the mitochondrial extracts, only the N-terminal fragments 
proved to be imported to the mitochondrial matrix. Moreover, the expression of 
these N-terminal fragments results in an increased susceptibility to acetic acid 
treatment, strongly suggesting the pro-apoptotic role of these fragments. The 
mitochondrial localization of eEF1A fragments raises the possibility that eEF1A is a 
key player in the promotion of the well described acetic acid-induced mitochondrial 
alterations, namely in the release of apoptotic factors, such as cytochrome c [199] 
and Aif1p [41]. Moreover, eEF1A translocation to mitochondria may have multiple 
implications for the cell, besides its role in the process of translation elongation, 
eEF1A plays a role in several other housekeeping processes [287, 345], such as 
actin cytoskeleton organization [295, 296]. During acetic acid-induced apoptosis 
the binding of eEF1A to actin proved to be compromised, which might affect actin 
conformational stability and therefore the actin cytoskeleton organization, 
ultimately leading to the induction of apoptosis. In fact, the decrease in the 
cytosolic levels of eEF1A during acetic acid-induced apoptosis led to alterations in 
the actin cytoskeleton [290] even though the F-actin structures were unaffected 
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[346]. The mammalian eEF1A isoform eEF1A1 was also shown to have a crucial 
role in STS-induced apoptosis in HeLa cells. In contrast to yeast, silencing of 
eEF1A1 mRNA increases susceptibility of HeLa cells to the apoptotic stimulus, 
suggesting the performance of a pro-survival role by eEF1A1, indicating that this 
translation factor is also an important player in mammalian cell death processes. 
Nevertheless, further studies using different apoptotic stimuli are crucial for a better 
understanding of the eEF1A role in apoptosis. Conservation of the eEF1A1-
regulated actin cytoskeleton organization is also maintained from yeast to 
mammalian. Epifluorescence microscopy analysis reveals that silencing of eEF1A1 
leads to alterations in the actin cytoskeleton, which are more pronounced upon the 
STS-induced apoptosis. These results suggest a role for the translation factor 
eEF1A unrelated to the translation process during the course of the apoptotic 
process both in yeast and mammalian in which eEF1A most likely acts as a pro- or 
anti-apoptotic proteins depending on the apoptotic process triggered. Nevertheless, 
in yeast, this role proved not to be mediated by metacaspase, unlike the alterations 
observed in levels of other translation factors during yeast acetic acid-induced 
apoptosis. Although a direct interaction and cleavage of translation factors by 
metacaspase could not be proven, an indirect regulation of eIF4A levels and of 
eIF2α phosphorylation, suggests a regulation of Gcn2p kinase activity, by 
metacaspase during acetic acid-induced apoptosis. 
The data obtained open new perspectives for the elucidation of the molecular 
cascade regulated by metacaspase activation. The specific cleavage of GAPDH, 
which in mammalian cells acts as a repressor of cap-independent translation, and 
the regulation of some translation factors levels, suggests a regulation of the 
translation process by this protease. Furthermore, the fragmentation of eEF1A and 
re-localization in mitochondria together with eEF2 suggest that during acetic acid-
induced apoptosis, these factors are part of the apoptotic process leading to actin 
cytoskeleton alterations from yeast to mammalian cells. 
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4.1 ABSTRACT 
Global mRNA translation impairment has been described during the course of 
apoptosis both in mammalian and yeast cells. Nevertheless, the molecular 
pathways modulating translation during different scenarios of apoptosis are still 
largely unexplored. Polysome profile analysis during yeast acetic acid-induced 
apoptosis revealed a global impairment of translation, correlated to the 
phosphorylation of eIF2 subunit by Gcn2 protein kinase (Chapter 2). 
Nevertheless, our previously reported proteomic analysis in the same apoptotic 
conditions revealed increased levels of heat shock protein 90 (HSP90) isoforms 
[215]. We herein demonstrate by microarray analysis of polysomal mRNAs 
combined with the HSP90 isoforms 5’ untranslated region (5’UTR) expression in 
monocistronic reporter plasmids harboring an hairpin, that HSP90 isoforms are 
translated by a cap-independent mechanism mediated by internal ribosome entry 
site (IRES) elements in the 5’UTR of the mRNA. Genetic abrogation of HSP90 
isoforms indicate divergent roles for HSP90 isoforms, Hsc82p acting as a pro-
survival and Hsp82p as a pro-death molecule, in response to acetic acid treatment. 
Moreover, the deletion of HSC82 leads to a severe necrotic cell death suggesting a 
role of these isoforms in the balance between apoptosis and necrosis, upon acetic 
acid treatment. These undisclosed functions of yeast HSP90 isoforms were 
confirmed through pharmacological inhibition of HSP90 activity, using 17-
allylaminogeldanamycin (17AGG), and overexpression of each HSP90 isoform in 
acetic acid challenged cells. These results suggest that the efficiency of HSP90 
isoforms mRNA translation is an important component of the cellular response to 
acetic acid. A role of HSP90 in the regulation of mammalian programmed cell 
death (PCD) has also been addressed, given the use of these proteins as attractive 
targets to cancer therapy. Our data show that different HSP90 isoforms are up-
regulated depending on the drugs used to modulate the apoptotic cell death in the 
Acute Myeloid Leukaemia cell lines suggesting that, similar to yeast, in mammalian 
cells HSP90 isoforms play distinct functions.  
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4.2 INTRODUCTION 
Programmed cell death (PCD) includes all types of cell death executed by 
regulated mechanisms and under rigorous molecular control, ranging from 
apoptosis to necrosis [27]. Nowadays, an increasing body of evidence is revealing 
the involvement of translation control in PCD processes [4, 76, 95, 243]. The 
specific fragmentation and/or alteration in the phosphorylation state of several 
translation factors during PCD [59, 286], prompts a selective cap-independent 
translation, mediated by internal ribosome-entry site (IRES) elements in the 5’ 
untranslated region (5’UTR) of mRNAs, which directly recruit ribosomes 
independent of the interaction with the mRNA cap-structure [4, 109, 118, 347, 
348]. Interestingly, in mammalian cells, IRES sequences were found in mRNAs of 
both inhibitors and inducers of PCD, such as XIAP and Apaf-1, respectively [101, 
109]. In yeast, the knowledge on translational control of apoptosis is still scarce. 
During oxidative stress a reduction of global translation mediated by the 
phosphorylation of eIF2 by Gcn2 kinase (the amino acid control kinase) has been 
described [220]. Moreover, during yeast nutrient starvation an eIF4G-dependent 
IRES-mediated translation of several genes is required for an efficient response to 
stress [227]. IRES were reported in yeast transcriptional regulators such as 
transcription factors FLO8 [227] and YAP1 [234], transcriptional activators HAP4 
[228] and MSN1 [227] and transcriptional repressor URE2 [230] being involved 
in the response to yeast stress stimulus. 
Heat shock protein 90 (HSP90) chaperones are a family of highly conserved 
proteins with crucial functions in protein folding/refolding [141, 144, 349] as well 
as in regulation of the balance between autophagy and proteasome activity [188, 
350-355], with a role in cell proliferation, apoptosis and necrosis [32, 141, 143, 
172-174, 185, 188, 223]. It has been described that the binding of HSP90 to 
Apaf-1, inhibits the formation of the apoptosome, and therefore the induction of 
apoptosis [140, 167]. Moreover, the interaction of HSP90 with the death domain 
kinase receptor interacting protein (RIP) was proved to be crucial for inhibition of 
tumor necrosis factor (TNF)-induced cell death [173]. HSP90 inhibitors, such as 
allylaminogeldanamycin (17AGG) and radicicol, proved to prevent necrosis 
induction by Fas- and tumor-necrosis factor receptor 1 in mammalian cells [172, 
97 
 
173] and by tunicamycin in yeast [223]. Besides the already described functions 
of HSP90 chaperones, in yeast, these isoforms also interact with a wide number of 
proteins [356], being required for pheromone signaling [357], mitochondrial 
proteins delivery [147, 357], transcriptional regulation [225, 226, 358, 359], and 
translational control, namely ribosome biogenesis [358], mRNA stability [358] and 
Gcn2 kinase maturation and regulation [360]. Nonetheless, despite the HSP90 
chaperones crucial role in cell death, the translation of HSP90 mRNAs mediated 
by IRES was never addressed neither in yeast nor in mammalian cells.  
Herein we show the occurrence of a translational rearrangement during the 
progression of acetic acid-induced apoptosis with the activation of a cap-
independent IRES-mediated translation regulation of the HSP90 isoforms 
expression, among several others molecules, and their antagonistic role in this 
apoptotic process.  
 
4.3 MATERIALS AND METHODS 
Strains, media and treatments 
S. cerevisiae strain BY4742 (MATa his31 leu20 lys20 ura30) and its 
respective HSC82 and HSP82 genes knockouts (EUROSCARF, Frankfurt, 
Germany) were used. For acetic acid treatment, S. cerevisiae cells were grown 
until the middle exponential phase in liquid YPD medium containing glucose (2%, 
w/v), yeast extract (0.5%, w/v) and peptone (1%, w/v). Cells were initially 
harvested, ressuspended in fresh medium (pH 3.0) and incubated at 26ºC for 1h. 
Then cells were ressuspended (10
8
 cells/mL) in fresh medium (pH 3.0) followed by 
the addition of 180 or 195 mM acetic acid and incubation during 15, 30, 60, 120 
and 200 min at 26ºC with stirring (150 r.p.m.) with or without the presence of 10 
and 100 µM of 17-allylaminogeldanamycin (17AGG). After the 200 min 
treatment, approximately 300 cells were spread on YPD agar plates and viability 
was determined by counting colony forming units after 2 days of incubation at 
26ºC [199]. Cells were also harvested to further studies described below.  
For construction of the Hsc82p- and Hsp82p-overexpressing strains, HSC82 
and HSP82 were amplified by PCR (HSC82 primers 5’-
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GGATCCATGGCTGGTGAAACTT-3’ and 5’-ATCGATTTAAAGATCTTCTTCAGA-3, 
HSP82 primers 5’-GGATCCGGAAGCTTGATGACAGA-3’ and 5’-
ATCGATTTAAAGATCTTCTTCAGAA-3’) using genomic DNA, isolated from HSP82 
and HSC82 deleted cells, respectively, and cloned into the BamHI and ClaI sites of 
pUG35 (EUROSCARF, Frankfurt, Germany), which displays a MET25 promoter, 
generating pUG35HSC82 and pUG35HSP82. Δhsc82 cells were transformed with 
pUG35HSC82 and Δhsp82 cells with pUG35HSP82, generating strains 
HSC82
overexp
 and HSP82
overexp
, respectively. HSC82
overexp
 and HSP82
overexp
 cells were 
grown until exponential growth phase (OD
640nm
=0.5) on synthetic complete (SC) 
medium containing glucose (2%, w/v), yeast nitrogen base (0.17%, w/v, Difco), 
300 mg/L of L-leucine, 50 mg/L of L-histidine and 50 mg/L of L-lysine at 26ºC 
with stirring (150 r.p.m.). Cells were washed, ressuspended in fresh SC medium 
(pH 3.0), treated with 160, 180 and 210 mM of acetic acid
 
and incubated for 
200 min at 26ºC with stirring (150 r.p.m.).  
 
For construction of p281HSC82, p281HSP82, p281TIF4632 and 
p281CLN3 plasmids, DNA encoding HSC82, HSP82, TIF4632 and CLN3 5’UTR 
was amplified by PCR using the primers described in Table 6, digested with 
BamHI and EcoRI, and cloned by homologous recombination into p281 vector at 
the 5’UTR of a β-galactosidase (LacZ) reporter gene with (p281h) or without a 
stable hairpin in the 5’UTR, and under the control of the GAL1/10 promoter [230, 
361, 362]. Δhsc82 cells were transformed with p281 empty vector, p281h empty 
vector, p281hHSC82 5’UTR, p281hTIF4632 or p281hCLN3 plasmid and Δhsp82 
cells p281 empty vector, p281h empty vector, p281hHSP82 5’UTR, 
Gene Primer sequences 
HSC82 
5’UTR 
F: ATTGTTAAGATCTCCGCGGCTCGAGAGCTTTTAACCGTACTAGATAGTTTATA 
R: GGTAACGCCAGGGTTTTCCCAGTCGGATCCCATATTTCAGAATGATTCTATTTTTCT 
HSP82 
5’UTR 
F: ATTGTTAAGATCTCCGCGGCTCGAGAGCTTAATCGGATTATTAACTCATACGCT 
R: GGTAACGCCAGGGTTTTCCCAGTCGGATCCCATATCTTTGCGTGTTTGTTTGTGCTT 
TIF4632 
5’UTR 
F: ATTGTTAAGATCTCCGCGGCTCGAGATGTATTCGTTTCACTTGGCTCATTGTATATG 
R: GGTAACGCCAGGGTTTTCCCAGTCGGATCCCATAGTGCCTACAATTGATCTATTGTTC 
CLN3 
5’UTR 
F: ATTGTTAAGATCTCCGCGGCTCGAGCACAATTTCTTTCTTGATTTTTTCTTCT 
R: GGTAACGCCAGGGTTTTCCCAGTCGGATCCCATCGTACAGAAAGCGTATCAAATCAGTG 
Table 6 - List of primers for construction of p281 monocistronic plasmids. 
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p281hTIF4632 or p281hCLN3 plasmid. Cells were grown until exponential growth 
phase (OD
640nm
=0.5) on synthetic complete (SC) medium containing glucose (2%, 
w/v), yeast nitrogen base (0.17%, w/v, Difco), 300 mg/L of L-leucine, 50 mg/L of 
L-histidine and 50 mg/L of L-lysine. Cells were washed, ressuspended in SC 
medium containing galactose (2%, w/v) and incubated at 26ºC or 37ºC with 
stirring (150 r.p.m.) for 18 hours.  
Mammalian cells, namely, HL-60 and Jurkat cell lines, were cultured in 
DMEM medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine 
serum (FBS), 1% glutamax, and 1% antibiotics mixture (Invitrogen) and grown at 
37°C in a 5% CO
2
 humidified chamber. 
 
Polysome profile analysis  
Yeast cells were grown to middle exponential phase and treated with acetic 
acid as described above. Five min before cells being harvested, cycloheximide 
(CHX) was added to a
 
final concentration of 100 µg/mL to freeze protein synthesis 
elongation, cells were collected, washed twice and disrupted using lysis buffer [20 
mM Tris at pH 8.0, 140 mM KCl, 1.5 mM MgCl
2
, 0.5 mM DTT, 100 µg/mL CHX, 
1 mg/mL heparin and 1% Triton X-100] and glass beads (Sigma). 40 units A
280nm 
were loaded onto 11 mL 15 - 50 % sucrose gradients containing 20 mM Tris-HCl 
at pH 8.0, 140 mM KCl, 5 mM MgCl
2
, 0.5 mM DTT, 100 µg/mL CHX and 500 
µg/mL heparin. Gradients were centrifuged using a SW41 rotor (Beckman-Coulter) 
at 35000 rpm for 2 hours and 45 min at 4ºC. Polysomal profiles were visualized 
by monitoring RNA absorbance at 254nm using a Bio-Rad Biologic LP system 
adapted for this use. Monosomal and polysomal fractions of the gradient were 
collected into tubes containing 8M guanidine-HCl and stored at – 80 ºC. In order to 
obtain sufficient quantity of mRNA for microarrays analysis, identical fractions were 
pooled into a single tube. 
 
Polysomal RNA preparation 
Polysomal mRNA was precipitated with ethanol 85%, extracted using phenol: 
chloroform and precipitated, first with 1.5 M lithium chloride (LiCl) for removing 
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any residual heparin, and then with 100% ethanol plus 110 mM sodium acetate, 
pH 5.3. 
 
RT-PCR analysis 
Total RNA isolated from both polysome profile fractions and mammalian cell 
lines reverse transcription to cDNA was carried out using the First-Strand cDNA 
synthesis kit (GE Biosciences). The quantitative PCR was performed on a CFX96 
Touch real-time thermocycler (Bio-Rad) using SsoFast EvaGreen Supermix (Bio-
Rad) and gene-specific primers as described in Table 7.  
Gene Primer sequences Eff (%) 
TIF4632 
F: TCCGAGGAGACATTAGAGTCCG 
R: ACCGAACCTTCAAGAGTTGCC 
99.1 
HSC82 
F: CCGGTGAATCTCTAAAGGCA 
R: ATCAATTGGGTCGGTCAAGA 
96.3 
HSP82 
F: GAGTTGACGAAGGTGGTGCT 
R: ATGCAAAGGAAGTTGGTTCG 
97.9 
CLN3 
F: GCCCCTTTGGAAGCTTTCATT 
R: TGGCACCCAATTTGATCTCG 
98.4 
TIF34 
F: CCTCTAAACACCGCCGTAAT 
R: CAAACTTACCTTCGTTGGCA 
99.7 
CAF20 
F: CTGTGCCAGTTGCTACCATT 
R: AACCAAGAATTGGCTTGTCC 
99.4 
CIT2 
F: GGTCATGCTGTGCTAAGGAA 
R: AGTCAATACGCCAGGTGCTA 
99.6 
COX3 
F: TTCCATTCAGCTATGAGTCCTG 
R: CGGTAGGTTGTACAGCTTCAAT 
99.8 
HSP104 
F: AAGCGAGAAGTATGCGGTCT 
R: AAAGCCACCTTCATCGTACC 
99.0 
ACT1 
F: GATCATTGCTCCTCCAGAA 
R: ACTTGTGGTGAACGATAGAT 
98.2 
TDH2 
F: CCGCTGAAGGTAAGTTGA 
R: CGAAGATGGAAGAGTTAGAGT 
95.1 
PDA1 
F: TGACGAACAAGTTGAATTAGC 
R: TCTTAGGGTTGGAGTTTCTG 
94.8 
TUB2 
F: TACCACATCCATTGCTGAG 
R: CACCTTCTTCCATACCTTCA 
93.2 
HSP90AA1-1 
F: GGCTTCAGCTAGTGGGGTCT 
R: TTCACCTCAGGCTCATGACA 
95.3 
HSP90AA1-2 F: GGTCCTGTGCGGTCACTTAG 99.8 
Table 7 - List of primers for quantification of mRNA expression by RT-PCR and their efficiency 
(Eff). 
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R: ATCAACTGGGCAATTTCTGC 
HSP90AB1 
F: GTCTGGGTATCGGAAAGCAA 
R: CTGCCTGAAAGGCAAAAGTC 
99.5 
HSP90B1 
F: GAAGGGGACTTGAGACTCACC 
R: TCCACATCAACTTCATCGTCA 
98.6 
HSP90N 
F: TCTGGTGAATTTCCTGTTTCC 
R: GACATGGGGGACATCAGAAC 
97.1 
 
Relative expression levels were determined using the standard curve method. 
Controls lacking reverse transcriptase (RT) demonstrated no significant genomic 
DNA amplification. 
 
Microarrays analysis 
Reverse transcription, cDNA transcription, cRNA labelling with Cyanine 3-
CTP and hybridization was carried out using the One-Color Microarray-Based Gene 
Expression Analysis (Low Input Quick Amp Labeling) kit (Agilent Technologies). 
Before hybridization, free dye was removed using RNeasy mini spin columns 
(Quiagen), and the efficiency of cRNA synthesis and dye incorporation (labelling 
efficiency in pmol Cy3/µg cRNA) was measured by spectrophotometry (NanoDrop 
1000, Thermo Fisher Scientific). Each hybridization was carried out using 600 ng 
of Cyanine 3-labelled cRNAs and the Yeast Gene Expression Microarray (V2: 
G4813A, Agilent Technologies), for 17 hours at 65ºC, in an Agilent hybridization 
oven. Microarrays were scanned using the Agilent DNA Microarrays Scanner 
G2565AA and raw data was extracted using the Agilent feature extraction protocol 
GE1_105_Dec08 (PerkinElmer).  
 
Data normalization and analysis 
Using the normalized M values (log2 ratios) obtained, statistical differences 
were calculated using the t-test. Differentially expressed genes were identified for a 
False Discovery Rate below 0.001 (FDR < 0.001). Functional analysis of 
expression data obtained was done using Expander software. The data sets are 
were submitted to ArrayExpress (http://www.ebi.ac.uk/arrayexpress/). 
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Immunoblot 
For immunoblot analysis, untreated or acetic acid-treated cells were collected 
and disrupted using glass beads in lysis buffer [1% v/v Triton X-100, 120 mM 
NaCl, 50 mM Tris-HCl pH 7.4, 2 mM EDTA, 10% v/v Glycerol, 1 mM PMSF and 
Complete Mini protease inhibitor cocktail (Roche, Mannheim, Germany)]. From 
total protein extracts, 40 g were resolved on a 12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to an nitrocellulose 
membrane (Amersham) over 90 min at 100 V. Membranes were then probed with 
polyclonal rabbit Ser51 phosphorylated eIF2 antibody (1:2000, Upstate), 
monoclonal rat anti-HSP90 (1:1000, Calbiochem) and polyclonal goat anti-actin 
(1:5000, kindly provided by Campbell Gourlay). Horseradish peroxidase (HRP)-
conjugated anti-rabbit, anti-rat and anti-goat IgG secondary antibody were used, at 
a dilution of 1:5000 and detected by enhanced chemiluminescence. 
 
β-galactosidase activity (LacZ) 
LacZ activity was measured following the protocol described in the Clontech 
Yeast Protocols Handbook using O-nitrophenyl-β-D-galactopyranoside (ONPG) as a 
substrate. Cells were disrupted using glass beads in Z buffer [60 mM 
Na
2
HPO
4
.7H
2
O, 40 mM NaH
2
PO
4
.H
2
O, 10 mM KCl, 1 mM MgSO
4
.7H2O, 0.27% 
(v/v) β-mercaptoethanol]. 
 
TUNEL assay 
DNA strand breaks were assessed by a TUNEL assay with the In situ Cell 
Death Detection Kit, POD (Roche Applied Science, Indianapolis, IN). Yeast cells 
were initially fixed with 3.7% formaldehyde followed by digestion of the cell walls 
with lyticase. After preparation of cytospins, the slides were rinsed with PBS, 
incubated in permeabilization solution (0.1%, v/v, Triton X-100 and 0.1%,w/v, 
sodium citrate) for 3 min on ice, rinsed twice with PBS, and incubated with 10 L 
of TUNEL reaction mixture (terminal deoxynucleotidyl transferase and FITC-dUTP) 
for 60 min at 37ºC . Finally, the slides were rinsed three times with PBS and a 
coverslip was mounted with a drop of anti-fading agent Vectashield (Molecular 
Probes, Eugene, OR) and with 2 µL of 50 µg/mL propidium iodide (PI, Molecular 
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Probes) solution in Tris buffer (10 mM, pH 7.0) with MgCl
2
 (5 mM) and RNase 
(0.5 µg/mL). Cells were visualized with an Olympus PlanApo 60X/oil objective, 
with a numerical aperture of 1.42. 
 
Statistical analysis 
Arithmetic means of cell survival rates are presented with standard deviation 
with a 95% confidence value. Statistical analysis was carried out using 
independent samples t-test analysis. A p-value <0.05 was assumed to denote a 
significant difference.  
 
4.4 RESULTS 
4.4.1 Microarray analysis of mRNAs translated during acetic acid treatment 
Data herein presented showing that the elongation factors and eIF4G levels 
were unaffected for a long period of the acetic acid treatment (Figure 10), together 
with our previous proteomic data revealing that some protein levels are increased 
under the same conditions [215], suggests that acetic acid treated cells and 
capable of cap-independent translation. Thus, microarray profiling of polysomal 
mRNAs of acetic acid treated cells was assessed (Figure 30). With this purpose, 
RNA was extracted from independent cultures, polysomal profile was performed 
and polysomal fractions (Figure 30A), corresponding to the fractions in which 
mRNAs are being actively translated, were collected for further RNA purification, 
reverse transcription, labeling using Cy3 and hybridized to Agilent Yeast Gene 
Expression Microarray (V2:G4813A). The data obtained were submitted to 
ArrayExpress. Data analysis revealed different translational profile at 0, 15 and 30 
min (Figure 30B, 30C, 30D). A 2-fold cut-off value was used to analyse the 
translatomics by cross-time point’s comparison. The mRNA profile of polysomal 
fractions revealed 323 mRNAs up-regulated genes (Figure 30BI - blue dots) and 
132 down-regulated mRNAs (Figure 30BI – red dots) after 15 min of acetic acid 
treatment, corresponding to 5.1% and 2.1% of the total number of mRNAs 
analysed (6392 genes in the array), respectively. After 30 min of treatment the 
cluster of the mRNAs altered showed only 165 up-regulated mRNAs (Figure 30BII 
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Figure 30 - Microarray analysis of mRNAs translated during acetic acid treatment. (A) 
Polysomal fractions (PF) of the polysomal profiles of yeast wild type cells untreated (0 min) or 
treated with acetic acid for 15 min and 30 min collected for microarray and RT-PCR analysis. 
(B) Graphical representations of the translational microarray data for mRNAs altered from 0 to 
15 min (I), 0 to 30 min (II) and 15 to 30 min (III) of acetic acid treatment. The mRNAs in 
polysomal fractions at 15 min or 30 min of acetic acid treatment (log
2
 PF) have been plotted 
against the mRNAs in polysomal fractions at 0 min of acetic acid treatment (control). Venn 
diagram of the (C) upregulated and (D) downregulated mRNAs at 15 min and 30 min of acetic 
acid treatment when compared with control. The data sets were submitted to ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/). 
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- blue dots) and 176 down-regulated mRNAs (Figure 30BII - red dots). These 
mRNAs correspond to 2.6% and 2.7% of the total number of genes mRNAs 
analysed, respectively. The clustering of the mRNAs altered from 15 to 30 min 
revealed 28 up-regulated mRNAs (Figure 30BIII - blue dots) and 71 down-
regulated mRNAs (Figure 30BIII - red dots) corresponding to 0.65% and 1.11% of 
the total number of mRNAs analysed. 
A Venn diagram for the up- and down-regulated mRNAs at 15 and 30 min of 
acetic acid treatment was obtained corroborating the dot plots presented. The Venn 
diagrams showed that from 15 to 30 min 88 mRNAs are maintained up-regulated 
and 31 down-regulated (Figure 30C and 30D). These results showed that up-
regulation of some mRNAs is maintained from 15 to 30 min, but most of the 
altered mRNAs at each time point was different, suggesting the occurrence of a 
remodelling of the translational process during the period from 15 to 30 min of the 
acetic acid treatment. The data points to an active translation of specific mRNAs 
under conditions of cap-dependent translation impairment. 
The acetic acid treatment induces a progressive decline of survival along the 
treatment time course (Figure 8A), compatible with a first response to the imposed 
stress and a later activation of the apoptotic cell death. Therefore, after 15 min of 
acetic acid treatment most of the up-regulated mRNAs are probably involved in the 
cells response to the acid stress. mRNAs up-regulated after 15 min of acetic acid 
treatment revealed several known apoptotic regulators such as the anti-apoptotic 
CDC48 [189] and SAP30 [363] and the pro-apoptotic FIS1 [200], among other 
mRNAs such as the translation initiation factors eIF3 (TIF34), responsible for the 
ribosome scanning, and eIF4G (TIF4632), important for the IRES-mediated 
translation (Attachment II, Table 1). At this time point we could also detect 
HSC82, ILV3, LYS7 and THR1 which were also found upregulated in a proteomic 
analysis of acetic acid treated cells [215], and CAF20, a described inhibitor of cap-
dependent translation [364] through the interaction with eIF4E (Attachment II, 
Table 1). However, at 30 min of acetic acid treatment about 20% of the cells have 
lost the proliferative capacity being committed to death. Thus, the up-regulated 
mRNAs at this time point may also be involved in the activation and progression of 
the apoptotic cascade. After 30 min of acetic acid treatment up-regulation of 
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CAP20, CDC48, SAP30 and HCS82 is maintained, as well as other mRNAs such 
as DNM1, involved in acetic acid-induced mitochondrial fission [200], and the 
HSP82 chaperone, also found up-regulated in the proteomic analysis [215] 
 (Attachment II, Table 3). Since at 15 and 30 min of acetic acid treatment a 
heterologous population of cells mounting a response to the acid stress and cells 
activating the apoptotic cascade is present, it is expected that in the microarray 
analysis mRNAs involved in both process are found up-regulated under the 
regulation of a cap-independent translation.  
 
Figure 31 – Validation of microarray data by RT-PCR analysis of selected genes. Microarray and 
RT-PCR data are shown for up-regulated mRNAs CAF20 and TIF34 and down-regulated mRNAs 
CIT2 and COX3 in polysomal fractions from yeast cells challenged with acetic acid for 0, 15 and 
30 min. The values are expressed relative to untreated control cultures and are the means of 
triplicate microarray and RT-PCR determinations.  
 
107 
 
The microarrays results were validated by RT-PCR analysis of mRNAs found 
altered in the polysomal fractions of the acetic acid treated cells using the same 
RNA samples. In fact, RT-PCR analysis confirmed the general tendency detected 
by microarray analysis (Figure 31). For this validation both mRNAs found up-
regulated and down-regulated in the polysomal fractions at 15 and 30 min of 
acetic acid treatment were used. We were able to confirm the up-regulation of 
TIF34 and CAF20 mRNAs and the down-regulation of COX3 and CIT2 mRNAs oth 
at 15 and 30 min of incubation with acetic acid. Although some variation in the 
levels of each mRNA was observed from microarray to RT-PCR analysis, the 
tendency of the levels of each mRNA is maintained in both analyses (Figure 31). 
 
4.4.2 Functional classification of mRNAs regulated during acetic acid treatment 
Microarray results were also analysed and grouped into functional categories 
according to the Expander software TANGO tool and the Saccharomyces Genome 
Database GO Term Mapper (db.yeastgenome.org/cgi-bin/SGD/GO/goTermMapper). 
Fifteen minutes of incubation with acetic acid induced the translation of mRNAs 
involved in different functional categories such as translation with the up-regulation 
Figure 32 - Functional analysis of the regulated mRNAs in microarray analysis of yeast cells 
treated with acetic acid during 15 min (15’) and 30 min (30’). 
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of the initiation factors eIF3, eIF4G, and the inhibitor of cap-dependent translation, 
CAF20 [364] and several structural constituents of the ribosomes (Figure 32 and 
Attachment II, Table 1). On the other hand, several of the reduced mRNAs at 15 
min participate in different metabolic processes such as transport, 
organophosphate, lipid and carbohydrate metabolism (Figure 32 and Attachment 
II, Table 2). However, functional categories analysis of the mRNAs whose 
expression was up-regulated at 30 min, revealed a shorter list of activated 
functions, exposing mainly cellular functions related to the ribosomal biogenesis 
and regulation of the translation process (Figure 32 and Attachment II, Table 4).  
At 30 min of acetic acid treatment besides the up-regulation of HSC82 
mRNA, already detected at 15 min, HSP82 mRNA was also increased, suggesting 
a role for HSP90 chaperones in acetic acid response. Heat shock protein 90 
(HSP90) isoforms, HSC82 and HSP82 were both found up-regulated during acetic 
acid treatment suggesting a role for HSP90 chaperones in acetic acid-induced 
apoptosis which will be further investigated. 
  
4.4.3 HSP90, IRES chaperones translated during acetic acid treatment  
mRNAs encoding molecular chaperones HSP90, namely HSC82 and HSP82 
were found up-regulated in the polysomal fractions of yeast cells challenged with 
acetic acid, both by microarrays analysis and by RT-PCR (Figure 33A). The HSC82 
mRNA levels at 15 min were higher than those from HSP82, about 4 fold, but at 
30 min this effect was reverted and HSP82 mRNA levels increased about 25 fold 
(Figure 33A). In fact, the percentage of HSC82 and HSP82 mRNA in monosomal 
and polysomal fractions was not altered upon 15 min or 30 min of acetic acid 
treatment (Figure 33C, 33D), demonstrating that although cap-dependent 
translation initiation was impaired (Figure 8, 9, 10), this did not affect HSP90 
isoforms translation. The increased HSP90 isoforms mRNAs detected in polysomal 
fractions was shown to have an imprint in total cellular RNAs (Figure 33E) and 
protein levels (Figure 33F). The RT-PCR analysis of total cellular RNA, performed 
in acetic acid treated cells revealed an increase in the levels of both isoforms, 
HSC82 and HSP82, dependent on the concentration of acetic acid tested (Figure 
33E). Supporting the data obtained in polysomal fractions, HSP82 displayed 
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Figure 33 - HSP90 isoforms translation during acetic acid treatment. (A) Microarray and RT-
PCR of HSC82 and HSP82 mRNAs levels in polysomal fractions from yeast cells challenged 
with acetic acid for 0, 15 and 30 min. The values are expressed relative to untreated cultures 
and are the means of triplicate microarray and RT-PCR determinations. (B) Illustration of the 
polysomal fractions from which mRNAs were extracted and analysed by RT-PCR (M, 
monosomal fraction; P1, P2, P3 and P4, polysomal fractions). RT-PCR of (C) HSC82 and (D) 
HSP82 mRNA expression in polysomal fractions demonstrate their translation upon 15 min 
treatment with acetic acid. (E) RT-PCR analysis of HSC82 and HSP82 expression in total 
mRNA of yeast cells after 200 min acetic acid treatment. (F) Immunoblot kinetic analysis of 
HSP90 in wild type cells after treatment with acetic acid.  
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higher relative mRNA levels when compared to HSC82 (Figure 33E). Although 
immunoblot analysis did not allow the discrimination between Hsc82p and 
Hsp82p, the kinetics showed an increase of HSP90 isoforms levels in acetic acid-
treated cells (Figure 33F). The levels of HSP90 progressively increased from 15 up 
to 60 min of acetic acid treatment after what a slight decrease was observed 
(Figure 33F).  
These results showed that HSC82 and HSP82 mRNAs are translated during 
the acetic acid treatment, in spite of the cap-mediated translation impairment 
observed under these conditions (Figure 8, 9, 10), raising the question of whether 
or not these mRNAs could be translated by a cap-independent mechanism. 
In mammalian cells, the presence of IRES in the 5’UTR of mammalian apoptotic 
regulators mediating their translation during an apoptotic stimulus has been 
described [4, 95-97, 99, 101, 108, 109, 111, 118, 243, 348, 365, 366]. In 
yeast, IRES are present in mRNAs of several transcriptional regulators controlling 
their contribution for an efficient stress response [227, 228, 230, 234]. However, 
the activation of this alternative translation mechanism has never been addressed 
in yeast apoptotic conditions. Thus, the increased mRNAs and protein levels of 
HSP90 isoforms observed during acetic acid treatment, despite the translation 
initiation impairment, led us to hypothesized that 5’UTR of HSP90 isoforms mRNA 
might enclose IRES sequence(s) mediating their efficient translation during acetic 
acid treatment. 
To test whether the 5’UTR of HSP90 isoforms mRNA harbor IRES 
sequence(s) and are capable of internal translation initiation, the 5’UTR of HSC82 
and HSP82 were inserted in-frame between the GAL1 gene promoter and the 
mRNA of β-galactosidase (LacZ) reporter gene of monocistronic plasmids 
containing a stable hairpin structure, which abolishes cap-dependent translation 
(Figure 34) [230, 361]. These constructs were transformed in HSC82 mutant cells 
or in HSP82 mutant cells according to the 5’UTR in study. The determination of 
the LacZ reporter activity was assessed in cells after 18h of galactose induction at 
26°C and at 37°C, the latter is a condition known to inactivate eIF4E activity and 
thus the cap-dependent translation [230]. As expected, constructs encoding LacZ 
mRNA with a 5’UTR derived from the GAL1 gene (p281 empty) [230, 361] 
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showed a high translation efficiency at 26°C and a significant decrease upon 
incubation at 37°C in both strains (Figure 34). Insertion of a stable hairpin 
structure in the 5’UTR [230, 361] (p281h empty) resulted in a significant 
reduction of LacZ activity (Figure 34). Control plasmids harboring the CLN3 
5’UTR, negative control [234], and TIF4632 5’UTR, positive control previously 
reported to harbor IRES in the 5’UTR [227], were constructed and transformed in 
both strains (Figure 34). TIF4632 5’UTR promoted an efficient translation as 
revealed by LacZ activity whereas CLN3 5’UTR did not display any IRES activity as 
demonstrated by the absence of LacZ activity (Figure 34). 
The LacZ activity was significantly higher in cells expressing monocistronics 
plasmids under the control of HSC82 5’UTR or HSP82 5’UTR in the presence of a 
stable hairpin both at 26°C and 37°C (Figure 34). These results indicated that the 
HSC82 5’UTR and HSP82 5’UTR harbor IRES that allow a competent translation 
in conditions of cap-dependent translation impairment promoted either by the 
Figure 34 - HSP90 isoforms translation mediated by IRES. Expression of HSC82, HSP82, 
TIF4642 and CLN3 5’UTR tagged with a β-galactosidase (LacZ) reporter gene in monocistronic 
plasmids under the control of the GAL1/10 promoter. LacZ activity (relative milliunits) was 
determined after 18 h induction of the cells in 2% galactose at the indicated temperature.  
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presence of a stable hairpin or by the inhibition of eIF4E binding at the cap-
structure at 37°C (Figure 34). 
 Altogether, these data reveal a new regulatory mechanism controlling 
translation during acetic acid treatment, a condition that we have previously shown 
to inhibit cap-dependent translation (Chapter 2). Furthermore, this IRES-mediated 
translation regulates HSP90 isoforms expression and most likely is involved in the 
regulation of the HSP90 increased mRNA levels observed during acetic acid 
treatment. 
 
4.4.4 Modulation of HSP90 isoforms expression suggests a dual role of these 
chaperones in response to acetic acid 
The data presented strongly suggests that Hsc82p and Hsp82p are translated 
by a cap-independent mechanism upon acetic acid treatment in conditions known 
to induce 50% of cell death [191, 215]. Thus, the contribution of these isoforms 
for the apoptotic process was studied. For such purpose, the 
susceptibility/resistance of HSC82 and HSP82 mutant cells to acetic acid 
treatment was determined. Deletion of HSC82 resulted in an increased 
susceptibility while deletion of HSP82 augmented the resistance to acetic acid 
treatment compared to wild-type cells (Figure 35A). These results indicate 
opposing roles for Hsc82p and Hsp82p in response to acetic acid treatment. 
Expression of HSC82 or HSP82 under a MET promoter in the respective deleted 
strains showed functional complementation and a reversion of the phenotype 
(Figure 35B and 35C). Due to the promoter’s strength not only the phenotypes of 
the deleted cells were reverted but also Hsc82p was able to confer additional 
protection and Hsp82p to increase susceptibility to acetic acid (Figure 35B, 35C). 
These results strongly support antagonist roles for the HSP90 isoforms during 
acetic acid treatment. Hsc82p is suggested to be involved in a pro-survival 
pathway activated as a stress response while Hsp82 seems to be enrolled in a pro-
death function upon acetic acid treatment. To further elucidate the HSP90 
isoforms functions, wild-type, hsc82 and hsp82 cells were challenged with 
acetic acid in the presence of a HSP90 inhibitor, 17-allylaminogeldanamycin 
(17AGG). The inhibition of HSP90 in HSP82 deleted cells had no effect on cell 
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survival but in wild-type cells it resulted in increased acetic acid induced cell death 
and in HSC82 deleted cells led to a moderated protection (Figure 35D). These 
data reinforce the opposite roles performed by the HSP90 isoforms in response to 
 
Figure 35 - Modulation of HSP90 isoforms expression suggests opposite roles for these chaperones 
during acetic acid treatment. (A) Comparison of the survival rates of wild type, Δhsc82 and 
Δhsp82 S. cerevisiae cells after acetic acid treatment. Analysis of the survival rates of (B) Δhsc82 
and (C) Δhsp82 S. cerevisiae cells harboring a pUG35 plasmid expressing HSC82 or HSP82, after 
treatment with acetic acid. (D) Comparison of the survival rates of wild type, Δhsc82 and Δhsp82 
S. cerevisiae cells treated with 180 mM of acetic acid after pharmacological inhibition of HSP90 
activity, using 17-allylaminogeldanamycin (17AGG). (E) Propidium Iodide (PI) staining of wild 
type, Δhsc82 and Δhsp82 S. cerevisiae cells after acetic acid treatment (180 mM) measured by 
flow cytometry. (F) Epifluorescence and bright field micrographs of untreated and acetic acid-
treated (180 mM) wild-type, Δhsc82 and Δhsp82 cells displaying TUNEL reaction to visualize 
double-strand DNA breaks. Cells were co-stained with propidium iodide in order to facilitate nuclei 
visualization. Bar, 5 µm. 
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acetic acid and attributes a pro-survival role for Hsc82 and a pro-death role for 
Hsp82. 
The evaluation of the type of programmed cell death (PCD) occurring in each 
of the above described strains showed that despite the higher susceptibility to 
acetic acid treatment demonstrated by the HSC82 deleted cells, almost no TUNEL-
positive cells were observed by microscopy analysis (Figure 35F), contrarily to the 
well described phenotype of TUNEL-positive staining in the wild-type cells [191]. 
Moreover, propidium iodine (PI) staining of HSC82 deleted cells revealed a high 
percentage of PI positive cells (Figure 35E), which did not occur in the HSP82-
disrupted cells (Figure 35E), meaning that the membrane integrity of HSC82 
mutated cells was affected, therefore suggesting the occurrence of a necrotic cell 
death. These data also suggests that HSP90 isoforms are key molecules in 
governing the balance between apoptotic and necrotic cell death when cells are 
challenged with acetic acid. In yeast, HSP90 chaperones have been implicated in 
the modulation of necrotic cell death [221, 223], pointing Hsp82p as the HSP90 
isoform involved in yeast necrotic cell death. 
 
4.4.5 HSP90 regulation of Gcn2p kinase activity during acetic acid-treatment  
Among the described functions of HSP90, these chaperones have a crucial 
role in the maturation and regulation of Gcn2p kinase activity [360]. HSP90 
interaction with Gcn2p is abolished in conditions leading of accumulation of 
uncharged tRNAs such as amino acid starvation, derepressing the mature Gcn2p 
mediated phosphorylation of the subunit α of the translation initiation factor 2 
(eIF2α) and consequently leading to the inhibition of cap-dependent translation 
[360]. However, the treatment of cells with 17AGG inhibits HSP90 activity and its 
release from Gcn2p, blocking the function of Gcn2p in the phosphorylation of 
eIF2α and translation regulation [360]. Since translation impairment has been 
observed upon acetic acid treatment, mediated by the Gcn2p kinase regulation of 
eIF2 phosphorylation (Figure 10, 11), we hypothesized if the role of HSP90 
chaperones in response to acetic acid was related with the regulation of the Gcn2p 
kinase activity. To evaluate this hypothesis, immunoblot kinetic analysis of eIF2 
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phosphorylation levels in HSC82 and HSP82 deleted cells and wild-type cells 
treated with 17AGG, was performed. The results obtained showed a delay in the 
phosphorylation of eIF2α in all the conditions upon acetic acid treatment (Figure 
36) when compared to wild-type cells (Figure 10A), suggesting a role of HSP90 
isoforms in the regulation of Gcn2p kinase activity in the first time point of acetic 
acid treatment, crucial for the early inhibition of cap-dependent translation 
initiation. However, at later time points this regulation does not occur, which could 
be explained by the recruitment of HSP90 chaperone for modulation of the acetic 
acid-induced apoptosis, and interaction with other client proteins.  
 
 
Figure 36 – HSP90 regulate Gcn2p activity at early time points of the acetic acid treatment. 
Immunoblot kinetic analysis of eIF2α phosphorylation in (A) wild-type S. cerevisiae cells after 
treatment with 195 mM acetic acid upon pharmacological inhibition of HSP90 activity using 
17AGG, and in (B) Δhsc82 or (C) Δhsp82 cells treated with 195 mM acetic acid. 
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4.4.6 HSP90 chaperones isoforms differential expression in mammalian cell lines 
Mammalian cells contain three types of HSP90 chaperones: cytosolic 
HSP90, mitochondrial HSP90 (Trap-1), and endoplasmic reticulum HSP90 
(Grp94) [367]. Prominent members of mammalian cytosolic HSP90 family are 
Hsp90alpha (HSP90AA-1, HSP90AA-2, and HSP90AB1) and Hsp90beta 
(HSP90B1) isoforms [141]. Hsp90beta is expressed constitutively to a higher level 
than Hsp90alpha, which is generally stress-inducible [141]. HSP90 chaperones 
are the only HSPs targeted in cancer therapy, namely in Acute Myeloid Leukemia 
(AML) therapy [186, 188], using the inhibitor of HSP90 activity, 17AGG. 
However, the outcome is below expectations, probably due to the indiscriminated 
inhibition of HSP90 isoforms, instead of targeting the isoform(s) specifically 
implicated in AML. Our results showed that yeast HSP90 isoforms, Hsc82p and 
Hsp82p, are IRES-mediated translated, upon global translation impairment during 
PCD. The yeast data also showed the divergent roles played by each HSP90 
isoform during PCD. Since HSP90 are conserved proteins from yeast to 
mammalian, with analogous described behavior and functions [141, 143, 188], it 
is of utmost importance to understand the contribution of each mammalian HSP90 
isoform for the PCD process. Thus, the levels of each HSP90 isoform in human 
 
Figure 37 – HSP90 isoforms expression pattern in leukemic cell lines. RT-PCR analysis of 
mammalian HSP90 isoforms (HSP90AA1-1, HSP90AA1-2, HSP90AB1, HSP90B1 and 
HSP90N) mRNA levels in Jurkat and HL-60 cell lines. 
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leukemic cell lines, the AML HL-60 cell line and the acute T-lymphoblastic 
leukemia Jurkat cell line, were assessed. Results showed a similar pattern of 
expression of each HSP90 isoform both in HL-60 and Jurkat cell lines (Figure 37). 
However, leukemic cell lines treatment with drugs involved in the modulation of 
distinct cellular processes revealed the upregulation of distinct HSP90 isoforms  
(Figure 38A, 38B). The 17AGG inhibits HSP90 activity [174, 178, 186, 368], 
rapamycin inhibits TOR pathway and therefore activates the autophagic process 
[267, 272, 369-373], chloroquine inhibits the autophagic process [276, 277, 
374], bortezomib inhibits the proteosome [375], and doxorubicin and cytarabine 
are two drugs widely used in AML therapy [376-379]. The data analysis revealed 
differential expression of the HSP90 isoforms correlated with the drug tested 
(Figure 38). The inhibition of HSP90 activity led to the accumulation of 
HSP90AA1-2 and HSP90AB1 mRNAs in the cell and the decrease in the levels of 
Figure 38 – HSP90 isoforms expression profile in leukemic cell lines. RT-PCR analysis of 
mammalian HSP90 isoforms (HSP90AA1-1, HSP90AA1-2, HSP90AB1, HSP90B1 and 
HSP90N) mRNA levels, relative to untreated cells, in (A) Jurkat and (B) HL-60 cell lines treated 
with 17AAG, rapamycin, chloroquine, doxorubicin or cytarabine. 
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HSP90AA1-1 and HSP90B1 mRNAs both in Jurkat and HL-60 cell line (Figure 
38). In physiological conditions HSP90AA1-2 and HSP90AB1 mRNAs are more 
expressed that the other isoforms in these cell lines (Figure 37) and the inhibition 
of their activity might lead to the accumulation of correspondent mRNAs in the cell 
which will not be recruited for translation (Figure 38A, 38B). Activation of 
autophagy has been correlated with the decrease of the HSP90 activity [353, 
355], which corroborated our results showing a decrease in the levels of all the 
HSP90 isoforms when cells were treated with rapamycin (Figure 38). The 
inhibition the autophagy using chloroquine did not induce a significant increase of 
HSP90 isoforms levels, with the exception of HSP90AB1 isoform which presented 
higher levels in Jurkat cell line (Figure 38A). Moreover, inhibition of proteosome by 
bortezomib induced an increase in the levels of HSP90AA1-2, HSP90AB1 and 
HSP90B1 in Jurkat cells (Figure 38A). However, the induction of apoptosis 
mediated by doxorubicin led to an increase in the levels of HSP90AA1-1 isoform 
and downregulation of all the others, particularly in HL-60 cells (Figure 38B). 
Cytarabine treated cells displayed higher levels of HSP90A1-1 and HSP90N 
isoforms in Jurkat cells and decrease in the expression of all the isoforms in HL-60 
cells (Figure 38A, 38B).  
These results combined suggest that each HSP90 isoform plays a distinct 
role in the cell, and depending on the stimulus distinct isoforms are activated. 
Using drugs known to affect the inter-regulatory processes of autophagy and 
ubiquitin-proteasome system, the HSP90 isoform HSP90AA1-2 and specially the 
isoform HSP90AB1 appear to be recruited and activated as modulators of these 
processes. However, drugs involved in the modulation of other pathways such as 
doxorubicin induce the translation of HSP90AA1-1 isoform. Doxorubicin and 
17AGG, two drugs used in cancer therapy triggering two different apoptotic 
processes [160, 170, 173, 186, 379-384], induce the expression of different 
isoforms of HSP90, strongly suggesting the targeting of different client proteins by 
each HSP90 isoform involved in distinct molecular pathways. Therefore, the unveil 
of the specific proteins interacting with each HSP90 isoform will allow a better 
understanding of the mechanism regulating HSP90 isoforms functions in the cell 
for a more efficient cancer therapy with less secondary effects. 
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4.5 DISCUSSION 
Over the past few years, the involvement of the translation process in the 
regulation of apoptosis has emerged as a crucial mechanism both in mammalian 
and yeast cells [59, 95, 215, 220]. Since translation is the final stage in the 
course of genetic information, regulation at this level leads to a direct response to 
changes in physiological conditions. During yeast S. cerevisiae acetic acid-induced 
apoptosis, a general amino acid starvation occurs [215] and a translation reduction 
might allow cells to conserve resources for a quick rearrangement of the gene 
expression in response to the stimulus. Microarrays kinetic analysis of polysomal 
mRNAs translated during acetic acid treatment, showed a decrease in the mRNA 
levels throughout the experiment. However, it revealed a list of up-regulated 
mRNAs at 15 and 30 min of acetic acid treatment, putatively involved in the 
cellular response to the acid stress or in the activation of the apoptotic process, 
since this analysis was performed at time points in which only a small percentage 
of the cells are undergoing apoptosis. HSP90 isoforms, HSC82 and HSP82, were 
found upregulated in the polysomal mRNAs, although HSP82 presented a higher 
fold change that HSC82 after 30 min of acetic acid treatment. Furthermore, 
insertion of HSP90 isoforms 5’UTR and eIF4G at the 5’UTR of a monocistronic 
LacZ reporter gene harboring a hairpin showed us that translation of these 
chaperones as well as of eIF4G is mediated by the presence of IRES in the 5’UTR 
of the mRNAs allowing the translation of these isoforms by a cap-independent 
mechanism upon the apoptotic stimulus. These results corroborate all the previous 
results, pointing for the activation of an alternative IRES-mediated translation upon 
inhibition of cap-dependent translation during acetic acid treatment, controlling the 
translation of HSP90 and eIF4G. Nevertheless, the Hsc82p and the Hsp82p 
isoforms appear to play antagonist roles during the apoptotic process. Hsc82p play 
an anti-apoptotic and Hsp82p a pro-apoptotic function upon acetic acid treatment. 
Moreover, a balance between the two isoforms levels, during acetic acid treatment 
is crucial for the induction of apoptosis. The absence of Hsc82 leads to a necrotic 
cell death upon acetic acid treatment, probably due to the absence of an anti-
apoptotic factor to balance the effect of the pro-apoptotic factor Hsp82. A role for 
HSP90 chaperones in the modulation of yeast necrotic cell death has been 
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addressed [223]. Moreover, interaction between the pro-apoptotic isoform Hsp82p 
and the yeast homologue of mammalian caspases, metacaspase, has been 
reported [209]. Therefore, a study of the role of Hsp82p in the folding of 
metacaspase upon its activation during the apoptotic process should be performed. 
Moreover, the dual role of HSP90 chaperones may be related with the fact that the 
different isoforms are responsible for the folding/refolding of different proteins 
playing distinct roles in different physiological conditions. HSP90 chaperones are 
target molecules for cancer therapy [141, 159, 174, 181, 185, 186, 188, 385]. 
The fact that in yeast, the two known isoforms of HSP90 chaperones, Hsc82p and 
Hsp82p, play distinct roles in the modulation of apoptotic cell death, and due to 
the high conservation of HSP90 chaperones from yeast to mammalians [141, 
143], it is of utmost importance to understand the individual relevance of 
mammalian HSP90 chaperones for the PCD process in an integrated view using 
mammalian cells, namely AML cell lines. In fact, the levels of HSP90 isoforms, 
HSP90AA1-1, HSP90AA1-2, HSP90AB1, HSP90B1 and HSP90N, in cells 
treated with different drugs which target distinct cellular processes previously 
associated with a modulation of the apoptotic process [170, 177, 277, 374, 375, 
384, 386-388], suggest that each HSP90 isoform has specific targets being 
involved in different processes which might be related to cell death or survival. 
These results suggest once more a conservation in the pathways/mechanism 
regulating PCD from yeast to mammalian cells, highlighting yeast as a good model 
for the study of apoptosis. Thus, future investigations using mammalian cells for 
the elucidation of the translation mechanisms regulating HSP90 expression, such 
as IRES, and the contribution of each HSP90 isoform to the PCD process is crucial 
for the screen of new drugs that directly act against the HSP90 isoform(s) involved 
in the disease for a more targeted less aggressive treatment.  
Altogether, our findings reveal a new apoptotic regulatory mechanism 
mediated by the balance between the levels of HSP90 isoforms, Hsc82p and 
Hsp82p, in the presence of an apoptotic stimulus. This balance appears to be 
tightly regulated by the activation of an alternative mechanism of HSC82 and 
HSP82 isoforms mRNA translation mediated by the IRES sequences present in 
their 5’UTR. The simultaneous IRES-mediated translation of both isoforms, with 
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antagonistic roles in the cell during acetic acid treatment further supports a 
conservation of the translation regulatory mechanisms from yeast to mammalian 
cells placing yeast as a powerful tool in the study of the mechanism underlying the 
regulation of cap-independent translation during apoptosis.  
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CHAPTER 5 
Concluding remarks and future prospectives 
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5.1FRAMEWORK OF THE RESULTS 
During evolution, organisms have to adapt to the surrounding environment in 
order to perpetuate the species, a mechanism called natural selection that Charles 
Darwin also liked to call “Survival of the fittest” [389]. Despite the divergent 
adaptation strategies undertaken by the different organism throughout evolution, 
they share the same origin, the same molecular basis. Therefore, the main basic 
and housekeeping molecular pathways regulating cells fate are most likely 
conserved.  
The phenotypical alterations induced by the activation of different types of 
programmed cell death (PCD), as apoptosis and necrosis, both in yeast and 
mammalian cells are widely recognized [27, 28, 30]. However, the knowledge of 
the molecular pathways behind these phenotypes is a continuous challenge in 
constant update. By itself this is an intricate task, and the fact that different PCD 
stimuli lead to the activation of distinct PCD pathways makes it even more 
complex.  
Over the last years, the translation process has been described as a crucial 
piece in mammalian cells PCD puzzle [95, 348]. Alterations in the translation 
machinery, such as the fragmentation of translation initiation factors eIF3, eIF4B, 
eIF4G mediated by caspases and post-translational modifications of eIF2α and 
eIF4E leading to the inhibition of the cap-dependent translation during the PCD 
process [59] prompt an alternative translation mechanism. This alternative 
translation is regulated by the presence of internal ribosome entry site (IRES) 
elements, usually at the 5’ untranslated region (5’UTR) of the mRNAs, which 
directly recruit ribosomes independent of the mRNA cap-structure [235, 390] but 
may also require the participation of canonical translation initiation factors such as 
the eIF4G, eIG4A, eIF3 and eIF2α [5, 227, 232, 235, 391-396]. IRES-mediated 
translation proved to be critical for cellular homeostasis and regulation of the cells 
fate upon triggering of the PCD process [4]. These sequences have been described 
not only in mRNAs related with the activation of the cell death cascade such as 
p53 [119], APAF-1 [109], c-myc [112], DAP5 [118] but also in mRNAs involved 
in the cell survival such as XIAP [132], HIAP2 [98], Bcl-2 [122] and HSP70 
[125].  
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In yeast, the study of IRES-mediated translation is still an emergent field and 
a correlation between IRES and PCD has not yet been made. Nonetheless, IRES 
sequences have been identified in several mRNAs related to response to stress 
through transcriptional regulation, such as FLO8 a transcription factor [227], YAP1 
[234], HAP4 [228] and MSN1 [227] transcription factors and activator, 
respectively, involved in the response to oxidative stress, URE2 a transcriptional 
repressor of genes involved in nitrogen catabolism [230], and eIF4G, a translation 
initiation factor crucial for yeast IRES-mediated translation [227].  
 
5.2 TRANSLATION MODULATING OF YEAST PCD 
A conservation in translation machinery alterations during apoptosis from 
yeast to mammalian cells was established by the observation of an impairment in 
translation initiation at early time points of acetic acid treatment through a drastic 
decrease in translation initiation factor eIF4A levels and the increased 
phosphorylation of eIF2α mediated by Gcn2p kinase, a key player in this apoptotic 
process. In mammalian cells, the phosphorylation of eIF2α is a common feature of 
different apoptotic processes [67, 72, 108, 242, 397] as well as in the response 
to stress conditions allowing cells to initiate a remodeling of the gene expression for 
a effective stress response [66, 108, 398]. The eIF2α phosphorylation or even a 
specific cleavage can be also mediated by caspases in the course of the apoptotic 
cascade as a mechanism of global translation inhibition [59, 64, 72, 399], 
allowing the activation of the IRES-mediated translation process [131, 390]. In 
yeast, the phosphorylation of eIF2α proved to be implicated in the apoptotic 
process since the deletion of GCN2, the only kinase described to be responsible for 
the phosphorylation of eIF2 in yeast [253, 256, 260, 261], leads to an 
increased resistance to acetic acid treatment together with a drastic decrease in the 
phosphorylation levels of eIF2α. Similar to what has been described in mammalian 
cells, during acetic acid treatment eIF2α phosphorylation is part of a regulatory 
process which inhibits global translation giving space for the activation of a 
selective IRES-mediated translation. In mammalian cells, IRES-mediated 
translation also requires the participation of canonical translation initiation factors 
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which vary with requirement of the IRES-containing mRNAs [4, 5]. Therefore, the 
analysis of our data suggests that eIF4A is not required for an IRES-mediated 
translation during acetic acid treatment, since the levels of this translation initiation 
factor decrease after 15 min of acetic acid treatment. On the other hand, the levels 
of eIF4G are maintained until later time points of the apoptotic process. In fact, in 
higher eukaryotes, IRES-mediated translation with the participation of eIF4G, with 
or without the interaction of eIF4A has been described [5, 400]. These evidences 
together with the fact that, in yeast, eIF4G is an IRES-containing factor involved in 
the efficient IRES-mediated translation in response to stress [227], further 
consolidates our hypothesis that an eIF4G-dependent IRES-mediated translation of 
mRNAs required for the apoptotic process, such as AIF1, occurs during acetic acid 
treatment. 
Similar to mammalian cells apoptotic process, the alterations observed in 
translation initiation factors eIF4A and eIF2α upon acetic acid challenge appear to 
be mediated by metacaspase, the yeast homologue of mammalian caspases [40]. 
However, if this effect is mediated by the direct interaction of metacaspase with 
the translation factors, inducing their cleavage, or through indirect regulation of 
their levels is still not known and further studies should be performed. 
Nevertheless, metacaspase digestome analysis revealed a metacaspase substrate, 
the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The 
extensive fragmentation of this enzyme during yeast apoptosis has been previously 
reported [211, 219, 401], but an association of this event to yeast metacaspase 
had never been made [219]. In mammalian cells, this enzyme is a known inhibitor 
of virus and mammalian mRNAs IRES-mediated translation [119, 134-138]. 
Hence, GAPDH is responsible for the inhibition/repression of cap-independent 
IRES-mediated translation in higher eukaryotes as a protective mechanism against 
opportunistic viral infections and apoptosis. Its specific cleavage by caspase-1 in 
mammalian cells [139] and metacaspase in yeast [219] in apoptotic conditions 
strongly suggests that GAPDH fragmentation might be crucial for the progression of 
IRES-mediated translation of apoptotic regulators mRNAs, emerging as a putative 
repressor of this translation mechanism both in yeast and mammalian cells. In 
order to clarify this possible regulation further studies are required. 
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Although we observed a loss-of-function by some of the translation initiation 
factors, such as eIF2α and eIF4A, other translation factors appear to have a gain-
of-function upon the apoptotic stimulus, being recruited for the modulation of other 
processes, which might be unrelated with translation. That is the case of eEF1A 
and eEF2, which are fragmented and translocated to mitochondria during acetic 
acid treatment. eEF1A N-terminal fragments are even imported to the 
mitochondrial matrix were they appear to perform a pro-apoptotic function. 
Mitochondria are organelles known to contain a separate protein synthesis 
machinery [402-404]. In fact, most of the mitochondrial transcription/translation 
machinery and proteins are synthesized in cytosol and imported to mitochondria 
[304, 327, 402-412] Therefore, the specific translocation of eEF1A and eEF2 
translation elongation factors fragments to mitochondria during acetic acid 
treatment might be a part of mitochondrial apoptotic cascade leading to the 
described severe mitochondrial alterations, such as the production of reactive 
oxygen species (ROS), depolarization of mitochondria outer membrane, 
translocation of Aif1p from mitochondria to the nucleus and release of cytochrome 
c to cytosol, culminating in mitochondria fission and fragmentation/degradation 
[41, 199, 200, 326, 328]. The recruitment of these factors might also be related 
with an alternative mitochondrial translation mechanism of important apoptotic 
regulators in hypothetical conditions of mitochondrial canonical translation factors 
degradation. Since eF1A N-terminal fragments codify for the GTP-binding domain 
involved in the delivery of the aminoacyl-tRNAs to ribosomes and eEF2 is involved 
in ribosomal translocation during protein synthesis their participation in the 
aminoacyl-tRNA delivery to mitochondria and translation elongation during 
apoptosis might be of great contribution for this process and should be further 
investigated. 
In order to identify the mRNAs capable of being translated by the IRES-
mediated translation, a screening of putative IRES-containing mRNAs translated 
during acetic acid treatment was performed. This study allowed us to confirm the 
presence of IRES in the 5’UTR of HSP90 isoforms, HSC82 and HSP82, as well as 
in the eIF4G exposing an alternative IRES-mediated mechanism controlling HSP90 
chaperones translation during acetic acid treatment. Similar to what occurs during 
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yeast nutrient-starvation [227], eIF4G IRES-mediated translation during acetic 
acid-induced amino acid starvation strongly suggests the participation of eIF4G in 
the IRES-mediated translation initiation, similar to what has been described 
regarding the IRES-mediated translation of several mammalian mRNA [5, 90, 95, 
393, 394, 396, 413, 414].  
Despite that, HSP90 isoforms individual translation appears to activate 
distinct cellular pathways. Hsc82p acts as a pro-survival molecule and Hsp82p as 
a pro-death molecule despite their high sequence identity (96%) and shared 
contribution for the regulation of Gcn2p activity during the earlier time points of the 
acetic acid treatment. Since these chaperones are involved in the folding/refolding 
of several client proteins involved in the regulation of several different processes 
[144, 162, 225, 226, 356-358, 360, 415-431], their antagonist role during 
acetic acid treatment might be related with their regulation of distinct processes, 
activating opposite responses to acetic acid treatment. In fact, the interaction of 
Hsp82p with the yeast metacaspase has been reported [209], suggesting the 
participation of Hsp82p in the acetic acid-induced apoptosis through 
interaction/folding of the active metacaspase, regulating its function in the cell. 
Since HSP90 are also involved in the protein delivery to mitochondria [149], a 
contribution of these chaperones for the translocation of eEF1A or eEF2 to 
mitochondria upon the apoptotic stimulus might occur. This is an aspect that 
deserves further attention. 
In mammalian cells, a deregulation of HSP90 levels has been associated to 
disease [140, 162, 177, 186, 432-437], such as in acute myeloid leukemia 
(AML) [146, 432]. Pharmacological modulation of distinct cellular pathways using 
different drugs, namely 17-allylaminogeldanamycin (17AGG), a specific-inhibitor of 
HSP90 activity, rapamycin, the inhibitor TOR and an inducer of autophagy, 
chloroquine, an inhibitor of autophagy, bortezomib, an inhibitor of the proteosome 
and doxorubicin and cytarabine, the common AML chemotherapeutic drugs, 
revealed the activation of distinct isoforms of HSP90. These results strongly 
suggest that each HSP90 isoform interacts and is responsible for the folding of 
distinct proteins involved in different cellular pathways and processes [438]. In 
fact, similar to what occurs in yeast, in mammalian cells HSP90 chaperones are 
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involved in the regulation of distinct processes and client proteins. HSP90 regulate 
the function of proteins involved in the cell survival such as Survivin [161], RIP 
[173], BcR-Abl [153, 186, 439, 440], Akt [153, 156, 433, 441], Zap-7 [164], 
rp53 [350], p23[442], cdc37 [163] and Raf-1 [443], among others, or in the cell 
death such as Apaf-1 [167] and FKBP38 [171]. A deregulation of HSP90 isoforms 
levels in the cell may affect their interaction with client proteins leading to a 
rupture of the cellular homeostasis. Therefore, a thorough study of the HSP90 
isoforms alternative translation mechanisms, specific client proteins and the 
involvement of these proteins in the disease are of utmost importance for de 
development of a more efficient treatment for AML and other diseases related to 
HSP90 deregulation. 
Summing up, during acetic acid treatment an intracellular amino acid starvation 
occurs, blocking of TOR pathway which induces a derepression of the Gcn2p 
kinase. The Gcn2p active kinase phosphorylates eIF2 inhibiting the formation of 
Figure 39 - Proposed illustrative scheme of the cell death pathway triggered by acetic acid, 
based on the main findings reported in this thesis. Dashed lines represent hypothesis that, 
although supported by our experiments, require further investigation. 
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the translation initiation ternary complex (Figure 39). Activation of metacaspase 
directly or indirectly reduces the levels to eIF4A and regulates the phosphorylation 
of eIF2, probably through interaction with Gcn2p (Figure 39). These alterations 
associated with the translation of Caf20p, an eIF4E binding protein, inhibit the 
cap-dependent translation initiation (Figure 39). The specific cleavage of GAPDH 
by metacaspase might favor the translation of the IRES-containing mRNAs, 
mediated with the participation of the canonical translation factor eIF4G, also 
harboring IRES (Figure 39). This mechanism will enable the translation of HSP90 
in conditions of cap-dependent translation initiation impairment and their 
participation in the modulation of the acetic acid-induced apoptosis, Hsc82p 
playing a pro-survival and Hsp82p a pro-death role (Figure 39). Furthermore, at 
latter time points, the re-localization of eEF2 and eEF1A to mitocondria occurs, 
possibly regulated by HSP90 chaperones, which has also been associated with 
mitochondrial proteins delivery [147, 149]. eEF1A is fragmented and two of these 
fragments corresponding to eEF1A N-terminal sequences are imported to the 
mitochondria, where appear to be involved in the apoptotic process which will 
induced the mitochondria fission/fusion (Figure 39). The translocation of eEF1A to 
mitochondria reduces its binding to actin a consequently to actin cytoskeleton 
organization alterations. The combination of all these events culminates in the 
yeast cell death (Figure 39). 
 
5.3 IMPLICATIONS FOR FUTURE RESEARCH 
Altogether, the results presented in this thesis yield new insights into the 
translation mechanisms regulating yeast PCD, opening new perspectives for future 
investigations. 
Microarray analysis generated a large amount of data regarding the mRNAs 
translated during acetic acid treatment, revealing several possible regulators of the 
cellular response to acetic acid treatment, namely mRNAs involved in the response 
to the acid stress and mRNAs involved in the activation of the acetic acid-induced 
apoptotic process. These mRNAs translation might be regulated by IRES. Since we 
have only focused in the function of the two HSP90 isoforms, Hsc82p and 
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Hsp82p, these data constitute a powerful database (submitted to ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress/) for future studies.  
It would be also important to clarify the role to metacaspase in the translation 
machinery alterations observed during acetic acid treatment. The study of the 
specific interactions of metacaspase with translation factors and the Gcn2p kinase 
is of utmost importance for the elucidation of the regulatory mechanisms 
controlling the remodeling of the translation process from cap-dependent to cap-
independent translation. With that purpose, specific digestome analysis of 
translation factors with active metacaspase, followed by immunoblot analysis 
should be performed in order to disclose if eIF4A and eIF2α among other 
translation factors are in fact substrates of metacaspase during acetic acid 
treatment. Studies of cap-dependent and IRES-mediated translation efficiency in 
the absence of metacaspase, using metacaspase deleted strain, would also 
contribute for the disclosure of this protease role in the modulation of translation. 
HPS90 chaperones play a preponderant role in cellular homeostasis. 
Therefore, the knowledge on the alternative translation mechanisms regulating 
HSP90 isoforms expression and the identification of their specific client proteins, 
as well as the effect of these interactions in the cell, is of great importance both in 
yeast and mammalian cells. The investigation of an IRES-mediated regulation of 
HSP90 isoforms translation in mammalian cells should be addressed. Furthermore, 
a yeast two-hybrid assay of HSP90 isoforms interactors both in yeast and in 
mammalian cells could be of great value in the understanding of the molecular 
pathways affected by each isoforms. In mammalian cells this information would 
allow a more targeted and effective cancer therapy. 
The data obtained from these hypothetical experiments might be of great 
contribution for the continuous expansion on the knowledge of regulatory pathways 
controlling the apoptotic process. 
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Yeast metacaspase (Yca1p) is required for the execution of apoptosis upon a wide range of stimuli. However,
the speciﬁc degradome of this yeast protease has not been unraveled so far. By combining different method-
ologies described as requisites for a protein to be considered a protease substrate, such as digestome analysis,
cleavage of recombinant GAPDH by metacaspase and evaluation of protein levels in vivo, we show that upon
H2O2-induced apoptosis, the metabolic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a
speciﬁc target of metacaspase. Nitric oxide (NO) signaling, which mediates H2O2-induced apoptosis, is re-
quired for metacaspase speciﬁc GAPDH cleavage. In conclusion, in this work we identiﬁed GAPDH as the
ﬁrst direct yeast metacaspase substrate described so far. Although mammalian caspases and yeast metacas-
pase apparently have distinct target cleavage sites, GAPDH arises as a common substrate for these proteases.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Over a decade ago, a family of proteases presenting structural sim-
ilarities to caspases was identiﬁed in protists, fungi and plants [1].
These proteases were named metacaspases and classiﬁed, according
to the presence or absence of a N-terminal prodomain containing a
proline-rich repeat motif, as type I or type II, respectively. In spite of
the structural similarity with the remotely related caspases, a large
body of accumulating evidence shows that all metacaspases are high-
ly speciﬁc for P1-Arg and P1-Lys substrates (reviewed in [2]).
Yeast cells have a single gene, YCA1, encoding a type I metacaspase
that was ﬁrst implicated in the execution of oxidative stress induced
cell death [3] but that is estimated to participate in approximately
40% of the described yeast apoptotic scenarios [4]. Nevertheless,
non-death functions have also been assigned to yeast metacaspase
such as cell cycle regulation [5] and protein catabolism [6]. Although
the mechanisms regulating this multifunctional protein, metacaspase,
still remain elusive, it is known that metacaspase activity is regulated
through S-nitrosation and thus dependent on the endogenous levels
of nitric oxide (NO) [7]. S-nitrosation of one metacaspase Cys residue
keeps it inactive. However, a second catalytic Cys residue, highly con-
served in all known metacaspases but absent in all members of cas-
pases, can rescue metacaspase activity in the presence of high NO
levels [7]. Accordingly, in yeast H2O2-induced apoptotic condi-
tions [3,8], a cell death process dependent on metacaspase activity
and NO generation, metacaspase activity and cell death are abolished
in the presence of L-NAME, an inhibitor of NO synthesis [9,10].
One of the major mechanistic challenges for understanding the
role of metacaspases in cell survival and death is still the identiﬁca-
tion of their natural substrates. At the present the only protein
found to be cleaved by metacaspases in vivo is the evolutionarily con-
served TSN (Tudor staphylococcal nuclease) [11] found in all eukary-
otes except in budding yeast [11]. Thus, although in yeast,
metacaspase is essential for apoptosis execution upon a wide range
of either physiological or external stimuli [3,12], the substrates tar-
geted by this protease are still unknown.
In this context, the identiﬁcation of yeast metacaspase speciﬁc
degradome is crucial for unraveling the signaling pathways regulated
by yeast metacaspase and to clarify its function in cell death. Using a
digestome analysis, together with in vitro and in vivo protein proces-
sing assays, we found evidence indicating that the yeast metabolic
enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a
speciﬁc substrate of yeast metacaspase.
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2. Materials and methods
2.1. Yeast strains and plasmids
Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0
ura3Δ0) strain and its isogenic derivative Δyca1 (EUROSCARF, Frankfurt,
Germany) were used. For construction of the metacaspase-
overexpressing strain, YCA1 was ampliﬁed by PCR (primers 5′-
ccgggaattcgatgtatccaggtagtggacgt-3′ and 5′-ccggggatccctacataat
aaattgcagatttacgtc-3′), using genomic DNA, isolated from
BY4742 strain and cloned into the EcoRI and BamHI sites of
pGREG546 (EUROSCARF, Frankfurt, Germany), which displays
GST at N-terminal and a galactose-inducible promoter, generating
pGREG546YCA1. Strain Δyca1 was transformed with pGRE-
G546YCA1, generating strain YCA1overexp.
2.2. Metacaspase overexpression and activation
YCA1overexp cells were grown until exponential growth phase
(OD640nm=0.5) on synthetic complete (SC) medium containing glu-
cose (2%, w/v), yeast nitrogen base (0.17%, w/v, Difco), 300 mg/l of
L-leucine, 50 mg/l of L-histidine and 50 mg/l of L-lysine. Cells were
washed, ressuspended in SC medium containing galactose (2%, w/v)
and incubated at 26 °C with stirring (150 r.p.m.) to induce metacas-
pase overexpression. After 16 h, 107 cells/ml were harvested and
resuspended in fresh SC medium with galactose (2%, w/v), and meta-
caspase was activated by the addition of 2 mM of H2O2 [3] and incu-
bation for 200 min at 26 °C with stirring (150 r.p.m.).
2.3. Inhibition of NO production
Inhibition of NOproductionwas achieved by pre-incubation of yeast
cells for 1 h with the non-metabolized L-arginine analog, Nω-nitro-L-
arginine methyl ester (L-NAME; Sigma-Aldrich), as described [8,9].
2.4. Protein extracts
Total protein extracts were prepared from untreated and H2O2-
treated yeast cells as described [9]. Protein concentration was deter-
mined by Bradford method [13].
2.5. Digestome analysis
Digestome analysis was performed according to the methodology
previously described in [14], with adaptations. Four hundred micro-
grams of total protein extracts obtained from untreated wild-type
yeast cells were resolved by SDS-PAGE 12% (ﬁrst dimension). After mi-
gration, the lanes were excised and treated as described in [14], soaked
in digestion buffer [50 mM Tris-HCl, 150 mM NaCl and 10 mM DTT]
with 5 mg of either active metacaspase-enriched extracts (obtained
from H2O2-treated YCA1overexp cells) or inactive metacaspase-enriched
extracts (obtained from H2O2-treated Δyca1 or untreated YCA1overexp
cells), incubated overnight at 37 °C, washed with ultrapure water and
incubated in loading buffer [50 mM Tris (pH 6.8), 2% SDS, 0.1% bromo-
phenol blue, 10% glycerol, 2.5% β-mercaptoethanol] for 10 min at
95 °C. After cooling, lanes were subjected to a second dimension SDS-
PAGE. Proteins in the gels were immunoblotted as described below or
stained using Colloidal Blue Staining Kit (Invitrogen) and the spots lo-
cated below the diagonal, corresponding to cleaved proteins, were ex-
cised from the gels and identiﬁed by MALDI-TOF mass spectrometry
as described in [13].
2.6. Assessment of intracellular reactive oxygen species (ROS)
Free intracellular ROS were detected with dihydrorhodamine 123
(DHR123) (Molecular Probes, Eugene, OR, USA). DHR123 was added
from a 1 mg/ml stock solution in ethanol, to 5×106 cells/ml sus-
pended in PBS, reaching a ﬁnal concentration of 15 μg/ml. Cells were
incubated for 90 min at 30 °C in the dark, washed in PBS and analyzed
by ﬂow cytometry. Flow cytometric assays were performed on a BD
LSR II™ (Becton Dickinson, NJ, USA) using BD FACSDiva Software 6.0
(Becton Dickinson, NJ, USA). Twenty thousand cells per sample were
analyzed using the FlowJo software (Tree Star, Ashland, OR, USA).
2.7. TUNEL assay
DNA strand breaks were assessed by a TUNEL assay with the In
situ Cell Death Detection Kit, POD (Roche Applied Science, Indianapo-
lis, IN). Yeast cells were initially ﬁxed with 3.7% formaldehyde fol-
lowed by digestion of the cell walls with lyticase. After preparation
of cytospins, the slides were rinsed with PBS, incubated in permeabi-
lization solution (0.1%, v/v, Triton X-100 and 0.1%, w/v, sodium cit-
rate) for 3 min on ice, rinsed twice with PBS, and incubated with
10 μL of TUNEL reaction mixture (terminal deoxynucleotidyl transfer-
ase and FITC-dUTP) for 60 min at 37 °C . Finally, the slides were rinsed
three times with PBS and a coverslip was mounted with a drop of
anti-fading agent Vectashield (Molecular Probes, Eugene, OR) and
with 2 μL of 50 μg/mL propidium iodide (PI, Molecular Probes) solu-
tion in Tris buffer (10 mM, pH 7.0) with MgCl2 (5 mM) and RNase
(0.5 μg/mL). Cells were visualized with an Olympus PlanApo 60X/oil
objective, with a numerical aperture of 1.42. For quantiﬁcation of
the number TUNEL-positive cells, at least 400 cells from three inde-
pendent assays were counted. Data express the percentage of
TUNEL-positive cells compared to the total number of counted cells.
2.8. Recombinant protein expression and cleavage assay
For production of recombinant GAPDH, yeast GAPDH (TDH3) was
ampliﬁed by PCR (primers 5′-ggggacaagtttgtacaaaaaagcaggctccatggt-
tagagttgctatt-3′ and 5′-ggggaccactttgtacaagaaagctgggtcttaagccttgg-
caacgtg-3′) from wild-type genomic DNA. PCR product was then
inserted into pDEST17 vector (Invitrogen) using the gateway® tech-
nology (Invitrogen), generating the plasmid pDEST17GAPDH. E. coli
strain BL21 pLys was transformed with vectors pDEST17GAPDH or
pET23aYCA1 (kindly provided by Dr. E. Lam).
Recombinant GAPDH and metacaspase expression was induced
with 1 or 0.4 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG), re-
spectively, at 37 °C (GAPDH) or 28 °C (metacaspase). GAPDH was
obtained as inclusion bodies that were solubilised in 50 mM Tris–
HCl, 0.2 M NaCl, 2 mM EDTA, pH 8.0. Refolding conditions were
screened using the iFOLD Protein Refolding System 2 (Novagen).
The protein was refolded by dilution in 50 volumes of refolding buffer
[50 mM TAPS, pH 8.5, 1.5 M Sorbitol, 24 mM NaCl, 1 mM KCl, 1 mM
TCEP] overnight at 22 °C with mild agitation. Bacterial cells expres-
sing YCA1 were broken by sonication as described in [15], and the
resulting supernatants used as described hereafter.
Metacaspase cleavage of GAPDH was assayed by incubating 500 μl
of recombinant GAPDH in refolding buffer with 20 μl of bacterial ex-
tracts obtained upon expression of metacaspase and 520 μl of 2×
buffer A [0.2% (w/v) CHAPS, 0.2 M HEPES, 20% (w/v) Sucrose,
20 mM TCEP, pH 7.5]. As a negative control, GAPDH was incubated
with bacterial extracts obtained from E. coli cells expressing the
empty vector, pET23a, and as a positive control, 500 μl of recombinant
GAPDH in refolding buffer was mixed with 100 μl of sea bass recom-
binant active caspase-1 in refolding buffer and with 600 μl of 2× buff-
er A. Samples were incubated overnight at 22 °C, precipitated with
trichloroacetic acid, resolved by SDS-PAGE and immunoblotted.
2.9. Immunoblotting
Proteins in the gels were transferred to nitrocellulose membranes.
Total protein extracts were probed with monoclonal mouse anti-
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GAPDH (MAB474, Chemicon) as described [9] or with the monoclonal
goat anti-actin (kindly provided by Dr. C.W. Gourlay) at a dilution of
1:5000. IgGs on the blots were detected with horseradish peroxidase-
conjugated anti-mouse, anti-rabbit or anti-goat IgG secondary anti-
bodies (Cell Signaling Technology) using an enhanced chemilumines-
cence kit (Pierce). The expression of active metacaspase in E. coli
harboring the pET23aYCA1 plasmid was conﬁrmed using polyclonal
rabbit anti-Yca1p antibody (kindly supplied by Dr. F. Madeo).
2.10. Statistical analysis
The arithmetic means for the free intracellular ROS and TUNEL
staining quantiﬁcation and comparison of cell survival rates are pre-
sented with standard deviation with a 95% conﬁdence value. Statisti-
cal analysis was carried out using independent samples t-test
analysis. A p-value lower than 0.05 was assumed to denote a signiﬁ-
cant difference.
3. Results
3.1. Digestome analysis reveals GAPDH as a cleavage target of metacaspase
To identify speciﬁc targets of yeast metacaspase we performed a
digestome analysis, as previously described [14]. Although digestome
analysis, an in vitro assay, does not mimic cellular physiological con-
ditions, it represents a starting point for searching putative speciﬁc
substrates of proteases. In a ﬁrst dimension SDS-PAGE, total protein
extracts from untreated wild-type yeast cells were resolved. Upon
protein separation, gel lanes were excised and incubated with active
metacaspase-enriched extracts obtained from YCA1overexp cells un-
dergoing apoptosis induced by H2O2 treatment (a condition known
to induce metacaspase activation [3]). After incubation, gel lanes
were mounted on a second SDS-PAGE gel and proteins resolved a sec-
ond time by molecular weight. Digestome analysis of total protein ex-
tracts revealed numerous spots below the diagonal, corresponding to
protein fragments that originated from cleavage during the incuba-
tion of the gel lane with active metacaspase-enriched extracts
(Fig. 1A). Three spots (Fig. 1A, spot 1, 2 and 3) were analyzed by
mass spectrometry and indicate the presence of peptide fragments
of the isoforms 2 or 3 (Tdh2p/Tdh3p), but not of the isoform 1
(Tdh1p), of the glycolytic enzyme glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (Fig. 1B). Immunoblotting of the digestome anal-
ysis gel with an anti-GAPDH antibody showed three GAPDH
fragments immediately below the diagonal (Fig. 1C1, spots 4, 5 and
6). Some of these labeled fragments are most likely the complemen-
tary GAPDH protein fragments of the peptides identiﬁed by mass
spectrometry (Fig. 1A and B).
The question whether GAPDH cleavage observed was due to meta-
caspase or to other activated proteases was addressed. For such pur-
pose, gel lanes were also incubated either with extracts from
untreated YCA1overexp cells or H2O2-treated Δyca1 cells, two paradig-
matic conditions of absence of metacaspase activity. Digestome anal-
ysis showed that the absence of metacaspase activity (Fig. 1C2 and
C3) resulted in the appearance of a GAPDH fragment (spot 6) below
the full-length GAPDH protein that is also present in the digestome
obtained with H2O2-treated YCA1overexp cells, indicating that this is a
biological phenomenon independent of metacaspase activity. Howev-
er, two other spots (spots 4 and 5) were detected in the digestome
analysis under active metacaspase conditions (Fig. 1C) and were not
generated when active metacaspase was absent. These data suggest
that GAPDH is cleaved by metacaspase and that speciﬁc cleavage
products only occur when metacaspase is active.
The observed in vitro cleavage of GAPDH by active metacaspase-
enriched extracts suggests a relevant role of metacaspase proteolytic
activity in targeting a crucial metabolic enzyme during yeast apopto-
sis. In mammals, the targeting of metabolic enzymes by caspases is
not a newly described phenomenon as evidenced in the caspase sub-
strate database (CASBAH database) [16].
3.2. Recombinant GAPDH is cleaved in vitro by recombinant metacaspase
To further support the speciﬁc cleavage of GAPDH by active meta-
caspase, recombinant metacaspase-enriched bacterial extracts were
added to recombinant GAPDH (isoform 3 - Tdh3p, the main target
of fragmentation during H2O2-induced apoptosis [9]). As shown in
Fig. 2, the addition of a metacaspase-enriched bacterial extract to re-
combinant GAPDH was sufﬁcient to induce its fragmentation, with
the appearance of fragments with molecular weights similar to the
ones detected in the immunoblot of the digestome gel (Fig. 1C1).
When protein extracts from E. coli cells expressing the empty vector
were added to GAPDH, no fragmentation was observed (Fig. 2).
GAPDH has also been reported to be speciﬁcally cleaved by caspase-
1 in higher eukaryotic cells [17]. Since GAPDH sequence is highly con-
served among species, as a positive control, we added recombinant
ﬁsh caspase-1 to recombinant yeast GAPDH. As expected, ﬁsh cas-
pase-1 was able to cleave yeast GAPDH (Fig. 2), although the four
resultingGAPDH fragmentswere distinct from the ones produced by in-
cubation with recombinant yeast metacaspase, showing that these pro-
teases have distinct cleavage target sites. Our results indicate that yeast
metacaspase recognizes target sequences distinct from the ones recog-
nized by caspases of higher eukaryotes corroborating previous results
that attributed to metacaspase an arginine/lysine-speciﬁc endopepti-
dase activity in contrast to the cysteine-aspartic proteases of caspases
[15].
Altogether, these results show that althoughmetacaspases have a pro-
teolytic activity distinct from caspases, their targetedmolecular pathways
upon an apoptotic stimulus display similarities and during apoptotic cell
death both of them degrade metabolic enzymes. Next, we went on to
evaluate if cleavage of GAPDH by metacaspase also occurs during in
vivo induction of yeast apoptosis by H2O2 [3].
3.3. In vivo metacaspase cleavage of GAPDH during H2O2-induced apoptosis
is dependent on NO levels
Several proteins shown to be speciﬁcally cleaved by in vitro meth-
odologies, such as the digestome analysis, proved later not to be sub-
strates of the caspases under in vivo apoptotic conditions. Thus,
metacaspase speciﬁc GAPDH fragmentation was evaluated by immu-
noblot analysis of the GAPDH levels, in total protein extracts from
wild-type and Δyca1 cells challenged with H2O2. As expected, H2O2
(concentrations ranging from 0.5 mM to 2 mM) induced apoptotic
cell death of wild-type cells as revealed by the increasing percentage
of cells displaying TUNEL positive phenotype and high levels of reac-
tive oxygen species (ROS) (Fig. 3). In contrast, Δyca1 cells were more
resistant to H2O2 and thus have increased survival, TUNEL negative
phenotype and lower percentage of cells with high ROS levels
(Fig. 3). Moreover, apoptotic cell death of wild-type cells was accom-
panied by a clear reduction of the GAPDH levels that was not ob-
served in Δyca1 cells (Fig. 3E), suggesting the requirement of
metacaspase for the occurrence of fragmentation of this protein in
vivo. Simultaneously, it was possible to detect a GAPDH fragment
with lower molecular weight (15 kDa) (Fig. 3E) compatible with
one of the fragments observed by digestome analysis (Fig. 1C1). The
absence of other fragments in the immunoblot analysis, as observed
by in vitro digestome assay, suggests that the peptides liberated
from the precursor protein, can be further processed, resulting in
fragments that are released or degraded.
These results suggest that GAPDH is a speciﬁc target of metacas-
pase during H2O2-induced apoptosis, reinforcing the link between
metabolism and cell death.
Our previous data have demonstrated that upon H2O2-induced ap-
optosis, yeast cells are able to synthesize nitric oxide (NO) leading to
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the S-nitrosation of GAPDH [9]. Therefore, we wondered if the meta-
caspase speciﬁc GAPDH cleavage and NO signaling are correlated. To
elucidate if GAPDH metacaspase-dependent fragmentation requires
its previous S-nitrosation, NO synthesis was inhibited, through the
pre-incubation of cells with the L-arginine analog Nω-nitro-L-arginine
methyl ester (L-NAME) [9,10], and the in vivo GAPDH levels assessed
by immunoblot. NO synthesis inhibition resulted in the maintenance
of GAPDH levels, in contrast with the H2O2-treated wild-type cells
without L-NAME pre-incubation (Fig. 3F). These results revealed a
causal relation between metacaspase activity and NO levels, as previ-
ously reported [7,10] indicating that the in vivo occurrence of meta-
caspase speciﬁc GAPDH cleavage upon H2O2-induced apoptosis
requires NO signaling.
4. Discussion
Metacaspase seems to be an executor of the apoptotic events ob-
served in S. cerevisiae (reviewed in [4,12]). Although signiﬁcant ef-
forts have gone into the clariﬁcation of the role of metacaspase in
yeast cell death processes, its role is still enigmatic. The routes to un-
ravel yeast metacaspase functions undoubtedly have to pass through
understanding howmetacaspase recognizes its substrates, the identi-
ﬁcation of its speciﬁc substrates and how substrate cleavage is in-
volved in the apoptotic phenotype. Although it was described that
in vivo metacaspases cleave the evolutionarily conserved TSN
(Tudor staphylococcal nuclease) [11], TSN is absent in budding
yeast [11] and thus the substrates targeted by yeast metacaspase
are still unknown.
Fig. 1. GAPDH is a target of cleavage by metacaspase-enriched protein extracts. (A) Total protein extracts from untreated wild-type cells subjected to SDS-PAGE, incubated with
active metacaspase-enriched extracts (from H2O2-treated YCA1overexp cells) and then subjected to a second SDS-PAGE. The gel was Coomassie blue-stained. Spots below diagonal
(1, 2 and 3), corresponding to cleaved proteins, were excised and analyzed by MALDI-TOF mass spectrometry. (B) Sequence of GAPDH isoforms Tdh1p (NP_012483.1), Tdh2p
(NP_012542) and Tdh3p (NP_011708) retrieved fromNCBI. Mass spectrometry analyses of the three spots identiﬁed peptides matches to Tdh2p and Tdh3p but not Tdh1p. Sequence
parts covered by the detected peptides are indicated with different colors. Pink colored peptide was identiﬁed both in spot 2 and 3. (C) Coomassie-stained diagonal gels of protein
extracts fromwild-type untreated cells incubated with protein extracts from (1) H2O2-treated YCA1overexp cells; (2) untreated YCA1overexp cells and (3) H2O2-treated Δyca1 cells, and
respective immunoblot analysis with a monoclonal anti-GAPDH antibody reveal spots 4, 5 and 6. Data are representative of at least three independent experiments.
Fig. 2. In vitro cleavage of recombinant GAPDH by metacaspase-enriched bacterial extracts
andpuriﬁed caspase-1. Immunoblot of recombinantGAPDH incubatedwith 20 μl of protein
extracts from bacteria harboring pET23a empty vector, 20 μl of protein extracts from bac-
teria expressing metacaspase or recombinant puriﬁed caspase-1. Twenty microliters of
protein extracts from bacterial cells expressing metacaspase were loaded as control. Data
are representative of at least three independent experiments.
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The use of different methodologies described as requisites for a pro-
tein to be considered a caspase substrate [18] allows us to assignGAPDH
as a metacaspase speciﬁc substrate. GAPDH cleavage was observed in
vitro by digestome analysis complemented with mass spectrometry
and immunoblot and validated by its speciﬁc cleavage after incubation
of recombinant GAPDH with recombinant metacaspase. Moreover, the
occurrence of GAPDH metacaspase-dependent cleavage was further
conﬁrmed by an in vivo assay in cells undergoing apoptosis with
GAPDH displaying reduced levels. Moreover, the physiological rele-
vance of GAPDH fragmentation is also supported by previous results
showing that GAPDH is a target of extensive fragmentation upon
H2O2-induced apoptosis [9,19]. It is important to acknowledge that,
proteolytic cleavage of GAPDH, as that of any protein, can result in a
gain- or loss-of-function for the protein. It is well known that H2O2
treatment (1.5 mM) of S. cerevisiae cells results in the decrease of
GAPDH activity associated with a drop of the ATP levels [20]. The re-
duced ATP levels affect cellular homeostasis and can decrease the efﬁ-
ciency of energy-dependent processes and ATP-mediated cell signal
transduction such as actin dynamics [21] increasing the sensitivity to
apoptotic insult. Nevertheless, the hypothesis that GAPDH cleavage re-
sults in a gain-of-function is also acceptable in the light of our previous
results [9] showing an increased survival of TDH2- and TDH3-disrupted
cells exposed to H2O2-induced apoptosis. The GAPDH pleiotropic
functions, linked to the various intracellular localizations of the enzyme,
as well as the observation that GAPDH overexpressing cells behave as
wild-type cells when challenged with H2O2 (data not shown) further
complicates the elucidation of this aspect. Nonetheless, the accumulat-
ing evidence indicates that yeast GAPDH cleavage bymetacaspase could
contribute to H2O2-induced apoptosis independently of whether or not
this proteolysis results in a gain- or loss-of-function. We and others
have shown that GAPDH is S-nitrosated by the NO generated upon
H2O2-induced apoptosis [9], and that inhibition of NO synthesis in
yeast cell leads to a dramatic reduction of metacaspase activity [10].
Hereinwe show that NO production is needed for themetacaspase spe-
ciﬁc cleavage of GAPDH upon H2O2-induced apoptosis, similar to what
occurs in higher eukaryotic cells, in which NO has already been ascer-
tained as a signalingmolecule with the capacity to promote caspase ac-
tivation [22]. The observed NO-dependent metacaspase speciﬁc
cleavage of GAPDHmight also be explained by the capacity of NO in ac-
tivating metacaspase as previously reported [7]. Further studies might
help in elucidating the relation between NO signaling and metacaspase
speciﬁc GAPDH cleavage. Nonetheless, all these results call attention to
the relevance of metabolic enzyme cleavage during H2O2-induced apo-
ptosis. Metabolic enzymes have complex roles, having proved their
multi-functional relation with different cellular processes, including
cell death [23,24]. In fact, GAPDH has been extensively implicated in
Fig. 3. GAPDH speciﬁc cleavage by metacaspase during H2O2-induced apoptosis is dependent on NO levels. (A) Comparison of the survival rate of wild-type and Δyca1 cells upon
H2O2 treatment. (B) Percentage of wild-type and Δyca1 cells exhibiting high levels of intracellular ROS detected by FACS measurements of the dihydrorhodamine 123 ﬂuorescence.
(C) Percentage of wild-type and Δyca1 cells displaying TUNEL positive phenotype. (D) Epiﬂuorescence and bright ﬁeld micrographs of untreated and H2O2-treated wild-type
and Δyca1 cells displaying TUNEL reaction to visualize double-strand DNA breaks. Cells were co-stained with propidium iodide in order to facilitate nuclei visualization.
Bar, 5 μm. (E) Immunoblot analysis of GAPDH and actin protein levels in 40 μg of total protein extracts of H2O2-treated and untreatedwild-type andΔyca1 cells. (F) Immunoblot analysis
of GAPDH levels in 40 μg of total protein extracts of untreated and H2O2-treated wild-type yeast cells after pre-incubation with the L-arginine analog, L-NAME. Statistical signiﬁcance
(*Pb0.05) was determined by Student's t-test.
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several mammalian apoptotic processes [25]. Additionally, alterations
in metabolic pathways are often related to neurodegenerative diseases,
cell damaging processes and cancers [23,25]. Our ﬁndings herein de-
scribed demonstrate for the ﬁrst time a yeast metacaspase speciﬁc sub-
strate, GAPDH. The data obtained open new perspectives for the precise
identiﬁcation of the molecular cascade regulated by metacaspase acti-
vation and its relevance to yeast apoptotic cell death.
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Table 1 - Microarrays analysis results of polysomal fractions of untreated and 15 min 
acetic acid treated cells. 412 genes were found up-regulated (more than two fold) 
upon acetic acid treatment. 
 
Probe ID Gene 
symbol 
Fold 
change 
p-value 
YCL027C-A #N/A 2.434 1,25E-05 
YMR178W 0 3.422 1,58E-03 
YNL149C 0 3.233 4,12E-04 
YMR074C 0 4.601 6,56E-03 
YBR231C 0 2.564 1,64E-03 
YCR051W 0 2.235 7,55E-03 
YGR173W 0 2.826 9.31E-6 
YGR277C 0 2.37 7.62E-7 
YFL046W 0 2.257 1,99E-03 
YPR118W 0 2.738 5,41E-03 
YCR090C 0 2.084 3,92E-03 
YHR020W 0 3.376 4,93E-04 
YDR533C 0 2.976 1,10E-03 
YOR164C 0 3.51 8,15E-04 
YMR067C 0 1.619 7.9E-6 
YJR085C 0 2.671 4,15E-03 
YNL081C 0 2.679 2.96E-8 
YBR052C 0 5.027 2,58E-05 
YNL208W 0 2.902 2,40E-03 
YDR287W 0 1.661 6,33E-04 
YDL158C 0 6.249 4,09E-03 
YGR021W 0 2.169 2,65E-03 
YGR017W 0 2.13 2,83E-03 
YHR121W 0 3.589 1,55E-04 
YER067W 0 4.324 2,36E-03 
YDR286C 0 4.045 2,80E-03 
YGL245W 0 3.033 1,32E-03 
YER030W 0 3.435 3,62E-03 
YER093C-A 0 2.085 8,70E-03 
YOR091W 0 1.676 8,03E-03 
YER138W-A 0 2.876 3,90E-03 
YOL026C 0 2.159 8,46E-03 
YPR188C 0 3.869 9,90E-03 
YPL098C 0 3.668 3,18E-03 
YGL068W 0 3.297 2,84E-03 
YKL018C-A 0 2.366 3,53E-05 
YPL183W-A 0 2.352 1.38E-6 
YLR408C 0 1.864 3,84E-03 
YDR071C 0 2.738 3,65E-03 
YPL267W 0 2.049 6,40E-03 
YNL134C 0 3.529 1,05E-03 
YOR112W 0 2.333 2,01E-05 
YNL201C 0 1.948 3,09E-03 
YLR022C 0 3.4 6,03E-03 
YKR065C 0 2.333 3.76E-6 
YIR036C 0 2.501 4,61E-04 
YMR226C 0 3.537 1,23E-04 
YPL225W 0 5.758 1,11E-04 
YNR046W 0 1.997 9.79E-6 
YNL168C 0 4.206 1,42E-04 
YJL217W 0 3.762 1,46E-04 
YIR035C 0 3.216 1,07E-03 
YMR009W 0 1.975 6,39E-03 
YDR063W 0 3.346 1,82E-04 
YBR137W 0 2.834 7,45E-04 
YER163C 0 2.029 4,34E-04 
YDR514C 0 2.185 6,67E-03 
YGR111W 0 2.046 6,89E-04 
YJL062W-A 0 4.087 6,51E-06 
YGL232W 0 5.921 7,52E-04 
YJR024C 0 2.433 3,41E-04 
YKL206C 0 1.818 5,36E-03 
YOR285W 0 8.172 1,14E-05 
188 
 
YGL231C 0 3.882 1,76E-03 
YHR034C 0 2.04 8,78E-03 
YGR001C 0 3.286 5,94E-05 
YNR040W 0 2.335 1,61E-04 
YHR029C 0 4.209 4,20E-06 
YNR036C 0 7.03 5,93E-05 
YFR043C 0 3.038 3,42E-03 
YER010C 0 1.768 1,70E-04 
YOR203W 0 6.442 1.98E-6 
YIL041W 0 2.889 2,27E-03 
YJL181W 0 1.464 9.96E-6 
YDR196C 0 2.919 6,97E-04 
YPR063C 0 2.325 9,01E-05 
YGR137W 0 3.523 4,75E-03 
YGL047W 0 3.509 5,25E-06 
YMR184W 0 3.766 3,12E-05 
YCL033C 0 8.464 1,92E-06 
YLL022C 0 1.739 9,28E-03 
YOR169C 0 5.731 9,45E-03 
YOL111C 0 2.781 2,51E-06 
YMR315W 0 4.836 5,59E-05 
YDR433W 0 3.77 9,92E-03 
YDR154C 0 3.021 6,36E-03 
YDL099W 0 3.714 5,89E-03 
YNL045W 0 2.521 4,52E-03 
YLR027C AAT2 2.636 1,27E-03 
YGR037C ACB1 2.728 4,03E-03 
YKL192C ACP1 3.18 5,30E-05 
YOR128C ADE2 1.877 2.11E-6 
YDR408C ADE8 1.81 8,64E-03 
YDR226W ADK1 3.878 2,62E-04 
YDR214W AHA1 2.064 5,44E-03 
YJR047C ANB1 5.128 8,29E-04 
YPR128C ANT1 2.26 7,26E-05 
YLR102C APC9 2.273 9,67E-03 
YML022W APT1 2.876 3,78E-03 
YBR149W ARA1 2.426 1,49E-03 
YGL105W ARC1 2.939 5,49E-03 
YIL062C ARC15 3.016 9,90E-04 
YKL013C ARC19 2.217 2,38E-03 
YHR013C ARD1 4.797 1,96E-04 
YDL100C ARR4 2.466 3,97E-03 
YGL017W ATE1 1.868 3.14E-7 
YNL315C ATP11 2.295 2.14E-6 
YDR298C ATP5 1.793 1,60E-04 
YKL016C ATP7 2.657 1,57E-04 
YFL010W-A AUA1 3.524 1,31E-03 
YER155C BEM2 1.437 5,06E-03 
YIL004C BET1 1.926 4,76E-03 
YPR176C BET2 2.356 1,33E-04 
YJL031C BET4 4.849 9,39E-04 
YFR047C BNA6 4.461 1,72E-04 
YLR078C BOS1 2.565 2,55E-03 
YHR114W BZZ1 2.446 7,20E-04 
YOR276W CAF20 6.022 3,49E-06 
YNL288W CAF40 2.324 9,24E-05 
YER048C CAJ1 2.757 5,77E-05 
YOR125C CAT5 2.415 1,97E-04 
YPL178W CBC2 2.951 4,30E-04 
YPL215W CBP3 2.264 4.44E-6 
YIL142W CCT2 1.739 6.42E-6 
YDL143W CCT4 3.126 1,75E-04 
YCR002C CDC10 2.249 1,11E-03 
YDL165W CDC36 1.742 1,73E-03 
YDR168W CDC37 2.214 8,91E-04 
YDL126C CDC48 2.643 1,80E-03 
YLR418C CDC73 2.671 5,06E-05 
YJR057W CDC8 2.132 4,20E-03 
YBR109C CMD1 2.157 6,21E-05 
YLL009C COX17 5.469 1,27E-05 
YIL111W COX5B 3.615 1.03E-6 
YML078W CPR3 4.73 1,11E-04 
YLR216C CPR6 2.827 3,81E-03 
YNL027W CRZ1 2.014 4,21E-04 
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YHR191C CTF8 2.503 2,84E-04 
YOR042W CUE5 3.479 9,22E-05 
YGL166W CUP2 1.685 6.81E-6 
YDR163W CWC15 3.032 1,69E-03 
YKL096W CWP1 5.528 3,12E-04 
YAL039C CYC3 2.265 6,19E-03 
YAL012W CYS3 3.644 1,54E-04 
YGR155W CYS4 2.777 1,81E-03 
YML113W DAT1 1.425 5,27E-03 
YOR046C DBP5 3.551 2,58E-05 
YOL149W DCP1 3.133 6.21E-6 
YOR163W DDP1 3.187 8,42E-04 
YKL054C DEF1 2.426 2,03E-03 
YIR004W DJP1 1.734 1.28E-6 
YDR121W DPB4 2.376 1,39E-03 
YMR276W DSK2 4.415 2.22E-6 
YDR424C DYN2 2.817 2,04E-04 
YLR390W ECM19 4.296 1,21E-03 
YHL030W ECM29 3.324 4,05E-04 
YBL047C EDE1 2.482 5,94E-03 
YHR193C EGD2 3.567 9,13E-03 
YNL084C END3 3.195 3,10E-04 
YJR125C ENT3 5.058 1,33E-05 
YDR153C ENT5 2.176 1,67E-03 
YPL028W ERG10 3.242 3,37E-03 
YML126C ERG13 3.009 7,82E-03 
YJL167W ERG20 3.215 7,46E-05 
YGL001C ERG26 3.343 9,03E-05 
YLR100W ERG27 2.974 1,25E-04 
YHR190W ERG9 2.347 4,07E-03 
YDL166C FAP7 3.001 5,90E-03 
YPL231W FAS2 1.648 2,32E-03 
YPR062W FCY1 2.466 7,16E-03 
YIL065C FIS1 2.633 2,87E-03 
YIL098C FMC1 2.095 3,99E-04 
YNL135C FPR1 3.371 4,88E-05 
YML074C FPR3 2.746 6,42E-04 
YFL022C FRS2 2.1 7,54E-03 
YHR049W FSH1 4.94 1,52E-04 
YMR222C FSH2 3.703 1,33E-03 
YAL035W FUN12 2.554 2,14E-04 
YER027C GAL83 2.013 5,72E-03 
YCL011C GBP2 1.689 6,76E-03 
YGR083C GCD2 2.863 6.52E-8 
YFR009W GCN20 2.502 3,48E-03 
YAL044C GCV3 2.937 3,96E-04 
YLR094C GIS3 2.004 2,38E-03 
YOR168W GLN4 6.049 3,46E-04 
YML004C GLO1 3.932 1,81E-03 
YDR272W GLO2 5.923 1,07E-04 
YHL031C GOS1 2.473 5,79E-03 
YLR293C GSP1 2.273 7,36E-03 
YGL181W GTS1 2.211 5,20E-04 
YIR038C GTT1 3.554 5,01E-04 
YNL281W HCH1 2.306 1.28E-6 
YLR192C HCR1 1.859 1,06E-03 
YOR176W HEM15 5.048 3,09E-08 
YBR248C HIS7 2.32 8,05E-03 
YDL125C HNT1 5.896 4,54E-04 
YDR305C HNT2 2.761 2.52E-6 
YJR139C HOM6 2.998 1,46E-03 
YEL066W HPA3 2.762 3,01E-04 
YMR186W HSC82 2.721 5,86E-03 
YHL002W HSE1 3.497 5,51E-03 
YOR020C HSP10 3.255 4,77E-03 
YLR259C HSP60 2.511 3,01E-03 
YIR037W HYR1 5.356 8.62E-8 
YJR016C ILV3 2.484 3,29E-03 
YCR046C IMG1 2.95 5,51E-03 
YBR011C IPP1 2.55 2.77E-7 
YNL265C IST1 3.325 2,55E-03 
YBR245C ISW1 1.597 1,86E-03 
YPR133C IWS1 2.951 5,75E-04 
YGL173C KEM1 2.363 5,06E-04 
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YDR148C KGD2 1.678 2,54E-03 
YKL183W LOT5 3.299 1,89E-03 
YBL026W LSM2 3.704 2,66E-03 
YER112W LSM4 1.831 2,44E-03 
YPL004C LSP1 3.811 4,17E-03 
YMR038C LYS7 3.017 3,75E-04 
YGL086W MAD1 3.233 2,86E-03 
YIL070C MAM33 6.55 2,58E-04 
YBL091C MAP2 2.878 4,33E-03 
YOR197W MCA1 3.586 2,24E-04 
YDL078C MDH3 6.345 5,33E-04 
YLR303W MET17 2.443 3,06E-03 
YOR241W MET7 1.639 5,78E-03 
YOR232W MGE1 3.441 6,51E-03 
YKR095W MLP1 1.454 3,00E-03 
YIL051C MMF1 3.26 7,05E-05 
YJR074W MOG1 2.8 1,43E-04 
YDR347W MRP1 3.939 2,87E-03 
YKL003C MRP17 1.774 1,73E-03 
YBL038W MRPL16 2.409 1,83E-03 
YKR085C MRPL20 4.251 2,04E-03 
YOR150W MRPL23 2.277 3,53E-03 
YBR282W MRPL27 2.591 9,64E-04 
YDR462W MRPL28 2.275 6,69E-03 
YKL138C MRPL31 1.971 6,68E-03 
YJL096W MRPL49 5.127 4,39E-04 
YPR100W MRPL51 2.169 6,48E-04 
YJL063C MRPL8 3.006 1,13E-04 
YGR220C MRPL9 2.309 5,45E-03 
YBR251W MRPS5 1.92 4,74E-04 
YMR158W MRPS8 3.957 1,07E-03 
YOR354C MSC6 1.391 8,35E-03 
YGL122C NAB2 2.121 1,78E-03 
YGR232W NAS6 3.63 1,38E-04 
YDL040C NAT1 2.23 1,60E-03 
YPR052C NHP6A 2.297 3,51E-03 
YBR089C-A NHP6B 2.994 7.69E-8 
YGL221C NIF3 2.169 8,73E-03 
YPL211W NIP7 2.348 3,68E-03 
YLR351C NIT3 3.165 2,26E-04 
YOL041C NOP12 2.204 2,14E-03 
YNL175C NOP13 4.616 2.44E-6 
YPR072W NOT5 4.422 3,14E-04 
YMR091C NPL6 1.761 2,63E-03 
YER126C NSA2 2.309 5.19E-6 
YER009W NTF2 3.864 2,01E-03 
YER006W NUG1 3.111 2.72E-6 
YIL115C NUP159 2.266 1,98E-03 
YBR129C OPY1 1.948 3,88E-03 
YHR063C PAN5 2.194 5,26E-05 
YDR228C PCF11 1.602 3,89E-03 
YNL231C PDR16 1.794 1.74E-6 
YER153C PET122 3.809 1,71E-03 
YOR158W PET123 1.546 3,02E-03 
YOL044W PEX15 4.079 1,59E-04 
YPL112C PEX25 2.616 4,14E-03 
YOR122C PFY1 2.83 4,22E-04 
YGL025C PGD1 2.401 8,95E-03 
YPL031C PHO85 3.07 4,32E-03 
YNL055C POR1 3.258 8,57E-04 
YDL134C PPH21 1.996 2,40E-03 
YDL188C PPH22 2.871 6,01E-03 
YMR314W PRE5 2.453 2,26E-04 
YOR323C PRO2 3.161 4,17E-04 
YBL068W PRS4 3.243 7,72E-05 
YJL166W QCR8 1.466 6,71E-03 
YDL103C QRI1 3.576 2,00E-03 
YMR022W QRI8 2.397 3,89E-04 
YER095W RAD51 1.688 3,06E-03 
YNL216W RAP1 1.884 4.46E-6 
YCR036W RBK1 2.185 2,69E-04 
YLR248W RCK2 3.24 2,12E-04 
YJL204C RCY1 1.679 2,97E-03 
YNL312W RFA2 2.224 2,53E-03 
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YJL173C RFA3 1.824 8,74E-03 
YDR487C RIB3 2.803 2,97E-04 
YER083C RMD7 3.565 3,26E-04 
YCL028W RNQ1 4.784 1,63E-05 
YDR156W RPA14 2.239 1,90E-04 
YOL005C RPB11 3.302 7,65E-04 
YJL140W RPB4 4.935 3,93E-03 
YDR404C RPB7 1.394 8,89E-03 
YJL121C RPE1 4.233 1.03E-6 
YMR121C RPL15B 3.335 4.34E-6 
YNL069C RPL16B 4.102 5,61E-03 
YPL079W RPL21B 4.027 1,50E-03 
YBL087C RPL23A 2.059 2,01E-03 
YDR471W RPL27B 3.546 2,94E-04 
YBR031W RPL4A 4.197 5,85E-03 
YDR012W RPL4B 3.28 2,90E-03 
YLL045C RPL8B 2.614 6,70E-03 
YDL097C RPN6 3.027 4,64E-03 
YPR187W RPO26 5.196 4,23E-03 
YDR064W RPS13 3.576 1,84E-03 
YCR031C RPS14A 2.179 2.6E-6 
YJL191W RPS14B 2.456 1,99E-03 
YOL121C RPS19A 3.619 9,20E-03 
YJL190C RPS22A 5.264 6,38E-03 
YLR367W RPS22B 2.913 1,35E-03 
YKL156W RPS27A 2.049 9,22E-03 
YLR167W RPS31 5.439 6,48E-03 
YPL090C RPS6A 3.674 7,29E-03 
YKL145W RPT1 2.805 4,85E-04 
YMR131C RRB1 2.279 9,35E-03 
YDL111C RRP42 1.592 5,89E-03 
YER050C RSM18 3.008 1,48E-03 
YJR113C RSM7 3.909 3,85E-03 
YGL244W RTF1 1.839 2,59E-03 
YOR216C RUD3 3.518 2,02E-03 
YPL235W RVB2 2.213 6,73E-03 
YCR009C RVS161 2.804 2,84E-05 
YDR388W RVS167 2.668 3,95E-04 
YLR180W SAM1 2.834 9,18E-04 
YMR263W SAP30 3.162 2,72E-04 
YPL218W SAR1 4.355 1,40E-03 
YHL034C SBP1 3.199 9,23E-03 
YGL011C SCL1 2.202 1,05E-03 
YJL080C SCP160 3.62 1,87E-03 
YER120W SCS2 4.536 5,15E-04 
YPL085W SEC16 1.794 2,49E-04 
YBL050W SEC17 2.83 2,29E-04 
YLR268W SEC22 3.154 2,99E-03 
YDR170C SEC7 2.773 7.48E-7 
YLR292C SEC72 2.732 7,77E-04 
YGR009C SEC9 2.846 2,44E-03 
YIL074C SER33 1.809 7,77E-03 
YDL168W SFA1 1.956 5,51E-04 
YJL145W SFH5 3.227 2,67E-04 
YJR134C SGM1 1.912 3,53E-03 
YKL130C SHE2 2.044 8,07E-03 
YBR258C SHG1 3.595 7,61E-05 
YBL058W SHP1 3.181 4,82E-03 
YNL236W SIN4 2.888 4,57E-03 
YGL208W SIP2 2.165 7,16E-03 
YDR328C SKP1 2.64 3,24E-03 
YML058W SML1 1.965 9,67E-03 
YFL017W-A SMX2 4.721 5,12E-04 
YPR182W SMX3 5.104 3,49E-03 
YKL079W SMY1 3.442 6,56E-04 
YAL030W SNC1 4.013 1,46E-03 
YGL115W SNF4 4.644 1.56E-6 
YJR104C SOD1 5.51 8,67E-05 
YHR163W SOL3 2.077 4,89E-04 
YGL093W SPC105 2.844 5,74E-04 
YER018C SPC25 2.297 6,38E-03 
YPR069C SPE3 3.145 3.49E-6 
YGL207W SPT16 1.746 9.49E-6 
YDR292C SRP101 2.05 8,60E-03 
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YOR027W STI1 4.129 5,54E-04 
YLR150W STM1 3.327 4,83E-03 
YPL237W SUI3 4.088 1,74E-03 
YDR172W SUP35 3.036 9,06E-05 
YDR167W TAF10 2.04 1,02E-03 
YJL052W TDH1 1.642 4,01E-03 
YHR025W THR1 1.739 9,45E-03 
YMR146C TIF34 2.579 2,61E-03 
YGL049C TIF4632 1.825 1,53E-04 
YJL143W TIM17 2.285 1,04E-03 
YJR135W-A TIM8 3.72 2,67E-04 
YEL020W-A TIM9 4.506 3,58E-06 
YER011W TIR1 2.279 4,51E-04 
YIL011W TIR3 1.915 3,96E-03 
YNL070W TOM7 3.081 2,72E-03 
YAL016W TPD3 2.92 2,96E-03 
YDR353W TRR1 1.966 1,18E-03 
YOR115C TRS33 3.016 7,10E-03 
YGR209C TRX2 4.381 5,92E-04 
YCR083W TRX3 2.845 3,46E-04 
YML028W TSA1 3.582 1,42E-05 
YBR058C-A TSC3 3.442 2,36E-03 
YDR513W TTR1 3.059 8,01E-03 
YER100W UBC6 2.465 1,69E-04 
YLL039C UBI4 3.689 6,60E-03 
YFR010W UBP6 2.65 5,26E-03 
YKL024C URA6 2.55 5,45E-04 
YDR400W URH1 2.39 2,09E-03 
YDL058W USO1 2.52 5,15E-04 
YGR128C UTP8 1.858 4,91E-03 
YEL038W UTR4 1.794 4,15E-03 
YHR039C-A VMA10 7.892 3,15E-03 
YPR036W VMA13 2.925 2,40E-03 
YOR132W VPS17 2.364 8.94E-6 
YKL041W VPS24 1.319 6,31E-03 
YFL010C WWM1 3.368 9,91E-06 
YPL252C YAH1 2.687 5,79E-04 
YHR135C YCK1 1.986 7,08E-03 
YDL120W YFH1 1.969 2,08E-04 
YDL198C YHM1 5.2 8,22E-05 
YNL263C YIF1 2.105 9,55E-04 
YNL044W YIP3 2.339 5,80E-03 
YLR200W YKE2 1.633 2,08E-03 
YML025C YML6 1.743 7,93E-03 
YKL067W YNK1 2.594 3,91E-04 
YPR028W YOP1 2.444 5,75E-04 
YML027W YOX1 1.926 6,88E-03 
YDL235C YPD1 2.353 8,33E-03 
YDR368W YPR1 1.847 2,13E-03 
YFL038C YPT1 2.348 1,65E-03 
YML001W YPT7 4.534 2,95E-05 
YIL063C YRB2 2.304 9,77E-03 
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Table 2 - Microarrays analysis results of polysomal fractions of untreated and 15 min 
acetic acid treated cells. 457 genes were found down-regulated upon acetic acid 
treatment. 
Probe ID Gene 
symbol 
Fold 
change 
p-value 
YGL217C 0 0,301 3,45E-04 
YAL064W-B 0 0,304 5,74E-02 
YOR343C 0 0,149 3,57E-02 
YLR361C 0 0,364 3,28E-02 
YLR077W 0 0,567 4,07E-02 
YLL055W 0 0,543 8,34E-02 
YOR378W 0 0,17 4,65E-02 
YOR019W 0 0,379 5,85E-02 
YBL029W 0 0,185 6,06E-02 
YBR095C 0 0,572 3,51E-02 
YIL177C 0 0,269 3,20E-02 
YBR094W 0 0,387 2,93E-02 
YNL083W 0 0,545 8,44E-02 
YJR115W 0 0,293 6,92E-04 
YJL065C 0 0,625 7,27E-05 
YBR162C 0 0,212 5,47E-04 
YER076C 0 0,232 7,72E-03 
YIR014W 0 0,06 8,00E-03 
YLR463C 0 0,27 4,56E-05 
YLR462W 0 0,45 4,63E-06 
YPR157W 0 0,121 1,36E-02 
YHL035C 0 0,104 6,13E-02 
YLL053C 0 0,206 1,73E-02 
YGL146C 0 0,469 8,11E-03 
YDL096C 0 0,168 2,22E-03 
YKR106W 0 0,253 6,28E-02 
YCR006C 0 0,242 3,99E-02 
YIL082W-A 0 0,313 3,40E-06 
YLL012W 0 0,265 1,80E-02 
YMR278W 0 0,567 3,78E-02 
YPL278C 0 0,152 4,99E-02 
YMR134W 0 0,376 6,11E-03 
YHR199C 0 0,495 4,01E-02 
YBR012C 0 0,309 9,99E-02 
YLR073C 0 0,535 1,78E-02 
YPL277C 0 0,235 2,30E-03 
YOL029C 0 0,488 5,30E-03 
YPL201C 0 0,284 1,32E-02 
YML003W 0 0,239 5,22E-02 
YKR040C 0 0,375 1,35E-02 
YGR125W 0 0,55 1,74E-05 
YGL139W 0 0,257 1,26E-02 
YLR312C 0 0,221 9,29E-02 
YDR459C 0 0,251 4,81E-02 
YIL172C 0 0,351 7,48E-02 
YDL156W 0 0,489 8,28E-03 
YBR113W 0 0,421 4,85E-02 
YLR414C 0 0,275 1,06E-02 
YHL026C 0 0,383 6,21E-04 
YLR241W 0 0,328 5,71E-02 
YDR352W 0 0,375 1,67E-05 
YHR219W 0 0,26 1,07E-02 
YDL010W 0 0,367 1,04E-02 
YNL176C 0 0,379 1,39E-03 
YHR218W 0 0,477 1,63E-02 
YPR150W 0 0,307 7,60E-02 
YFR020W 0 0,475 2,32E-02 
YLR063W 0 0,49 6,95E-03 
YOR364W 0 0,2 1,46E-03 
YGR012W 0 0,471 9,03E-03 
YEL077C 0 0,2 4,90E-03 
YFR055W 0 0,482 5,38E-02 
YMR086C-A 0 0,244 1,02E-03 
YMR266W 0 0,271 4,38E-02 
YHR112C 0 0,534 6,32E-02 
YGR259C 0 0,133 6,15E-03 
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YER097W 0 0,314 8,30E-03 
YHL017W 0 0,293 2,83E-04 
YLR125W 0 0,204 1,51E-02 
YLR057W 0 0,255 2,18E-02 
YBR139W 0 0,301 4,98E-02 
YJL193W 0 0,31 3,36E-02 
YEL075C 0 0,463 7,09E-02 
YIL092W 0 0,598 6,04E-02 
YBR178W 0 0,17 4,59E-03 
YLR376C 0 0,455 2,19E-03 
YDL038C 0 0,163 1,46E-02 
YOR314W-A 0 0,075 7,68E-02 
YER053C-A 0 0,481 2,11E-02 
YOR105W 0 0,41 3,05E-02 
YOR396W 0 0,269 1,02E-02 
YFL066C 0 0,423 1,95E-05 
YMR088C 0 0,546 4,44E-02 
YOR356W 0 0,455 2,36E-02 
YMR155W 0 0,646 9,24E-02 
YCR026C 0 0,443 3,15E-02 
YDR338C 0 0,277 6,86E-02 
YIL090W 0 0,312 9,71E-02 
YMR007W 0 0,322 8,79E-04 
YML133C 0 0,266 2,25E-02 
YPR204W 0 0,292 1,31E-02 
YEL068C 0 0,266 6,28E-07 
YIL006W 0 0,326 7,80E-03 
YJR129C 0 0,323 3,80E-06 
YLL032C 0 0,639 7,69E-02 
YOL092W 0 0,465 8,63E-02 
YMR085W 0 0,224 5,25E-05 
YEL067C 0 0,363 5,22E-02 
YLL067C 0 0,231 3,03E-06 
YBL113C 0 0,207 3,29E-03 
YLR224W 0 0,401 2,99E-03 
YIL152W 0 0,274 6,12E-04 
YMR221C 0 0,469 2,80E-02 
YOR389W 0 0,196 8,88E-02 
YCR099C 0 0,197 8,81E-02 
YPR202W 0 0,341 6,63E-03 
YBL108W 0 0,091 5,52E-04 
YNL095C 0 0,284 7,42E-04 
YLL066C 0 0,268 1,55E-05 
YLL030C 0 0,155 5,21E-02 
YHL008C 0 0,282 3,64E-02 
YHR033W 0 0,4 3,88E-02 
YDL033C 0 0,276 8,06E-03 
YOR205C 0 0,267 8,31E-07 
YML018C 0 0,272 1,46E-02 
YBL111C 0 0,477 1,98E-02 
YIL082W 0 0,283 1,40E-02 
YHL050C 0 0,323 4,06E-03 
YER189W 0 0,531 8,14E-02 
YMR317W 0 0,162 8,36E-03 
YMR293C 0 0,469 1,97E-02 
YHR202W 0 0,229 8,53E-02 
YKL174C 0 0,587 2,79E-02 
YLL059C 0 0,284 7,22E-02 
YNL087W 0 0,245 1,59E-04 
YLR112W 0 0,149 5,59E-03 
YDR048C 0 0,326 3,01E-02 
YDL237W 0 0,48 1,82E-02 
YJR015W 0 0,372 2,26E-02 
YGL114W 0 0,406 2,52E-03 
YPL207W 0 0,24 3,45E-04 
YNR068C 0 0,187 3,09E-05 
YJR013W 0 0,203 2,52E-02 
YNL217W 0 0,541 1,30E-02 
YBR124W 0 0,384 6,55E-06 
YKL134C 40817 0,351 2,68E-06 
YJR155W AAD10 0,224 1,96E-02 
YFL057C AAD16 0,316 2,97E-02 
YBL015W ACH1 0,543 1,88E-02 
YGL256W ADH4 0,314 5,50E-02 
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YEL052W AFG1 0,35 1,14E-02 
YER017C AFG3 0,212 1,53E-06 
YCL025C AGP1 0,194 3,68E-03 
Q0050 AI1 0,507 9,30E-02 
YBR110W ALG1 0,589 3,51E-02 
YNL048W ALG11 0,445 9,52E-02 
YBR243C ALG7 0,375 6,60E-04 
YNL219C ALG9 0,387 2,71E-02 
YFL050C ALR2 0,483 5,32E-02 
YBR158W AMN1 0,569 5,80E-02 
YGL156W AMS1 0,285 6,17E-03 
YBR286W APE3 0,403 4,47E-02 
YPL195W APL5 0,512 7,08E-03 
YPR192W AQY1 0,305 8,68E-04 
YHL040C ARN1 0,282 5,96E-02 
YHL047C ARN2 0,229 4,61E-02 
YPR034W ARP7 0,633 6,66E-02 
YLR155C ASP3-1 0,267 6,64E-03 
YLR157C ASP3-2 0,259 1,77E-02 
YLR158C ASP3-3 0,265 1,38E-02 
YLR160C ASP3-4 0,255 1,31E-02 
YCR068W ATG15 0,213 2,89E-03 
YPR026W ATH1 0,291 9,11E-02 
YKL004W AUR1 0,393 2,57E-02 
YLR465C BSC3 0,574 5,69E-02 
YOL137W BSC6 0,388 5,57E-02 
YFL025C BST1 0,286 6,00E-02 
YLR353W BUD8 0,43 2,99E-02 
YEL063C CAN1 0,255 5,42E-03 
YML042W CAT2 0,269 2,46E-02 
YHL038C CBP2 0,235 5,22E-04 
YDR270W CCC2 0,329 5,17E-02 
YGR217W CCH1 0,253 8,39E-02 
YBR131W CCZ1 0,447 9,89E-03 
YLR307W CDA1 0,231 4,51E-02 
YDR182W CDC1 0,421 2,28E-02 
YGL116W CDC20 0,378 6,20E-02 
YDR364C CDC40 0,28 5,29E-02 
YBR202W CDC47 0,436 8,87E-02 
YDL164C CDC9 0,437 3,01E-02 
YLR245C CDD1 0,482 3,79E-02 
YBR029C CDS1 0,298 7,44E-04 
YER061C CEM1 0,37 7,79E-02 
YBR038W CHS2 0,525 8,48E-02 
YCR005C CIT2 0,186 7,69E-05 
YKL219W COS9 0,41 8,63E-03 
YOR316C COT1 0,49 6,53E-02 
Q0045 COX1 0,198 9,74E-02 
YER141W COX15 0,371 2,52E-02 
YLL018C-A COX19 0,572 2,68E-05 
Q0275 COX3 0,128 5,48E-02 
YJL172W CPS1 0,209 2,10E-02 
YNL130C CPT1 0,509 1,33E-02 
YOR031W CRS5 0,229 2,61E-02 
YBR161W CSH1 0,298 3,30E-02 
YPR124W CTR1 0,334 9,56E-04 
YDL209C CWC2 0,528 1,81E-02 
YGL027C CWH41 0,359 1,55E-02 
YCR017C CWH43 0,2 4,82E-02 
YML054C CYB2 0,299 2,88E-02 
YJR152W DAL5 0,188 2,15E-03 
YLR037C DAN2 0,327 9,11E-02 
YKL046C DCW1 0,236 3,04E-04 
YBR163W DEM1 0,642 5,67E-05 
YDL024C DIA3 0,233 2,84E-02 
YPL265W DIP5 0,167 1,39E-02 
YER166W DNF1 0,41 2,67E-03 
YDR093W DNF2 0,349 2,55E-02 
YAL026C DRS2 0,256 1,21E-03 
YHR132C ECM14 0,35 3,95E-03 
YLR436C ECM30 0,47 2,32E-02 
YBR078W ECM33 0,331 7,08E-04 
YLR443W ECM7 0,358 1,65E-02 
YKR004C ECM9 0,387 8,57E-03 
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YLR083C EMP70 0,317 4,07E-05 
YDR040C ENA1 0,264 3,85E-02 
YLL038C ENT4 0,521 1,06E-02 
YIL005W EPS1 0,356 1,82E-03 
YHR007C ERG11 0,3 8,72E-04 
YGR060W ERG25 0,358 1,01E-02 
YML067C ERV41 0,496 4,60E-02 
YMR219W ESC1 0,599 3,88E-02 
YDR261C EXG2 0,504 5,81E-02 
YBR041W FAT1 0,352 5,13E-03 
YLR377C FBP1 0,219 6,26E-03 
YMR058W FET3 0,287 8,26E-02 
YMR319C FET4 0,33 4,10E-02 
YFL041W FET5 0,264 1,24E-02 
YBR040W FIG1 0,186 3,19E-02 
YLR342W FKS1 0,278 1,92E-03 
YHR211W FLO5 0,309 7,44E-02 
YER109C FLO8 0,586 4,87E-02 
YHR176W FMO 0,495 9,43E-06 
YLR214W FRE1 0,179 1,64E-02 
YKL220C FRE2 0,245 9,52E-02 
YOR381W FRE3 0,214 2,59E-02 
YJL221C FSP2 0,373 9,67E-02 
YBL042C FUI1 0,165 5,44E-04 
YBR021W FUR4 0,331 2,46E-02 
YBR179C FZO1 0,55 9,52E-02 
YLR088W GAA1 0,391 5,25E-03 
YML051W GAL80 0,311 4,71E-05 
YMR307W GAS1 0,303 3,99E-02 
YMR215W GAS3 0,516 6,40E-02 
YOL030W GAS5 0,439 1,11E-02 
YAL062W GDH3 0,438 1,83E-02 
YJR040W GEF1 0,422 4,45E-02 
YCL039W GID7 0,385 7,94E-02 
YKR030W GMH1 0,48 3,92E-02 
YDR508C GNP1 0,309 1,31E-03 
YER020W GPA2 0,328 3,66E-03 
YOR371C GPB1 0,222 9,65E-03 
YAL056W GPB2 0,188 3,54E-02 
YLL031C GPI13 0,283 2,38E-02 
YHR188C GPI16 0,272 3,04E-06 
YKR067W GPT2 0,457 1,44E-02 
YGR032W GSC2 0,261 6,28E-04 
YGL084C GUP1 0,219 6,62E-03 
YHL032C GUT1 0,348 7,41E-02 
YIL155C GUT2 0,136 5,29E-03 
YJL091C GWT1 0,246 2,85E-02 
YFL031W HAC1 0,509 6,22E-03 
YNL014W HEF3 0,351 1,84E-02 
YER014W HEM14 0,487 8,52E-02 
YMR207C HFA1 0,332 1,56E-02 
YDR528W HLR1 0,618 5,13E-02 
YML075C HMG1 0,562 8,39E-02 
YLR205C HMX1 0,458 2,53E-02 
YMR032W HOF1 0,489 1,01E-02 
YCR021C HSP30 0,211 6,84E-02 
YJL077C ICS3 0,372 2,65E-02 
YER086W ILV1 0,425 2,42E-02 
YMR081C ISF1 0,28 5,20E-05 
YBR086C IST2 0,607 3,26E-05 
YOL103W ITR2 0,568 8,62E-02 
YJL034W KAR2 0,341 1,13E-03 
YGL203C KEX1 0,453 4,83E-03 
YNL238W KEX2 0,508 5,73E-03 
YJL094C KHA1 0,307 8,82E-05 
YOR336W KRE5 0,347 1,70E-02 
YPR159W KRE6 0,331 6,05E-03 
YKL110C KTI12 0,442 4,62E-02 
YNL029C KTR5 0,584 8,83E-02 
YPL053C KTR6 0,307 3,36E-05 
YHL003C LAG1 0,234 1,28E-02 
YJL062W LAS21 0,17 2,90E-03 
YDR062W LCB2 0,356 4,58E-03 
YOR108W LEU9 0,297 4,70E-02 
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YNR008W LRO1 0,303 1,69E-04 
YNL268W LYP1 0,226 5,53E-03 
YGR289C MAL11 0,165 3,51E-02 
YER106W MAM1 0,221 1,85E-03 
YOL060C MAM3 0,394 5,26E-02 
YKL165C MCD4 0,253 1,84E-03 
YDL054C MCH1 0,363 9,10E-02 
YLR188W MDL1 0,338 3,44E-03 
YML104C MDM1 0,393 1,11E-05 
YOR147W MDM32 0,43 5,02E-05 
YJL112W MDV1 0,582 2,84E-02 
YLR069C MEF1 0,258 1,25E-03 
YNL142W MEP2 0,129 1,40E-02 
YPR138C MEP3 0,324 3,02E-03 
YNL277W MET2 0,422 4,08E-02 
YIL046W MET30 0,447 6,04E-02 
YOR211C MGM1 0,379 3,12E-02 
YNL291C MID1 0,469 6,60E-03 
YBR084W MIS1 0,331 7,34E-02 
YDR144C MKC7 0,365 1,63E-02 
YPL140C MKK2 0,597 5,57E-05 
YPL164C MLH3 0,34 2,96E-02 
YHR204W MNL1 0,426 4,43E-02 
YER001W MNN1 0,322 3,79E-03 
YBR015C MNN2 0,49 7,46E-02 
YKL201C MNN4 0,344 6,43E-02 
YPL050C MNN9 0,26 7,36E-03 
YGL257C MNT2 0,406 7,91E-02 
YIL014W MNT3 0,488 7,53E-03 
YIR021W MRS1 0,623 6,26E-02 
YOR370C MRS6 0,577 3,93E-02 
YGR014W MSB2 0,533 3,19E-02 
YLR219W MSC3 0,512 3,40E-02 
YHR120W MSH1 0,351 8,78E-05 
YKL194C MST1 0,31 7,57E-03 
YGR055W MUP1 0,338 7,35E-02 
YHL036W MUP3 0,18 7,81E-04 
YOR326W MYO2 0,542 8,28E-02 
YMR080C NAM7 0,644 8,92E-02 
YPR155C NCA2 0,48 4,16E-03 
YJL116C NCA3 0,138 1,09E-02 
YPR149W NCE102 0,445 5,73E-02 
YHR042W NCP1 0,46 3,15E-03 
YMR145C NDE1 0,298 1,74E-06 
YOL104C NDJ1 0,114 5,83E-02 
Q0130 OLI1 0,515 2,48E-02 
YOR085W OST3 0,433 1,46E-03 
YER154W OXA1 0,336 4,15E-04 
YEL049W PAU2 0,409 7,02E-02 
YBR233W PBP2 0,422 3,10E-02 
YPR002W PDH1 0,349 7,67E-02 
YOR328W PDR10 0,447 7,17E-02 
YOR153W PDR5 0,332 3,59E-05 
YBL017C PEP1 0,355 2,46E-02 
YPL154C PEP4 0,412 5,73E-02 
YCL004W PGS1 0,24 1,67E-03 
YKL043W PHD1 0,213 7,39E-07 
YAR071W PHO11 0,27 8,77E-03 
YHR215W PHO12 0,357 4,81E-02 
YBR092C PHO3 0,272 2,00E-02 
YBR093C PHO5 0,118 3,89E-03 
YDR481C PHO8 0,39 2,29E-05 
YML123C PHO84 0,138 1,26E-03 
YJL198W PHO90 0,477 3,05E-02 
YNR013C PHO91 0,371 4,15E-02 
YML061C PIF1 0,456 8,32E-02 
YOL011W PLB3 0,169 2,40E-04 
YGL008C PMA1 0,389 3,26E-02 
YCR024C-A PMP1 0,43 3,38E-02 
YGL167C PMR1 0,462 5,14E-05 
YDL095W PMT1 0,257 2,24E-07 
YAL023C PMT2 0,331 1,40E-02 
YOR321W PMT3 0,272 5,62E-02 
YJR143C PMT4 0,368 2,97E-02 
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YDL093W PMT5 0,465 5,34E-02 
YGR199W PMT6 0,234 3,60E-03 
YBR088C POL30 0,562 3,30E-02 
YMR129W POM152 0,334 1,51E-03 
YNL282W POP3 0,463 1,41E-02 
YIL037C PRM2 0,255 2,19E-02 
YPL156C PRM4 0,275 5,84E-05 
YDL039C PRM7 0,271 5,51E-02 
YBR237W PRP5 0,518 7,84E-02 
YKR013W PRY2 0,47 6,88E-03 
YGR170W PSD2 0,435 1,16E-02 
YMR137C PSO2 0,601 7,57E-02 
YKL039W PTM1 0,242 2,97E-05 
YGL063W PUS2 0,165 3,56E-02 
YLR142W PUT1 0,122 2,47E-03 
YGR258C RAD2 0,449 1,48E-02 
YDL059C RAD59 0,455 4,14E-02 
YOR380W RDR1 0,403 3,87E-03 
YBL020W RFT1 0,264 6,42E-03 
YMR182C RGM1 0,325 1,29E-02 
YOR107W RGS2 0,34 3,79E-05 
YBL082C RHK1 0,361 2,07E-03 
YLL046C RNP1 0,28 2,16E-02 
YBR229C ROT2 0,366 4,35E-03 
YIL075C RPN2 0,417 2,78E-02 
YIR015W RPR2 0,436 1,58E-03 
YMR030W RSF1 0,279 8,50E-03 
YJR004C SAG1 0,182 2,28E-03 
YER147C SCC4 0,44 9,72E-02 
YMR214W SCJ1 0,522 3,93E-02 
YGL126W SCS3 0,591 4,01E-02 
YLR378C SEC61 0,348 1,39E-03 
YOR254C SEC63 0,52 3,38E-02 
YLR430W SEN1 0,592 3,07E-02 
YJR095W SFC1 0,162 3,70E-03 
YIL099W SGA1 0,069 7,32E-03 
YPR198W SGE1 0,378 4,03E-03 
YCL010C SGF29 0,424 5,03E-03 
YGR112W SHY1 0,368 3,88E-02 
YEL065W SIT1 0,187 3,46E-02 
YBL061C SKT5 0,452 3,18E-02 
YOR307C SLY41 0,462 5,14E-02 
YOR149C SMP3 0,395 1,30E-02 
YFL060C SNO3 0,39 2,38E-02 
YDR011W SNQ2 0,334 1,07E-02 
YEL031W SPF1 0,512 1,80E-02 
YCR018C SRD1 0,478 8,11E-02 
YPL092W SSU1 0,435 5,08E-02 
YHR084W STE12 0,407 8,98E-02 
YOR219C STE13 0,395 1,23E-02 
YDR103W STE5 0,592 7,54E-02 
YKL209C STE6 0,379 6,59E-04 
YGL022W STT3 0,354 2,05E-03 
YGL169W SUA5 0,587 2,83E-02 
YLR092W SUL2 0,284 5,31E-02 
YPL057C SUR1 0,442 7,15E-03 
YLR372W SUR4 0,359 1,64E-03 
YIL047C SYG1 0,214 5,79E-03 
YBR069C TAT1 0,438 1,24E-02 
YOL020W TAT2 0,508 1,95E-02 
YKL028W TFA1 0,58 5,63E-05 
YKL140W TGL1 0,383 7,14E-02 
YPL258C THI21 0,226 8,03E-03 
YPR121W THI22 0,224 8,24E-05 
YDL080C THI3 0,612 4,80E-02 
YDR105C TMS1 0,344 9,55E-03 
YJL093C TOK1 0,37 3,46E-03 
YLR234W TOP3 0,367 4,93E-02 
YGL096W TOS8 0,428 9,06E-02 
YGR138C TPO2 0,28 8,14E-03 
YJL129C TRK1 0,31 3,24E-02 
YDR120C TRM1 0,498 8,71E-03 
YKL034W TUL1 0,415 9,24E-02 
YKR042W UTH1 0,227 2,96E-04 
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YEL040W UTR2 0,414 4,50E-02 
YGL225W VRG4 0,452 9,18E-02 
YNL197C WHI3 0,646 8,84E-05 
YNL283C WSC2 0,483 1,87E-02 
YAR035W YAT1 0,294 3,72E-07 
YCR059C YIH1 0,528 2,40E-02 
YMR106C YKU80 0,388 1,03E-03 
YPR024W YME1 0,237 2,44E-02 
YDR545W YRF1-1 0,27 1,04E-02 
YER190W YRF1-2 0,278 4,35E-02 
YGR296W YRF1-3 0,276 2,51E-02 
YLR466W YRF1-4 0,273 1,61E-02 
YLR467W YRF1-5 0,281 2,64E-02 
YNL339C YRF1-6 0,295 1,25E-02 
YPL283C YRF1-7 0,277 2,20E-02 
YMR089C YTA12 0,412 1,34E-02 
YMR243C ZRC1 0,552 7,59E-02 
YGL255W ZRT1 0,247 1,59E-02 
YLR130C ZRT2 0,25 2,55E-03 
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Table 3 - Microarrays analysis results of polysomal fractions of untreated and 30 min 
acetic acid treated cells. 211 genes were found up-regulated (more than two fold) 
upon acetic acid treatment. 
 
Probe ID Gene 
symbol 
Fold 
change 
p-value 
YJL012C-A 0 2.791 2.87E-03 
YGR001C 0 3.0 7.04E-03 
YNL149C 0 3.317 8.31E-03 
YOR285W 0 8.996 8.04E-03 
YDR248C 0 2.358 4.05E-02 
YBL107W-A 0 2.287 2.66E-02 
YNL045W 0 2.624 9.66E-02 
YPR063C 0 2.235 3.03E-03 
YCL047C 0 1.783 2.12E-02 
YER138W-A 0 2.0 5.07E-5 
YLR022C 0 4.056 2.79E-5 
YOL087C 0 2.148 1.0E-5 
YHR020W 0 2.822 1.89E-02 
YMR315W 0 4.626 9.06E-02 
YMR126C 0 1.767 5.08E-02 
YKL084W 0 2.843 3.63E-5 
YPL221W 0 1.71 3.08E-03 
YHR138C 0 3.648 4.29E-02 
YJL062W-A 0 4.499 1.76E-04 
YNL058C 0 1.584 4.32E-02 
YNL081C 0 3.08 8.62E-7 
YGL232W 0 4.364 9.85E-02 
YKR007W 0 2.784 1.37E-02 
YLR345W 0 2.171 3.24E-02 
YMR122W-A 0 3.154 7.20E-04 
YMR226C 0 4.189 1.93E-02 
YML072C 0 3.117 3.49E-02 
YNL157W 0 2.086 2.75E-02 
YIR035C 0 2.959 5.52E-02 
YDL110C 0 2.846 5.75E-02 
YDR034W-B 0 4.306 3.68E-02 
YER053C 0 2.075 3.81E-02 
YNR034W-A 0 4.499 8.53E-04 
YIL108W 0 3.044 2.18E-02 
YPR172W 0 3.702 6.92E-02 
YKL161C 0 1.873 4.91E-03 
YER067W 0 6.093 2.01E-02 
YLR187W 0 1.832 5.65E-02 
YKL160W 0 2.278 5.91E-02 
YIL130W 0 2.043 6.35E-03 
YNL201C 0 2.541 6.38E-7 
YLR356W 0 1.467 8.79E-02 
YOR227W 0 1.778 1.10E-02 
YDR063W 0 2.787 1.95E-03 
YCL033C 0 6.6 5.49E-02 
YKL069W 0 1.947 5.53E-02 
YKL192C ACP1 2.834 2.38E-03 
YDR226W ADK1 3.193 1.02E-02 
YBR059C AKL1 2.697 2.52E-02 
YOR374W ALD4 2.731 3.01E-02 
YJR047C ANB1 3.461 2.26E-02 
YIL062C ARC15 4.145 7.00E-02 
YKL185W ASH1 4.779 4.18E-02 
YGR097W ASK10 1.937 2.22E-5 
YKL016C ATP7 3.07 6.02E-02 
YER155C BEM2 1.593 7.74E-02 
YPR176C BET2 1.537 4.39E-02 
YJL060W BNA3 2.334 8.40E-02 
YOR276W CAF20 6.567 3.49E-02 
YNL288W CAF40 2.018 1.18E-02 
YER048C CAJ1 2.014 8.08E-02 
YDL126C CDC48 2.805 2.76E-02 
YER164W CHD1 2.106 1.51E-6 
YLL009C COX17 4.073 4.60E-02 
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YML078W CPR3 4.431 1.22E-02 
YOR042W CUE5 2.639 1.58E-03 
YAL012W CYS3 3.064 5.02E-03 
YGR155W CYS4 2.475 9.78E-03 
YKL054C DEF1 2.362 8.46E-02 
YBR201W DER1 1.837 5.48E-03 
YLL001W DNM1 1.676 5.88E-02 
YNR067C DSE4 2.2 3.02E-02 
YKR076W ECM4 3.079 6.20E-03 
YNL327W EGT2 1.984 6.72E-02 
YGR175C ERG1 2.019 8.72E-02 
YML126C ERG13 3.529 1.16E-02 
YLR100W ERG27 2.589 3.27E-02 
YOR280C FSH3 1.758 1.64E-02 
YLR094C GIS3 2.715 5.98E-02 
YMR311C GLC8 2.052 1.56E-02 
YOR168W GLN4 3.645 9.80E-03 
YPR160W GPH1 4.009 7.57E-02 
YLR293C GSP1 2.103 2.40E-02 
YDL223C HBT1 3.506 9.13E-03 
YOR176W HEM15 4.481 1.83E-02 
YML075C HMG1 1.406 9.45E-02 
YDL125C HNT1 5.18 1.43E-02 
YJR139C HOM6 2.872 6.67E-02 
YMR186W HSC82 2.815 3.68E-03 
YFL014W HSP12 2.417 1.13E-02 
YLR259C HSP60 2.624 2.30E-02 
YPL240C HSP82 3.203 2.08E-02 
YJR016C ILV3 2.426 7.55E-02 
YCL009C ILV6 2.376 8.14E-03 
YGL173C KEM1 1.715 4.73E-02 
YNL132W KRE33 1.688 2.69E-02 
YIL070C MAM33 2.56 6.88E-02 
YBL091C MAP2 3.129 9.12E-02 
YGL209W MIG2 2.872 9.12E-02 
YPL082C MOT1 3.345 9.15E-5 
YPR166C MRP2 2.01 7.13E-7 
YKR085C MRPL20 3.509 2.99E-5 
YOR150W MRPL23 2.162 4.36E-03 
YBR282W MRPL27 2.756 2.4E-5 
YJL096W MRPL49 4.329 3.95E-02 
YGR220C MRPL9 2.177 7.83E-04 
YMR158W MRPS8 2.657 3.64E-02 
YOR354C MSC6 1.475 1.61E-02 
YMR109W MYO5 2.693 7.07E-04 
YNL137C NAM9 1.991 9.98E-02 
YGR232W NAS6 4.102 4.04E-02 
YDR176W NGG1 1.234 3.23E-02 
YPR052C NHP6A 3.173 1.59E-03 
YOL041C NOP12 2.043 9.83E-04 
YNL175C NOP13 3.319 3.36E-02 
YMR091C NPL6 1.572 5.41E-5 
YJR042W NUP85 1.337 1.11E-02 
YIR006C PAN1 3.828 3.37E-02 
YNL015W PBI2 2.98 7.54E-03 
YLR134W PDC5 1.926 4.19E-02 
YER153C PET122 2.863 4.85E-02 
YKL164C PIR1 1.782 2.50E-02 
YNL055C POR1 3.055 4.94E-5 
YDL188C PPH22 4.072 1.64E-5 
YBL068W PRS4 2.918 4.27E-5 
YDR055W PST1 3.4 1.27E-02 
YOR265W RBL2 2.152 6.48E-02 
YCL028W RNQ1 4.701 2.93E-03 
YDR156W RPA14 3.761 1.66E-03 
YOL005C RPB11 3.363 1.35E-02 
YDR418W RPL12B 2.468 1.91E-02 
YNL069C RPL16B 3.118 2.98E-03 
YBR191W RPL21A 2.057 5.67E-02 
YBL087C RPL23A 1.71 8.54E-03 
YDR471W RPL27B 3.573 5.24E-03 
YFL036W RPO41 2.213 6.43E-03 
YDR064W RPS13 2.752 1.46E-02 
YJL191W RPS14B 1.911 9.91E-02 
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YOL040C RPS15 2.061 4.92E-02 
YOL121C RPS19A 2.897 1.93E-02 
YER074W RPS24A 2.416 1.36E-04 
YIL069C RPS24B 2.626 7.16E-04 
YGR027C RPS25A 2.247 9.46E-02 
YGL189C RPS26A 3.573 1.64E-03 
YER131W RPS26B 2.977 8.33E-02 
YKL156W RPS27A 2.232 4.07E-02 
YDL061C RPS29B 3.668 1.75E-02 
YJR145C RPS4A 2.117 1.39E-02 
YHR203C RPS4B 1.816 6.49E-02 
YPL090C RPS6A 2.771 1.04E-02 
YBR181C RPS6B 3.536 4.04E-02 
YOR096W RPS7A 1.931 5.38E-02 
YDL111C RRP42 1.896 2.85E-02 
YMR229C RRP5 3.533 4.89E-02 
YDR129C SAC6 2.555 8.61E-02 
YFR040W SAP155 2.207 8.94E-03 
YMR263W SAP30 2.459 1.30E-02 
YER120W SCS2 3.368 5.55E-03 
YPL085W SEC16 2.112 4.90E-02 
YBR080C SEC18 1.733 1.95E-02 
YDR170C SEC7 2.246 7.33E-6 
YGR009C SEC9 2.785 1.52E-02 
YJL145W SFH5 2.16 2.78E-5 
YJR134C SGM1 2.146 4.02E-03 
YDR393W SHE9 2.313 6.03E-02 
YBR258C SHG1 3.065 3.34E-03 
YNL007C SIS1 2.201 1.92E-02 
YNL167C SKO1 2.63 2.48E-02 
YBL007C SLA1 3.129 8.71E-02 
YFL017W-A SMX2 4.894 2.02E-02 
YPR182W SMX3 4.858 6.51E-03 
YKL079W SMY1 3.74 4.16E-02 
YDR525W-A SNA2 4.328 2.26E-02 
YAL030W SNC1 6.557 4.60E-02 
YJR104C SOD1 6.135 6.05E-02 
YGL093W SPC105 2.143 3.27E-02 
YHR139C SPS100 2.298 9.52E-5 
YGR116W SPT6 1.621 6.94E-02 
YBR169C SSE2 3.267 2.72E-02 
YOR027W STI1 3.884 3.30E-02 
YLR150W STM1 2.465 2.96E-02 
YMR054W STV1 2.15 7.40E-02 
YDR172W SUP35 3.079 1.30E-03 
YPL016W SWI1 4.407 7.28E-03 
YJL052W TDH1 3.061 8.20E-02 
YGR186W TFG1 2.193 8.67E-03 
YGR181W TIM13 2.338 1.35E-5 
YER011W TIR1 1.864 5.96E-02 
YNL070W TOM7 2.737 3.21E-5 
YJL164C TPK1 1.752 5.33E-03 
YGL026C TRP5 2.028 9.31E-02 
YCR083W TRX3 4.106 1.34E-03 
YDR513W TTR1 3.38 4.20E-02 
YBR082C UBC4 2.562 5.90E-02 
YPL072W UBP16 2.408 9.99E-02 
YGR184C UBR1 2.545 6.94E-02 
YDL058W USO1 2.36 3.16E-02 
YHR039C-A VMA10 6.915 2.19E-04 
YGR020C VMA7 1.859 7.09E-5 
YEL051W VMA8 2.568 9.03E-02 
YLL040C VPS13 4.182 1.05E-02 
YOR132W VPS17 3.846 7.90E-03 
YKR020W VPS51 1.982 8.56E-02 
YER072W VTC1 4.169 4.96E-03 
YPL252C YAH1 2.43 1.58E-02 
YLR200W YKE2 2.024 3.74E-02 
YKL196C YKT6 2.274 9.95E-5 
YFR049W YMR31 2.438 6.62E-02 
YDL235C YPD1 2.37 6.14E-5 
YML001W YPT7 3.513 1.57E-03 
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Table 4 - Microarrays analysis results of polysomal fractions of untreated and 30 min 
acetic acid treated cells. 368 genes were found down-regulated upon acetic acid 
treatment. 
Probe ID Gene 
symbol 
Fold 
change 
p-value 
YGL177W 0 0.394 4,95E-01 
YLL012W 0 0.597 4.84E-4 
YCR064C 0 0.14 4,77E-01 
YLR057W 0 0.693 4,76E-01 
YFL068W 0 0.609 4,64E-01 
YDR090C 0 0.423 4,56E-01 
YGL146C 0 0.527 4,51E-01 
YEL077C 0 0.368 4,51E-01 
YLR161W 0 0.7 4,49E-01 
YCR022C 0 0.35 4.36E-4 
YPL264C 0 0.455 4,20E-01 
YNL080C 0 0.612 4,15E-01 
YNL337W 0 0.482 4,11E-01 
YIL176C 0 0.666 4,09E-01 
YDR492W 0 0.55 3,97E-01 
YHR202W 0 0.592 3,90E-01 
YGL114W 0 0.57 3,87E-01 
YDR015C 0 0.418 3,74E-01 
YHR199C 0 0.527 3,67E-01 
YDR338C 0 0.506 3,63E-01 
YOR084W 0 0.564 3.55E-4 
YPL062W 0 0.275 3,38E-01 
YOL155C 0 0.533 3.35E-4 
YOR389W 0 0.443 3,33E-01 
YDL023C 0 0.592 3,32E-01 
YDR491C 0 0.265 3.29E-4 
YKL223W 0 0.156 3,26E-01 
YJL225C 0 0.391 3,25E-01 
YOL124C 0 0.497 3,23E-01 
YJR015W 0 0.547 3,21E-01 
YPR123C 0 0.294 3,06E-01 
YLL067C 0 0.372 3,06E-01 
YDR455C 0 0.171 3.05E-4 
YEL028W 0 0.403 3,02E-01 
YIL177C 0 0.387 3,01E-01 
YKL162C-A 0 0.5 3,01E-01 
YHR033W 0 0.666 2,85E-01 
YOR333C 0 0.176 2,79E-01 
YLR125W 0 0.435 2.73E-4 
YFL032W 0 0.239 2,67E-01 
YLR124W 0 0.121 2.62E-4 
YLR123C 0 0.299 2,61E-01 
YOR378W 0 0.236 2.57E-4 
YFL055W 0 0.384 2,54E-01 
YBL096C 0 0.378 2,52E-01 
YHL046C 0 0.688 2,51E-01 
YOR298W 0 0.366 2,34E-01 
YAR023C 0 0.449 2,21E-01 
YDL187C 0 0.445 2,21E-01 
YCR072C 0 0.592 2.18E-4 
YAR053W 0 0.185 2,11E-01 
YPR174C 0 0.52 2,10E-01 
YBL044W 0 0.267 2,03E-01 
YFR026C 0 0.393 1.98E-4 
YEL067C 0 0.444 1,97E-01 
YJL028W 0 0.244 1,90E-01 
YBR209W 0 0.134 1,86E-01 
YOR396W 0 0.357 1,85E-01 
YDL033C 0 0.353 1,84E-01 
YLL059C 0 0.519 1,79E-01 
YLL064C 0 0.696 1,78E-01 
YGR164W 0 0.127 1,71E-01 
YLL066C 0 0.358 1,66E-01 
YMR323W 0 0.38 1,65E-01 
YLR162W 0 0.11 1,63E-01 
YLR042C 0 0.558 1,61E-01 
204 
 
YIL054W 0 0.414 1,59E-01 
YCL073C 0 0.407 1,57E-01 
YGR266W 0 0.576 1,55E-01 
YMR057C 0 0.303 1,47E-01 
Q0010 0 0.096 1,46E-01 
YKR043C 0 0.5 1,42E-01 
YIL012W 0 0.205 1,42E-01 
YKR011C 0 0.651 1,41E-01 
YHR219W 0 0.348 1,38E-01 
YPR204W 0 0.395 1,38E-01 
YBR162C 0 0.344 1,38E-01 
YKR005C 0 0.516 1,32E-01 
YNR062C 0 0.409 1,32E-01 
YPR170C 0 0.361 1,31E-01 
YGL072C 0 0.495 1,28E-01 
YNL227C 0 0.57 1,28E-01 
YEL008W 0 0.152 1,21E-01 
YML003W 0 0.441 1,19E-01 
YML133C 0 0.37 1,17E-01 
YIL152W 0 0.364 1,12E-01 
YML018C 0 0.533 1,12E-01 
YEL075W-A 0 0.428 1.09E-4 
YDL032W 0 0.185 1,08E-01 
YGR190C 0 0.3 1,06E-01 
YFR055W 0 0.625 1,05E-01 
YMR253C 0 0.49 1,05E-01 
YBR124W 0 0.219 1,05E-01 
YOR072W 0 0.335 1,01E-01 
YPL017C 0 0.376 9,97E-02 
YPR136C 0 0.214 9.85E-5 
YNL087W 0 0.505 9.78E-5 
YGL138C 0 0.268 9,67E-02 
YIL174W 0 0.105 9,52E-02 
YGR122C-A 0 0.495 9,31E-02 
YDL034W 0 0.241 9,08E-02 
YHR212C 0 0.565 9,00E-02 
YPR157W 0 0.24 8,94E-02 
YOL101C 0 0.362 8,71E-02 
YFR056C 0 0.334 8,61E-02 
YNL158W 0 0.463 8,39E-02 
YLR317W 0 0.418 7,92E-02 
YGR012W 0 0.655 7,81E-02 
YJL213W 0 0.145 7.78E-5 
YNL105W 0 0.183 7,67E-02 
YDR526C 0 0.377 7,13E-02 
YDL222C 0 0.648 7,01E-02 
YNL176C 0 0.577 6,91E-02 
YGL007W 0 0.226 6,77E-02 
YOL159C-A 0 0.522 6,32E-02 
YLR041W 0 0.603 6,11E-02 
YMR290W-A 0 0.202 6,01E-02 
YFL012W-A 0 0.064 5,84E-02 
YEL068C 0 0.433 5,82E-02 
YIL082W 0 0.391 5,78E-02 
YLR122C 0 0.389 5,55E-02 
YKL102C 0 0.404 5,15E-02 
YPL162C 0 0.293 5,02E-02 
YJR129C 0 0.458 4,57E-02 
YJR013W 0 0.436 4,40E-02 
YMR007W 0 0.301 4,21E-02 
YJR071W 0 0.437 3,77E-02 
YML034C-A 0 0.172 3,70E-02 
YBR174C 0 0.24 3,69E-02 
YIR040C 0 0.156 3,27E-02 
YNR020C 0 0.594 3,06E-02 
YBL083C 0 0.518 3,05E-02 
YIR014W 0 0.307 3,02E-02 
YBL109W 0 0.352 3,02E-02 
YOL134C 0 0.09 2,61E-02 
YBR012C 0 0.375 2,59E-02 
YNR064C 0 0.418 2,50E-02 
YOR343C 0 0.424 2,44E-02 
YJL120W 0 0.138 2,26E-02 
YMR252C 0 0.496 2,24E-02 
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YKR040C 0 0.369 2,21E-02 
YEL074W 0 0.482 2,14E-02 
YPL279C 0 0.469 2,09E-02 
YIL032C 0 0.134 2,03E-02 
YBR113W 0 0.365 1,80E-02 
YER091C-A 0 0.166 1,41E-02 
YIL175W 0 0.107 1,35E-02 
YFL051C 0 0.239 1,31E-02 
YLR463C 0 0.413 1,30E-02 
YGR291C 0 0.071 1,25E-02 
YKR106W 0 0.466 1,25E-02 
YHR095W 0 0.095 1,24E-02 
YPL277C 0 0.498 1,23E-02 
YHL026C 0 0.43 1,20E-02 
YOR364W 0 0.43 1,14E-02 
YGR035C 0 0.471 1.14E-5 
YNL095C 0 0.541 1.13E-5 
YDR114C 0 0.158 1,03E-02 
YKL030W 0 0.348 1,03E-02 
YFR012W 0 0.126 9,15E-03 
YPL114W 0 0.235 8,05E-03 
YLL030C 0 0.095 7.82E-6 
YML089C 0 0.258 7,37E-03 
YGR287C 0 0.491 6,84E-03 
YIL082W-A 0 0.527 6,50E-03 
YBL108W 0 0.024 6,12E-03 
YDL038C 0 0.209 5,90E-03 
YBR232C 0 0.152 5.76E-6 
YBR250W 0 0.303 5,53E-03 
YOR314W-A 0 0.046 3,03E-03 
YMR086C-A 0 0.399 2,97E-03 
YGR259C 0 0.136 2.44E-6 
YDR112W 0 0.201 1,79E-03 
YJL119C 0 0.349 1,50E-03 
YMR194C-A 0 0.18 1,34E-03 
YDR053W 0 0.182 1,32E-03 
YLR112W 0 0.231 1,28E-03 
YPL182C 0 0.135 9.66E-7 
YEL059W 0 0.368 5,71E-04 
YMR122C 0 0.217 4,01E-04 
YMR317W 0 0.22 2,17E-04 
YBR178W 0 0.15 1,76E-04 
YPL201C 0 0.232 9.46E-8 
YDL096C 0 0.194 5,72E-05 
YBL015W ACH1 0.541 5.36E-5 
YCR010C ADY2 0.241 4.03E-4 
YLR227C ADY4 0.639 3,29E-01 
YBR243C ALG7 0.518 2,72E-02 
YFL050C ALR2 0.598 1,79E-01 
YPR192W AQY1 0.295 2,37E-02 
YLL052C AQY2 0.452 1,48E-01 
YOL058W ARG1 0.302 1.09E-4 
YOL140W ARG8 0.632 9,42E-02 
YNL020C ARK1 0.522 1,64E-01 
YPR034W ARP7 0.576 2,28E-02 
YPR200C ARR2 0.424 4,11E-01 
YCR068W ATG15 0.386 4,82E-01 
YLL063C AYT1 0.483 4,30E-01 
YGR224W AZR1 0.154 2,31E-02 
YBL085W BOI1 0.668 1,86E-01 
YNR069C BSC5 0.3 1,37E-01 
YOL137W BSC6 0.656 1,38E-01 
YDR241W BUD26 0.165 4,78E-01 
YCR063W BUD31 0.392 1.59E-4 
YKR036C CAF4 0.671 2,92E-01 
YEL063C CAN1 0.491 3,01E-01 
YGR036C CAX4 0.569 1,52E-01 
YLR175W CBF5 0.609 8,18E-02 
YLR307W CDA1 0.386 1,22E-01 
YDL220C CDC13 0.583 2,29E-01 
YDL102W CDC2 0.717 3,50E-01 
YGL116W CDC20 0.558 1,14E-01 
YLR245C CDD1 0.482 3,59E-01 
YCR005C CIT2 0.209 3,17E-04 
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YPR001W CIT3 0.461 4,55E-01 
YGL263W COS12 0.363 4,12E-01 
YLL018C-A COX19 0.662 3,25E-01 
YCR017C CWH43 0.578 6,91E-02 
YJR152W DAL5 0.303 7,02E-03 
YKL046C DCW1 0.563 4,53E-02 
YDL024C DIA3 0.472 6.6E-6 
YGR227W DIE2 0.631 4,44E-01 
YPL265W DIP5 0.168 1,93E-03 
YER088C DOT6 0.598 1,17E-01 
YDL101C DUN1 0.598 3,35E-01 
YHL016C DUR3 0.297 6,08E-02 
YHR068W DYS1 0.537 2,20E-01 
YDR446W ECM11 0.268 2,04E-01 
YHR021W-A ECM12 0.239 2,53E-01 
YBL043W ECM13 0.294 3,53E-01 
YMR128W ECM16 0.539 1.26E-4 
YPL021W ECM23 0.142 1,09E-01 
YBR078W ECM33 0.505 5,45E-02 
YHL043W ECM34 0.248 1,29E-01 
YKR004C ECM9 0.473 1,97E-01 
YDR261C EXG2 0.739 4,23E-01 
YMR246W FAA4 0.486 3.12E-4 
YLR377C FBP1 0.273 4,43E-02 
YCR028C FEN2 0.504 4,39E-01 
YMR058W FET3 0.442 3,21E-02 
YBR040W FIG1 0.241 1.72E-7 
YOR383C FIT3 0.541 3,79E-01 
YBL013W FMT1 0.267 1,01E-02 
YAL036C FUN11 0.646 8,12E-02 
YLR088W GAA1 0.532 2,19E-01 
YLR081W GAL2 0.197 2,11E-01 
YKR039W GAP1 0.401 1,45E-02 
YMR215W GAS3 0.47 7,04E-02 
YAL062W GDH3 0.258 9,57E-02 
YEL046C GLY1 0.433 1.92E-4 
YKR030W GMH1 0.73 3,98E-01 
YOR371C GPB1 0.463 3,83E-01 
YLL031C GPI13 0.625 1,50E-01 
YPL189W GUP2 0.478 6,93E-02 
YJL091C GWT1 0.401 4,15E-01 
YCL030C HIS4 0.595 3,22E-01 
YLR205C HMX1 0.61 6,43E-02 
YCR021C HSP30 0.235 4,64E-02 
YER039C HVG1 0.585 3,48E-01 
YFL011W HXT10 0.282 6,55E-03 
YOL156W HXT11 0.138 2,24E-01 
YIL170W HXT12 0.148 2.66E-5 
YIL171W HXT12 0.311 1,16E-02 
YMR011W HXT2 0.477 3,19E-01 
YJL214W HXT8 0.431 4,42E-01 
YJL077C ICS3 0.382 5,00E-02 
YMR195W ICY1 0.372 1,35E-02 
YOL103W ITR2 0.536 1,73E-01 
YLR347C KAP95 0.593 2,03E-01 
YHL003C LAG1 0.539 3.45E-4 
YJL062W LAS21 0.396 2.16E-5 
YNL268W LYP1 0.389 4,15E-01 
YKL029C MAE1 0.425 1,68E-01 
YGR289C MAL11 0.258 3,26E-02 
YBR298C MAL31 0.221 4,33E-01 
YER106W MAM1 0.252 3,77E-03 
YDL054C MCH1 0.454 1,98E-01 
YOL126C MDH2 0.497 3,96E-01 
YLR288C MEC3 0.685 3,66E-01 
YOR351C MEK1 0.156 9.11E-6 
YNL142W MEP2 0.329 2,36E-03 
YNL210W MER1 0.301 3,35E-01 
YLL061W MMP1 0.27 5,14E-02 
YJL186W MNN5 0.568 8.66E-5 
YHR120W MSH1 0.62 4,90E-02 
YFL003C MSH4 0.426 4.97E-4 
YMR023C MSS1 0.716 3,09E-01 
YGR257C MTM1 0.507 2,80E-01 
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YIR019C MUC1 0.315 1.03E-4 
YHL036W MUP3 0.458 6,00E-02 
YJL116C NCA3 0.422 2,80E-01 
YBL024W NCL1 0.533 2,17E-01 
YOL104C NDJ1 0.194 1,81E-01 
YKR104W NFT1 0.44 1,65E-01 
YIL164C NIT1 0.449 4,98E-01 
YOR310C NOP58 0.55 4,41E-01 
YDR488C PAC11 0.479 6,74E-02 
YKR097W PCK1 0.393 5,27E-02 
YGR087C PDC6 0.482 8,38E-02 
YIL013C PDR11 0.486 8,73E-02 
YHR185C PFS1 0.329 1.84E-4 
YCL004W PGS1 0.577 4,43E-02 
YKL043W PHD1 0.527 1,48E-02 
YMR006C PLB2 0.349 3,43E-02 
YOL011W PLB3 0.507 1,66E-01 
YCR024C-A PMP1 0.387 8,25E-02 
YEL017C-A PMP2 0.518 4,31E-01 
YOR321W PMT3 0.578 1,12E-01 
YJR143C PMT4 0.522 3,70E-01 
YCR014C POL4 0.582 3,33E-01 
YIL037C PRM2 0.441 1,73E-01 
YDL039C PRM7 0.381 1,71E-01 
YGL120C PRP43 0.509 3.03E-4 
YKR013W PRY2 0.487 4,90E-01 
YDL055C PSA1 0.57 1,70E-01 
YMR137C PSO2 0.659 4.31E-4 
YGL063W PUS2 0.305 8,12E-02 
YOR380W RDR1 0.509 6,70E-02 
YHL024W RIM4 0.371 1,48E-02 
YLL046C RNP1 0.373 2,35E-02 
YNL330C RPD3 0.595 2.03E-4 
YMR127C SAS2 0.628 1,43E-01 
YER147C SCC4 0.306 1,84E-02 
YMR305C SCW10 0.585 4.94E-4 
YGL056C SDS23 0.425 1,37E-02 
YER081W SER3 0.414 1,52E-01 
YJL105W Set-04 0.25 8.42E-6 
YJR095W SFC1 0.206 3,73E-03 
YIL099W SGA1 0.166 2,04E-02 
YBL031W SHE1 0.679 3,17E-01 
YER118C SHO1 0.613 1,74E-01 
YIL123W SIM1 0.384 1,26E-02 
YOR307C SLY41 0.604 3.6E-4 
YDL123W SNA4 0.578 2,68E-01 
YMR017W SPO20 0.262 2,42E-02 
YCR018C SRD1 0.542 3,48E-01 
YOR247W SRL1 0.388 6,34E-04 
YMR101C SRT1 0.548 8,79E-02 
YDR082W STN1 0.548 3,46E-01 
YGL022W STT3 0.624 3,65E-01 
YLR092W SUL2 0.546 1,45E-02 
YNL066W SUN4 0.56 2,85E-01 
YAR042W SWH1 0.381 4,32E-01 
YIL047C SYG1 0.486 1.2E-4 
YDR058C TGL2 0.572 7,77E-02 
YBR240C THI2 0.429 2,49E-01 
YLR234W TOP3 0.34 7,35E-02 
YLL028W TPO1 0.467 4,88E-03 
YGR138C TPO2 0.511 7,95E-03 
YHR070W TRM5 0.359 3,51E-02 
YML085C TUB1 0.463 3.84E-4 
YKR042W UTH1 0.348 1,52E-02 
YDR398W UTP5 0.63 6,19E-02 
YGL225W VRG4 0.461 4,81E-01 
YNL283C WSC2 0.638 6.59E-5 
YDR259C YAP6 0.643 3,58E-01 
YCR059C YIH1 0.65 2,75E-01 
YMR106C YKU80 0.62 3,56E-01 
YDR545W YRF1-1 0.343 1,54E-01 
YER190W YRF1-2 0.384 1,07E-01 
YGR296W YRF1-3 0.391 1,17E-01 
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Table 5 - Microarrays analysis results of polysomal fractions of 15 and 30 min acetic 
acid treated cells. 42 genes were found up-regulated (more than two fold) upon acetic 
acid treatment. 
 
Probe ID 
Gene 
symbol 
Fold 
change 
p-value 
YOR343C 0 2.903 0.0020 
YLR125W 0 2.191 2.98E-01 
YDL089W 0 2.739 7.30E-01 
YGR110W 0 2.163 6.45E-4 
YDR003W 0 2.119 2.44E-4 
YHL008C 0 2.724 0.0010 
YNL217W 0 2.323 2.58E-03 
YMR134W 0 2.029 5.95E-01 
YBR284W 0 2.045 0.0080 
YOR105W 0 2.671 3.36E-01 
YDL027C 0 2.962 3.60E-01 
YLR312C 0 3.596 0.0010 
YIR014W 0 5.396 4.96E-4 
YKL134C 40817 2.062 0.0030 
Q0080 AAP1 12.234 6.74E-01 
Q0050 AI1 6.807 0.0010 
Q0055 AI2 7.842 0.0040 
Q0085 ATP6 10.422 8.83E-01 
YCL064C CHA1 4.271 0.0030 
Q0250 COX2 7.447 3.60E-01 
Q0275 COX3 10.148 6.05E-01 
YLR436C ECM30 2.261 0.0020 
YFL041W FET5 2.476 0.0010 
YKR067W GPT2 2.608 4.44E-02 
YOR267C HRK1 2.154 0.0010 
YMR081C ISF1 2.329 0.0020 
YOR336W KRE5 2.665 9.64E-01 
YDR062W LCB2 2.849 9.94E-02 
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YNR008W LRO1 2.341 7.87E-02 
YOL060C MAM3 2.69 7.07E-01 
YDR194C MSS116 2.412 0.0020 
Q0130 OLI1 7.65 2.78E-01 
YMR257C PET111 2.105 3.74E-01 
YCL004W PGS1 2.424 1.55E-01 
YOL084W PHM7 2.475 0.0050 
YOL011W PLB3 2.968 1.02E-4 
YIL147C SLN1 2.163 4.37E-01 
YHR139C SPS100 10.534 1.74E-01 
YJL093C TOK1 2.161 3.84E-02 
YLR121C YPS3 2.428 0.0010 
YMR089C YTA12 2.485 0.0020 
YDR285W ZIP1 2.158 2.46E-01 
 
 
 
 
